THE “ATHLETIC HEART”: INSIGHTS FROM MODERN IMAGING TOOLS IN CAUCASIAN AND WEST AFRICAN ATHLETES. by Utomi, VS
1 
  
 
THE “ATHLETIC HEART”: INSIGHTS FROM MODERN IMAGING 
TOOLS IN CAUCASIAN AND WEST AFRICAN ATHLETES. 
 
Victor Segun Utomi 
 
 
A thesis submitted in partial fulfilment of the requirements of 
Liverpool John Moores University for the Degree of Doctor of 
Philosophy 
 
November 2014 
 
 i 
 
Director of Studies 
Professor Keith George PhD, FACSM, FECSS, FBASES 
Associate Dean for Scholarship, Research and Knowledge Transfer Faculty of Sciences Tom Reilly 
Building Liverpool John Moores University 
 
Second Supervisor 
Professor Greg Whyte 
Professor of Applied Sport & Exercise Sciences 
Research Institute for Sport & Exercise Sciences  
Liverpool John Moores University 
 
Third Supervisor 
Professor John Somauroo 
Honorary Research Fellow, Liverpool John Moores University  
& Consultant Cardiologist, Countess of Chester Hospital, Chester. 
 
 
 
 
ii 
  
Acknowledgements 
I would like to thank my Director of Studies, Professor Keith George for giving me the 
opportunity to engage in fantastic, novel research project. I have thoroughly enjoyed 
working with Keith and I could not have asked for more support and guidance from a DOS. I 
cannot thank you enough for the support you have given me to develop on a personal as 
well as professional level. Completing the PhD has given me the opportunity to continue to 
learn and has helped me grow as a research scientist. 
I would also like to thank my other supervisors, Prof Greg whyte, Prof John Somauroo and 
Dr David Oxborough for being a fantastic support network. Dave and John, many thanks for 
your massive technical support and sacrifices during our numerous field trips. 
I will also like to thank Prof Greg Atkinson, Prof Rob Shave, Prof Sanjay Sharma and Dr Nick 
Sculthorpe who gave support in so many ways. Also, my special thanks to the subjects who 
participated in this study and to my friends and colleagues at the PhD hub. 
Finally, I would like to give a very special thanks to my wonderful family – my fiancee Jacqui, 
my three musketeers Victor jr, Charles and Anthony for all their love, positive support and 
encouragement. This thesis is dedicated to my parents Mr Patrick Nweke Utomi (JP) and 
Mrs Sarah Adejoke Utomi, my late wife Esther Nma Utomi and all those individuals who 
have encouraged and believed in me. Once again, thank you and God bless you all.  
 
 
 
iii 
  
ABSTRACT  
A seminal study by Morganroth et al (1975) demonstrated a differential pattern of cardiac 
adaptation with prolonged exercise training; of eccentric pattern of left ventricular 
hypertrophy (LVH) in endurance trained athletes (ET) and concentric LVH in resistance 
trained athletes (RT). Specific inconsistencies related to the nature of any adaptation to RT; 
the value of new imaging technologies; the relative importance of scaling of cardiac data for 
differences in body size; the impact of training on the right ventricle (RV) and the fit of 
differential pattern of adaptation in athletes with Black ethnicity have driven the rationale 
for the studies included in this thesis.  
Study one employed meta-analysis techniques to critically evaluate the evidence base 
supporting or refuting that MH exists in elite male Caucasian ET & RT. Modern 
echocardiographic techniques were used to test whether a dichotomous LV and RV 
structural as well as global and regional functional adaptation was apparent in elite 
Caucasian ET & RT in studies 2 & 3. The final study (exploratory) was to characterize the 
athletic heart phenotype in a homogenous population of elite RT of West African origin 
(WRT) to provide new insight in relation to cardiac adaptation and ECG characteristics in 
non-Caucasian athlete groups. Allometric scaling approach was deployed to index LV and RV 
data for individual body variance in body size. 
The novel findings of this thesis; larger LV data in ET (LVMg: ET 232 (200 to 260), RT 220 
(205 to 234), CT 166 (145 to 186) but no concentric hypertrophy in RT within the meta-
analysis, predominance of normal geometry in male athletes (65% of ET and 95% of RT) and 
the lack of concentric pattern of hypertrophy in RT in a cross-sectional study; no RV 
adaptation in RT athletes (RVD1mm: ET 45 ± 5 (39 to 57), RT 40 ± 5 (32 to 51) CT 39 ± 4 (31 
to 45); no LV or RV adaptation in WRT athletes; the importance of appropriate scaling of 
cardiac parameters; provide a useful re-evaluation of concepts and models in the athletic 
heart literature. The findings have important implications for cardiovascular screening of 
athletes. 
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CHAPTER 1 
 
GENERAL INTRODUCTION 
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Athletes’ (derived from the Romanization of the Greek word - άθλητὴς, athlētēs) are 
individuals who participate in a sporting contest. Elite athletes are those operating at the 
highest levels of their sport who strive to achieve optimum performance.  Various 
adaptations may be observed in organ systems of athletes, in particular with the heart 
(Henschen, 1899, Shapiro, 1984, Morganroth et al., 1975, Maron and Pelliccia, 2006 ) that 
allows training and performance progression.  
The term ‘Athlete’s Heart’ (AH) is commonly used by the public, sporting community, 
physicians and research scientists to describe the physiological effects of long term athletic 
training on the heart. Clinical awareness of the AH came to light over a century ago 
(Bergmann, 1884, Henschen, 1899). Exercise training was found to be accompanied by 
hypertrophy of the heart, both in man (Henschen, 1899) and in experimental animals 
(Bergmann, 1884). Until the development of non-invasive imaging technologies, cardiac 
adaptation to exercise was identified by physical examination (Shapiro, 1987).   
The AH as initially described, included sinus bradycardia with often a soft systolic murmur of 
mitral regurgitation and audible 3rd and 4th heart sounds (Henschen, 1899).  Consequent to 
on-going technical developments it is currently believed that the AH represents a complex 
range of structural, functional and electrical adaptations to prolonged periods of training 
(Morganroth et al., 1975, Pelliccia et al., 1991, George et al., 1991, Naylor et al., 2008). The 
AH appears to be largely benign, but there have been specific concerns throughout the past 
150 years about over exertion and negative effects in the heart (Whyte et al., 2004b, George 
et al., 2012).  
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A landmark sports medicine study involving echocardiographic assessment of the left 
ventricle (LV) was undertaken by Morganroth et al (1975) in a small sample of highly trained 
endurance (15 swimmers and 15 long-distance runners), resistance-trained athletes (12 
wrestlers and 4 shot putters) and sedentary controls (15). Morganroth and colleagues used 
M-mode echocardiography, which was at its infancy in the mid 70’s, to describe two 
different morphological forms of the AH, often referred to as a dichotomous pattern of LV 
hypertrophy/geometry (Morganroth et al., 1975, Morganroth and Maron, 1977).   
Morganroth et al (1975) postulated that endurance or aerobic training (swimming, running) 
was associated with prolonged periods of high cardiac output and increased LV volume 
(preload) at end-diastole. The chronic adaptation to these repeated exercise bouts (isotonic) 
was an increase in LV volume at rest with minor but proportional changes in LV wall 
thickness. This has been termed eccentric hypertrophy (balanced increase in chamber and 
wall dimensions).  
Conversely, with repeated periods of high afterload (pressure overload) in resistance 
training (isometric - wrestlers, shot putters, and weight lifters), Morganroth and colleagues 
postulated that LV wall hypertrophied, with little or no change in LV dimension/volume. This 
was termed concentric hypertrophy i.e. a disproportionate increase in wall thickness 
(Morganroth and Maron, 1977, George et al., 1991, Naylor et al., 2008).   Morganroth’s 
cross-sectional observations were thus easily mapped differential haemodynamic loading 
during acute training (Grossman et al., 1975).  
This differential adaptation of the AH has been referred to as the ‘Morganroth’s hypotheses’ 
(MH) and has been widely adopted in textbooks, scientific papers and professional 
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guidelines (Lang et al., 2005, Rudski et al., 2010, Naylor et al., 2008), including the 26th 
Bethesda Conference: Recommendation for determining eligibility for competition in 
athletes with cardiovascular abnormalities (Mitchell et al., 1994). 
Despite the pervasive nature of the MH, continuous evaluation of both our understanding 
and application of the AH phenotype is clinically important (George et al., 1991, Fagard, 
1996, Pluim et al., 2000, Whyte et al., 2004a, Naylor et al., 2008). There have been specific 
concerns related to the nature of any adaptation to resistance training as work subsequent 
to Morganroth et al. (1975) has been inconsistent (Haykowsky et al., 2001, Naylor et al., 
2008).  Other issues pertinent to the MH are noteworthy. Specifically, the impact of training 
on the right ventricle (RV) and left atria (LA) is less clear although a recent studies from Italy 
and around the world have reignited the debate about how the RV responds to training 
(Oxborough et al., 2012b, D'Andrea et al., 2013).  
Part of the reason that the MH did not include the RV and LA is related to the technical 
difficulties associated with echocardiography in the 1970’s. ‘Ice-pick’ M-mode 
echocardiography used by Morganroth was in its infancy in the mid-1970s (Henry et al., 
1980). Most now recognize the technical limitations of M-mode echocardiography. Aside 
from the limited B-mode spatial resolution (1-2 mm) and M-mode axial resolution of 
approximately 0.5 mm (Henry et al., 1980, George et al., 1991, Lang et al., 2005, Mor-Avi et 
al., 2011), geometric assumptions for volume calculations were applied in estimating LV 
mass which can lead to significant prediction error (Lang et al., 2005, Naylor et al., 2008, 
Spence et al., 2011).   
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Recent developments in echocardiography have improved spatial resolution due to 
transducer technology and processing capabilities, and new studies continue to shed light 
on this field, especially in relation to elite resistance training. Also, new modes of imaging 
e.g. Tissue Doppler Imaging (TDI) and Speckle Tracking Echocardiography (STE) have 
developed our understanding of global and regional function in the AH.  The MH made no 
references to LV function and despite more recent studies assessing global and regional 
systolic and diastolic function in small groups of athletes, contradictory data still exist 
(Maron et al., 1993, Pelliccia et al., 1993, Scharhag et al., 2002, George et al., 2010, Spence 
et al., 2011). The emergence of tissue Doppler Imaging (TDI) and myocardial speckle tracking 
(to quantify strain, strain rates, rotation, rotation rates and twist) promise to grossly enrich 
scientific knowledge about the AH (Jenkins et al., 2006, Marwick, 2006, Mor-Avi et al., 
2011).  
Of emerging interest, as technology spreads globally, is the application of basic and 
advanced cardiovascular research tools (physical examination, history, ECG and ultrasound 
echocardiography) to describe the cardiac phenotype in athletes of different ethnicity 
(Lewis et al., 1989, Ekelund et al., 1990, Basavarajaiah et al., 2008, Rawlins et al., 2010, 
Sheikh et al., 2013). Current data suggests that the AH phenotype, as observed by ECG and 
echocardiogram, may be different in Black versus Caucasian athletes (Basavarajaiah et al., 
2008, Magalski et al., 2011, Rawlins et al., 2010, Papadakis et al., 2012, Sheikh et al., 2013).   
The development of an appropriate AH phenotype for use in cardiac screening, to diagnose 
the presence of diseases that promote the risk of sudden cardiac death, has been poorly 
observed and characterized in resident West African groups (Chandra et al., 2012).  This 
would be helped by fully describing the AH phenotype in these athletes. The rationale is that 
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the incidence of sudden cardiac death in Black athletes has been reported to be higher than 
in Caucasian athletes (Maron and Pelliccia, 2006 , Chandra et al., 2012).   
Intuitively, the lack of normative values of upper limits of quantitative ECG and 
echocardiographic data in West African athletes, coupled with the lack of established pre-
participation screening guidelines specific to this athlete group, indicates the specific 
rationale for detailed study of the AH in West African athletes. Finally, to date there is no 
clear knowledge of how different training stimuli would alter the AH phenotype in West 
African (WA) athletes and as such it is clear we need to develop knowledge in relation to the 
presentation of the AH phenotype in WA athletes.   
Finally, an another important concern in the interpretation of AH research is the association 
between body size and cardiac morphology (George et al., 2001). Most studies now 
recognise that potential differences in body size between athletes and sedentary subjects 
could alter cardiac data interpretation (Batterham et al., 1999) but the impact of body size 
and composition on the AH remains contentious. The use of simple ratio scaling is popular in 
the published literature despite the fact that a large number of cardiovascular variables 
relate to body size in a nonlinear fashion (Batterham et al., 1999, Dewey et al., 2008, George 
et al., 2001). Appropriate scaling in a re-evaluation of the MH will be unique. 
In summary, concerns and controversies in previous / contemporary works related to the 
AH drives the rationale for the following studies included in this thesis; a) A systematic 
review and meta-analysis of training mode, imaging modality and body size influences on 
the male AH, b) A comprehensive technical assessment of the left and right ventricles to 
determine AH phenotype, c) An assessment of the impact of resistance training on a 
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homogenous group of West African athletes. In order to develop our knowledge of the AH, 
this thesis will attempt to achieve the following aims and specifically test the stated 
hypothesis. We have linked these aims and hypothesis to four empirical studies included 
within this thesis. 
 
1.1 Aims 
The aims of this thesis are to; 
1) Critically evaluate the evidence base, supporting or refuting that Morganroth’s hypothesis 
exists in elite male Caucasian resistance and endurance trained athletes. 
2) Determine the structural, global and regional function of the LV in Caucasian resistance and 
endurance trained athletes using a cross sectional design with standard 2D, Doppler, tissue-
Doppler and speckle tracking echocardiography. 
3) Describe the structural, global and regional function of the RV in Caucasian resistance and 
endurance trained athletes using the above mentioned state-of-the-art echocardiographic 
assessment tools. 
4) Assess the impact of resistance training on cardiac structure, function and electrical 
conduction in male elite WA and Caucasian athletes. 
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1.2 Hypotheses 
1) I hypothesize that training mode, imaging modality and body size influence the morphology 
and function of the male AH in chapter 2. 
2) I hypothesize that LV structure and function will follow a dichotomous training specific 
adaptation in chapter 3.    
3) I hypothesize that global RV adaptation to exercise is mediated by training type and that 
scaling of RV data will alter specific direction and data interpretation in chapter4. 
4) I hypothesize that elite male West African resistance trained athletes will not present with a 
concentric AH pattern in chapter 5.  
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CHAPTER 2 
 
LITERATURE REVIEW 
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2.1 Background context: Historical perspectives of the Athlete’s Heart 
 
The heart, as a muscle, has the ability to respond to chronic training and the 
elevated demand for blood flow to the body during training and competition. In 
physiological terms, the structural response of the heart is largely a change in the size of the 
chambers and heart walls due to signalling events in the cardiac myocyte that lead to 
protein synthesis.  The exact mechanisms and signalling pathways are still debated but the 
outcome is that the heart has the potential to increase its size and efficiency when adapting 
to the increased load on the heart that occurs with exercise (George et al., 2011).  
Exercise remains one of the most popular and best studied models of physiologic 
cardiac adaptation. The study of cardiac adaptation to exercise really came to the fore over 
a century ago when Bergmann (1884) noted that wild animals had bigger hearts in 
proportion to their body size in comparison to their domestic counterparts. Similar 
observations have been made in exercised dogs versus untrained dogs, and migratory birds 
were also found to have bigger hearts (Pedoe, 2003).  
The ability of the human heart to adapt to endurance exercise was first documented 
in the nineteenth century by Henschen (1899). During a physical examination Henschen 
found, by percussion, “dullness” of the anterior chest wall in well-trained cross-country 
skiers suggesting a cardiac hypertrophy.  It was also noted that cross country skiers with 
bigger hearts did better in endurance events (Henschen, 1899). In association with 
suspected cardiac hypertrophy Henschen also observed reduced resting heart rates and 
presence of a 3rd and 4th heart sound on auscultation of the heart in the cross-country 
skiers. Consequently, the heart of an athlete became associated with functional, structural 
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and electrical differences compared to the normal or untrained heart. In the scientific 
literature, these observations have been popularised under the general term of the ‘athletic 
heart syndrome’ (Gott et al., 1968 , Morganroth and Maron, 1977, George et al., 1991).  
With the discovery of X-rays in 1895 by Wilhelm Conrad Roentgen the field of 
radiology was born and the first “imaging” studies of the athlete’s heart were produced 
(Blake and Larrabee, 1903, Bardeen, 1918, Gott et al., 1968). Cardiac hypertrophy can be 
demonstrated by X-ray but a major limitation remained in that only a silhouette of the heart 
is produced and this reduces effective interpretation of physiological and pathological 
adaptation.  
Numerous studies have shown that even when there were no differences between 
the athletic group and untrained subjects in physical findings, a relative increase in heart 
size on X-rays was more apparent in athletes (Gott et al., 1968, Ikäheimo et al., 1979, 
Assmus, 1995, Howell and Harden, 1996). Ikaheimo et al (1979) reported that 75% of 
endurance athletes and 20% of sprinters studied demonstrated a higher relative cardiac size 
on chest x-ray (p<0.02). It is important to note that results of x-ray are quite often 
challenging, difficult to interpret and cannot discriminate between specific/finite cardiac 
structures (Roeske et al., 1976, Peronnet et al., 1980, Rost, 1982).  
In tandem with evolving scientific understanding of the athlete’s heart was the 
observation that physiological adaptations of the heart to prolonged, intense physical 
training produced electrocardiographic (ECG) changes considered abnormal in untrained 
persons. Increased vagal tone, anatomical and / or chemical changes in the heart (Beswick 
and Jordan, 1961, Gott et al., 1968 , Ikaheimo et al., 1979) and recently, ethnicity 
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(Basavarajaiah et al., 2008, Magalski et al., 2008, Maron et al., 2009) were thought to cause 
a spectrum of ECG changes characteristic of the AH in professional athletes.  
The ECG changes associated with intense training are of interest because they are 
similar, and often difficult to differentiate from pathological ECG changes in certain disease 
states that can result in the sudden death of an athlete (Lichtman et al., 1973, Ferst and 
Chaitman, 1984, Cuspidi et al., 1996, Pelliccia et al., 2002, Corrado et al., 2003).  
Historically, it could be argued that the advent of ultrasound imaging was the 
greatest single radiological advance in the 20th century (Coleman et al., 1966, Haber, 1980). 
Though sonar technology has been around since 18th century (Donald, 1980, Haber, 1980), it 
was not until 1950 that Ian Donald, an Obstetrician in Glasgow, began to experiment with 
the use adapted industrial sonar equipment to examine the pregnant uterus (Donald, 1980, 
Haber, 1980, Oakley, 1986).  The importance of ultrasound lay in the fact that it made 
possible the examination of organs which had previously been completely inaccessible, or 
which had only been imperfectly visualised using complex invasive procedures (Feigenbaum, 
2001). Edler and Hertx (1954) were the first to publish the use of ultrasound for cardiac 
investigations i.e. echocardiography (Feigenbaum et al., 1968, Edler and Lindström, 2004).  
Cardiac ultrasound began with a single-crystal transducer display of the amplitude 
(A-mode) of reflected ultrasound waves versus depth on the oscilloscope screen (Troy et al., 
1972, Luisada et al., 1975).  Repeated pulse transmission and receive cycles allow rapid 
updating of the amplitude versus depth information so that rapidly moving structures such 
as aortic valve or mitral valve can be identified by their characteristic timing and pattern of 
motion  (Teichholz et al., 1976, Henry et al., 1980).  
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Whilst A-mode displays are limited to amplitude of reflected ultrasound waves at 
different depths, M–mode (motion) extended this by the inclusion of a temporal factor of 
time dimension explicitly on the horizontal axis. Each amplitude signal along the length of 
the ultrasound beam is converted to a corresponding grey scale level to produce a motion 
display on the oscilloscope. Because only a single ultrasound beam is included in an A-mode 
/ M-mode display, both techniques share an advantage of high sampling rate (1800 s-1) 
which is valuable for accurate evaluation of rapid normal intra-cardiac motion (Sahn et al., 
1974, Luisada et al., 1975).  
Morganroth and colleagues employed the “ice-pick” M-mode technique using an 
Aerotech gamma transducer (Aerotech laboratories, Division of Branson Instrument Co., 
Lewiston, Pennsylvania) available in the mid 70’s. The transducer was attached to a 
modified Ekoline 20A ultrasonic unit (Smith Kline Instrument Co., Philadelphia, 
Pennsylvania) with a signal component custom built video amplifier – Honeywell 1856 
Viscorder (Honeywell Co., Denver, Colarado). This study literally “opened the flood gates” 
for AH research with thousands of athlete’s research to date. These investigations enabled a 
detailed description of cardiac structure and function (George et al., 2011; 2012). Since then 
there has been significant technological advancements with improved spatial resolution of 
cardiac images as well as the development of new imaging modalities which will be 
described later. 
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2.2 The Morganroth Hypothesis (MH)   
Echocardiographic evidence of the cardiac adaptation to exercise has been reported 
since the mid-1970s.  A landmark assessment of the left ventricle (LV) was undertaken by 
Morganroth and colleagues (Morganroth et al., 1975) in a small sample of highly-trained 
endurance (15 swimmers and 15 long distance runners), resistance-trained athletes (12 
wrestlers and 4 shot putters) and sedentary controls (15). Mean LV end-diastolic diameter 
(LVIDd) (figure 2.1) and mass (figure 2.2) were increased in endurance athletes; swimmers 
56.6 ± 0.8 mm, 308g ± 9.3; runners 54.1 ± 0.9 mm, 302 g ± 9.0, compared to controls, 46.4 ± 
0.7 mm, 211g ± 7.7, wall thickness was normal (≤ 12mm) (figure 2.3). 
 
 
 
The Figure 2.1: Echocardiographically measured LV internal dimensions at end diastole in 
college athletes originally presented here cannot be made freely available via LJMU Digital 
Collections because of copyright reasons. The image was sourced at Morganroth et al 1975, 
page 52, http://annals.org/article.aspx?articleid=689311). 
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The Figure 2.2: Echocardiographically measured LV mass in college athletes, numbers 
represent mean values ± SEM. Data of swimmers and runners are statistically different from 
wrestlers and normal subjects (p < 0.001), originally presented here cannot be made freely 
available via LJMU Digital Collections because of copyright reasons. The image was sourced 
at Morganroth et al 1975, page 53, http://annals.org/article.aspx?articleid=689311). 
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The Figure 2.3: Echocardiographically measured LV free wall thickness (upper panel) and 
septal wall thickness (mm) in college athletes, numbers represent mean values ± SEM. Data 
of swimmers and runners are statistically different from wrestlers and normal subjects (p < 
0.001), originally presented here cannot be made freely available via LJMU Digital 
Collections because of copyright reasons. The image was sourced at Morganroth et al 1975, 
page 53, http://annals.org/article.aspx?articleid=689311). 
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Resistance trained athletes (college wrestlers, world class short-putters) had normal mean 
LVEDV (110ml, 122ml), but increased wall thickness (13 mm, 14mm) and mass (330g, 348g). 
Thus endurance trained athletes demonstrated an increased left ventricular mass with 
cardiac geometry similar to chronic overload states e.g. mitral regurgitation. The resistance 
trained athletes had increased LV mass with cardiac geometry similar to those in pressure 
overload e.g. aortic stenosis. Despite limited details related to training-related 
haemodynamic loading on the LV, a dichotomous morphology was observed with an 
eccentric hypertrophy - (balanced increase in chamber and wall dimensions) in endurance 
athletes versus a concentric hypertrophy (disproportionate increase in wall thickness) in 
resistance athletes. It was hypothesised that these adaptations reflect differential 
haemodynamic loading during acute training (Grossman et al., 1975).  
This differential adaptation of the athlete’s heart (AH) has been referred to as the 
“Morganroth Hypothesis” (Morganroth et al., 1975, George et al., 1991, George et al., 1995) 
and has been widely adopted in textbooks, scientific papers and professional guidelines 
(Rudski et al., 2010) including the 26th Bethesda Conference: Recommendation for 
cardiovascular screening among athletes (Maron et al., 1994a). 
The reason for the broad adoption of the MH is that it made teleological sense.  In 
endurance sports the AH, including chamber enlargement, allow an increased maximal 
stroke volume (SV) and cardiac output (CO) and thus blood flow, and oxygen delivery, to the 
skeletal muscles which is vital to maintain exercise. This adaptation also underpins the 
increase in maximal oxygen delivery to meet the expanded metabolic needs of the trained 
state since no training effect is evident at maximal heart rate (HRmax) (Blomqvist and Saltin, 
1983, Whyte et al., 2008). 
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Endurance sports is characterised by rhythmic contraction and shortening of large muscle 
group i.e. dynamic exercise activity (isotonic) which subjects the LV to repetitive increase in 
cardiac preload (Schaible and Scheuer, 1985) e.g. running. In endurance athletes, the 
myocardium remodels proportionately in cavity dimension and wall thickness to normalise 
end-diastolic wall stress.  
In contrast, resistance exercise has been categorised as predominantly involving static 
muscle contraction at high force/power levels with very limited joint and muscle group 
movements  (isometric) e.g. wrestling and weight lifting (Mitchell and Wildenthal, 1974). It 
is thought that the repetitive increase in skeletal muscle tension results in increased 
peripheral vascular resistance that results in a potentially vast increase in systemic arterial 
blood pressure and  afterload on the LV (MacDougall et al., 1985).  This results in cell 
signalling and adaptation that manifests as a disproportionate increase in LV wall thickness 
with little or no effect on cavity dimension.  This increase in wall thickness serves to 
normalise the increase in end-systolic wall stress associated with the rise in arterial pressure 
and LV afterload (Mitchell and Wildenthal, 1974, Morganroth and Maron, 1977, MacDougall 
et al., 1985, Lentini et al., 1993). 
In the context of the Law of La Place, the Morganroth schema is logical. An increase in 
preload or afterload can be normalised by chamber and/or wall adaptation (Sandler and 
Dodge, 1963, Moriarty, 1980). Empirical studies have demonstrated a strong correlation 
between sub maximal exercise systolic blood pressure (BP) and LV mass (LVM) in humans 
[r=0.88, p < 0.05] (Douglas et al., 1986) and in animals [r = 0.71, P < 0.02] (Muntz et al., 
1981). This suggests a tight coupling of exercise haemodynamics, cardiac adaptation 
signalling and a hypertrophic response. Specific concerns with study design and the 
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methodology employed by the seminal study of Morganroth will be evaluated in the 
following sections. 
Despite the pervasive nature of the MH there are pertinent methodological concerns with 
conduct of this seminal study that are worthy of contiuing (re)evaluation. Firstly, the study 
subjects were not completely homogenous (97% Caucasians) although homoegeneity in age 
[18 to 24 years] limits the impact of accumulated years of training on the AH and may not 
reflect the reality of range of age in real life sports competitions.   
Secondly, though no subject was known to be on any pharmacological agent, there is 
anecdotal evidence of unregulated use of metabolic supplements and anabolic drugs for 
muscle building to improve performance in mostly resistance trained athletes in the 70’s  
(Salva, 1987, Sjöqvist et al., 2008). In a CMR (Cardiac Magnetic Resonance) study of 156 
male subjects (52 resistance athletes, 52 endurance athletes and 52 controls), Lujikx et al 
(2013) reported that RT who used anabolic steroids demonstrated significantly different 
cardiac dimensions, biventricular systolic dysfunction and impaired ventricular inflow as 
compared to non-athletes and non-anabolic steroid using athletes (Luijkx et al., 2013).  
The use of anabolic agents also raises another relevant issue; that of disparate or variation 
in body size. In the work of Luijkx et al (2013) there was a severe disparity in BSA of world 
class runners (1.82 ± 0.4) vs shot putters (2.52 ± 0.03 m2). Interestingly, the authors did not 
observe a statistically significant difference in cardiac parameters between the results of any 
set of data corrected to BSA; hence all data were presented as absolute values.  
Given that body organs do not relate to size and weight in a log linear fashion, the 
complexity of the influence of body size and composition on  cardiac dimension has been 
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demonstrated in a number of empirical studies (De Simone et al., 1992, George et al., 1998, 
Oxborough et al., 2012b) and has been highlighted in review articles (Batterham et al., 2008, 
Dewey et al., 2008). More so, appropriate scaling is known to alter data interpretation in a 
small number of previous studies (George et al., 1999, Oxborough et al., 2012b). The 
deployment of appropriate scaling model to re-evaluate the MH in on-going research is 
vital. 
Finally, Morganroth et al (1975) obtained echocardiograms with Aerotech gamma 
transducers (Aerotech Laboratories, Division of Branson Instrument Co., Lewistown, 
Pennsylvania) and a modified Ekoline 20A ultrasonic unit. ‘Ice pick’ T-scan technique was 
used to visualise the interventricular septum (IVS) and the posterior basal LV wall (Henry et 
al., 1973). LVEDV was estimated at end diastole using the method of Feigenbaum et al 
(1972). LV mass was calculated from the echocardiographic measurement methods of Troy, 
Pombo and Rackey (1972).  
Aside from the limited resolution of M-mode echocardiography in the mid 70’s, it is 
interesting to note Troy et al’s method of calculation of LV mass was derived from a cross-
sectional study that validated echocardiogram against angiography in 24 patients with 
valvular and/or myocardial disease. An arbitrary correction factor of 1.047 and 1.05 were 
added to the formulae for LVEDV and LV mass (Feigenbaum et al., 1968, Troy et al., 1972) 
and current professional guidance has largely superceded the work and analysis processes 
adopted by Morganroth and colleagues. 
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2.3 Contemporary evaluation of Morganroth’s Hypothesis  
Whilst the conceptual framework of cardiac adaptation to exercise based on MH has 
been dominant for many decades, contradictory evidence exists (Fagard, 1996, George et 
al., 1991, Haykowsky et al., 2001, Pluim et al., 2000, Whyte et al., 2004a) and often relates 
to the methodological issues raised above. Numerous, usually small studies have 
undertaken echocardiographic examinations in athletes and compared the results with 
those of sedentary control subjects who are non-athletes. A PubMed MESH search of 
‘athlete’s heart’ post 1975 gave over 3000 hits. Consequently, a plethora of original AH 
research papers, supplemented by numerous reviews (George et al., 1991, Naylor et al., 
2008) and meta-analysis (Fagard, 1996, Pluim et al., 2000, Whyte et al., 2004a) provide 
analysis demonstrating no, partial or total support of the MH.  
Specifically, Fagard et al (1996) tested the hypothesis of divergent cardiac adaptation 
to different sports by applying meta-analytical techniques to published echocardiographic 
data on competitive male long distance runners, cyclists, and resistance athletes (135 
athletes, 173 controls). Athletes had lower heart rate, larger LV internal diameter (LVID) and 
wall thickness. The calculated LV mass was larger in athletes by 67g or 48% (p < 0.001). 
Relative wall thickness (RWT), i.e. the ratio between wall thickness and LV internal diameter 
(LVID), was slightly but significantly higher in runners than in controls (p < 0.05) (Fagard, 
1996).  Contrary to the MH, the increase in wall thickness was pronounced in the runners 
who have generally been considered to demonstrate pure eccentric LV hypertrophy (LVH). 
Secondly, the value of LV septal wall thickness of the runners fell within normal limits.   
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The resistance component of Fagard et al’s study included 178 athletes (42 weight or 
power lifters, 40 body builders, 50 wrestlers, 25 throwers, and 21 bobsledders) and 105 age, 
size and sex matched controls. LVID, wall thickness and LV mass were all larger in the 
resistance athletes group (RWT > 12%; p < 0.05). Despite this there was no convincing 
evidence of an isolated increase in septal or posterior wall ratio in resistance athletes, but 
rather a relative pattern of LV hypertrophy (Fagard, 1996). These results contribute to the 
controversy over the MH. 
A few years later, and in an attempt to shed more light on the interpretation of the 
AH with a larger sample size, Pluim et al (2000) incorporated 59 echocardiographic studies 
involving 1451 male athletes. The study participants were endurance trained (413 runners), 
combined endurance 494 (cycling and rowing), resistance trained 544 (weight lifting, power 
lifting, body building, throwing and wrestling), and 813 control subjects aged between 18-40 
years (Pluim et al., 2000). The authors reported that overall mean relative wall thickness 
(RWT) of control subjects (0.36) was significantly smaller than that of ET (0.39, p = 0.001), 
combined endurance + resistance trained athletes (0.40, p = 0.001) or resistance trained 
athletes (0.44, p = 0.001).  LVIDd, inter ventricular septal wall thickness (IVSWT) and 
posterior wall thickness (PWT) were higher in athletes than controls.  The results of Pluim et 
al’s meta-analysis provide some support for the MH, with an intermediate form of LV 
hypertrophy in those sports with combined components (Pluim et al., 2000). 
Previous studies and meta-analysis have focused mostly on investigating the AH in 
male athletes and with conflicting outcomes related to the MH (Fagard, 1996, Pluim et al., 
2000). Whyte et al (2004a) applied meta-analytical techniques to 13 published 
echocardiographic studies between 1987 – 2000 examining cardiac structure and function in 
female athlete (Whyte et al., 2004a). Their study group included 890 athletes and 333 
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control subjects of which 227 were strength and sprint athletes, 442 were endurance 
athletes and 168 team game players. The authors reported that significant (p < 0.05) 
differences existed between sporting groups for LVID and LV mass only, with ET and team 
games demonstrating the larger effect size when compared to strength athletes.  No 
significant effect of training was observed for LV function with exception of stroke volume 
(SV) – athletes > controls ( p < 0.05) with no observed difference between sporting groups 
(Whyte et al., 2004a). The results of this meta-analysis offered little support for MH of a 
differential cardiac remodelling relating to sporting discipline.  
The variance in individual studies and meta-analysis is worthy of some reflection and 
assessment of technical issues. Given that different researchers employ different 
measurement techniques (Figure 2.4) and formulae for the calculation of cardiac 
parameters, it is not unlikely that the lack of clear standardised guidelines for much of the 
last 40 years may partially contribute to inconsistencies in echocardiographic measurements 
and lack of consensus in previous work.  
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The Figure 2.4: Methods for echocardiographic measurement of inter-ventricular septal 
thickness (IVSWT), LV internal dimension (LVID) and posterior wall thickness (PWT). Panel A) 
The standard measurement convention includes the thickness of the right and left septal 
endocardial echoes in IVSWT and includes the posterior wall endocardial echoes in PWT. 
Panel B) The Penn Convention excludes right and left septal endocardial echo thickness from 
IVSWT and excludes the posterior wall endocardial echoes from PWT. Left septal 
endocardial echo thickness and posterior wall endocardial thickness are thus included in the 
LVID by this method originally presented here cannot be made freely available via LJMU 
Digital Collections because of copyright reasons. The image was sourced at Devereux et al 
1977, page 614 http://circ.ahajournals.org/content/55/4/613.full.pdf+html. 
For instance, some researchers may include (Paterson et al 2006) or exclude (Esch et 
al 2010) the papillary muscles in their methods of cardiac assessments. LV mass can be 
derived from multiple equations and measurements of IVSWT, PWT and LVID with different 
geometric assumptions using various methods: Troy et al (1972) method - Morganroth et al 
(1975), Cahill et al (1979), Hauser et al (1985,) Vos et al (1985); or Schiller and Bird (1983) 
method  - Gregorie et al (1989); or Devereaux and Reichek (1986) method –  George et al 
(1999), D’ Andrea et al (2003); or Teichloz method – Indermule et al (2009); or Feigenbaum 
IVSW
T 
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method – Brown et al (1987); or Benneth and Evans (1994) method – Nishimura et al 
(1981); or Cubed function method – Bekaert et al (1981); or cross sectional area method – 
Selpulveda et al (1989); or Wyatt method – Giada et al (1998); or Simpsons biplane method 
– Caselli et al (2008); Area length method by Helak and Reichek (1981) – Pelliccia et al 
(2000); Reichek method – Pluim et al (1997); ASE method – Oxborough et al (2012), La 
Gerche et al (2012). There are significant differences in results obtained by different 
measurements techniques and mathematical assumptions in deriving formulae and 
algorithms for the calculation of cardiac parameters. These differences should be taken into 
account to limit heterogeneity in any propsective study or meta-analysis.  
A smaller number of recent works have used cardiac magnetic resonance imaging 
(CMR; De Castro et al 2006, Prakken et al 20011) or a combination of echocardiography and 
CMR (Petersen et al 2005, Scharhag et al 2010, La Gerche et al 2011, Armstrong et al 2012) 
with significant difference being noted between the two imaging modalities (Bellenger et 
al., 2003, Prakken et al., 2011b, Armstrong et al., 2012).  Whilst CMR has now become the 
gold standard for cardiac structural measurement it is still expensive and has made only a 
limited penetration into the AH field. Despite this some reflection on CMR data is warranted 
in any new meta-analysis. 
Because of the contentious nature of data related to LV morphology and function in 
small case series reports in the published literature, the American Society of 
Echocardiography (ASE), working together with the European Association of 
Echocardiography, a branch of the European Society of Cardiology, has critically reviewed 
the literature and updated the recommendations for quantifying cardiac chambers using 
echocardiography (Lang et al., 2005). Forteen years of new data with new technical 
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guidelines, inconsistencies in previous studies and meta-analysis, the developing role of 
CMR and a growing knowledge base related to scaling of data (none of the previous meta 
analyses have analysed scaled data) suggest that it is important to re-visit the AH data base 
to ascertain the veracity of MH in a modern meta-analysis. 
Whilst a number of meta-analyses have been produced targetted at understanding 
the AH, original research studies continue to be produced and often provoke new technical 
issues or specific hypotheses. Recent investigations in clearly distinct athlete groups with 
similar accumulated years of training stimuli have reported AH data partially in support  
(Maron and Pelliccia, 2006, Pelliccia et al., 2010, D'Andrea et al., 2013, Baggish et al., 2008) 
or refuting (Haykowsky et al., 2002, George et al., 2011, Oxborough et al., 2012b, Spence et 
al., 2011) the MH. Of specific interest are the large database studies from Italy. Previous 
reports by Pelliccia et al (1993) in 100 resistance trained athletes demonstrated that no 
athlete showed a maximal absolute LV wall thickness that exceeded the generally accepted 
upper limits of normal [i.e., 12 mm; (Pelliccia et al., 1993)]. However, when compared with 
26 normal sedentary control subjects, there was partial support for a concentric LVH in that 
LVID and LV mass was similar in both groups but maximal septal thickness was mildly but 
significantly greater in athletes (9.6 ± 0.6 vs 9.0 ± 0.5 mm; p < 0.001), as was the calculated 
LV mass index (96 ± 12 vs 61 ± 6 g/m; p < 0.001). Also, LVID was similar in athletes and 
controls (55 ± 4 and 54 ± 3, respectively; p > 0.05) (Pelliccia et al., 1993). 
Of recent interest has been a small number of longitudianal studies which do not 
suffer from the same extent of selection bias and unknown factors (i.e. genetics) influencing 
cardiac structure and function. Not surprisingly the two most cited training studies have 
presented differential outcomes. Baggish et al (2008) performed a 90 days longitudinal 
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study of 40 endurance and 24 resistance-trained athletes, and reported that LV mass 
increased by 11% in the endurance (116 ± 18 vs. 130 ± 19 g/m2; P < 0.001) and by 12% in 
resistance athlete (115 ± 14 vs. 132 ± 11 g/m2; P < 0.001). The endurance trained 
experienced LVID dilation (66.6 ± 10.0 vs. 74.7 ± 9.8 ml/m2, P < 0.001) while resistance 
trained athletes presented with greater PWT 4.5 ± 0.5 vs. 5.2 ± 0.5 mm/m2 (p < 0.001) after 
training. The authors concluded that the endurance athletes demonstrated an eccentric LVH 
adaptation whereas the resistance trained athletes demonstrated an isolated concentric 
LVH adaptation (Baggish et al., 2008) that mirrored and outcome predicted by the MH.   
A recent CMR study by Spence et al (2011) contradicted both Baggish et al (2008) 
and the MH. Spence et al (2011) completed a longitudinal CMR study in young (27.4 ± 1.1 
years) untrained male subjects who were randomly assigned to  supervised, intensive, 
endurance (n = 10) or resistance (n = 13) exercise. CMR scans, 2D standard 
echocardiography and myocardial speckle tracking echocardiography were performed at 
baseline, after 6 months of training and after a subsequent 6 weeks of detraining.  
The authors reported that CMR derived left ventricular (LV) mass increased 
significantly following endurance training (112.5 ± 7.3 to 121.8 ± 6.6 g, P < 0.01) but not with 
resistance training, whilst training increased LV end-diastolic volume (LVEDV) to a greater 
extent with endurance training: + 9.0 ± 5.0 vs. resistance training + 3.1 ± 3.6 ml, P = 0.05). 
IVSWT significantly increased with endurance-training (1.06 ± 0.0 to 1.14 ± 0.06, P < 0.05) 
but not with resistance-training. Longitudinal strain and strain rates did not change 
following either form of exercise training (Spence et al., 2011). 
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In the scientific literature, there is a comparatively small number of 
echocardiographic research on the right ventricle (RV) in athletes (Vos et al., 1985, Schattke 
et al., 2012). A MESH search of PubMed with key words ‘right ventricle’ and ‘athlete’s heart’ 
yielded less than 500 hits. This is partially because earlier investigators found assessment of 
the morphology and functional properties of the RV to be problematic (Ho and 
Nihoyannopoulos, 2006) due to its crescent shape wrapped around the LV, a lack of 
uniformity, excess trabeculation, and a separate infundibulum (Levine et al., 1984, Foale et 
al., 1986).   
It is not surprising, therefore, that the seminal work of Morganroth et al (1975) did 
not assess the RV. Consequently, whether the RV demonstrates a training dependent AH 
phenotype has received less attention.  Technological advancements of modern imaging 
techniques, with greater access to structural and functional data from the RV and left atrium 
(LA) (Mor-Avi et al., 2008, Rudski et al., 2010, Prakken et al., 2010) have resulted in the 
establishment of standardised assessment protocols for the RV (Lang et al., 2005, Rudski et 
al., 2010).  
A limited number of studies have demonstrated greater RV structural parameters in 
endurance athletes compared to controls (Baggish et al., 2008, Teske et al., 2009b, D'Andrea 
et al., 2013). In a cross sectional study, Teske et al (2009) evaluated RV dimension and 
echocardiographic tissue deformation imaging parameters in 61 non-athletes, 58 non-elite 
athletes and 63 elite athletes and reported that RV dimensions were significantly increased 
(P < 0.001) in both groups of athletes compared with controls.  
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Similar to work by D’ Andrea et al (2003) RV systolic velocities and displacement 
were not different between the groups (D'Andrea et al., 2003, Teske et al., 2009b). D’ 
Andrea et al (2003) was one of the few studies to look at athletes with divergent training 
emphasis when assessing 32 endurance (long distance swimmers) and 26 sprint athletes 
(short distance swimmers) and reported that though LV mass index did not differ between 
the 2 groups. RV end-diastolic diameter was significantly larger in the endurance focussed 
swimmers (p < 0.001) and TDI parameters (LV and RV) were higher values in the endurance 
group (D'Andrea et al., 2003).  This hardly fits the true divergent training background 
observed in the Morganroth study and there is surprisingly little RV data reported in elite 
resistance-trained athletes.  
In summary of this section there are some specific directives for the content of this 
thesis. It is important to conduct a new inclusive (echocardiography and CMR datasets) 
systematic review and meta-analysis of published AH studies from 1975 to date to re-visit 
the MH and most importantly to gain new insight in our understanding of the AH 
phenotype. The impact of body size scaling must be addressed in any meta-analysis. There is 
still the requirement for more prospective studies of athletes vs. controls, especially when 
one consider previous contradictory data, the newly developed echocardiogrpahic tools 
now available and, again, the issue of scaling should be integrated appropriately. These 
prospective studies should move beyond the LV and the caucasian athlete.  
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2.4 Contemporary technical developments in Echocardiogrpahy 
As detailed earlier, echocardiography utilises ultrasound to image the heart and 
great vessels. Early developments of echocardiography provided amplitude-mode (A-mode 
more latterly referred to as M-mode) technique as was used in the seminal study of 
Morganroth et al (1975). Over time, and due to significant advances in technology and 
scientific evidence, echocardiography has gained a wide acceptance in the assessment of 
cardiac patients (Cheitlin et al., 2003) as well as in the world of sports cardiology and the 
assessment of the AH. “Traditional” echocardiographic tools for the assessment of LV and 
RV are detailed in appendix – 9.1, 9.2, 9.3. Because of the contentious nature of data related 
to LV morphology and function in small case series reports in the published literature, new 
echocardiographic measurement guidelines from expert consensus panels are  currently 
available (Lang et al., 2005, Mor-Avi et al., 2011, Rudski et al., 2010).  
Additionally, a number of new technologies have emerged to address image quality, 
accurate quantitative / qualitative assessments and inter observer variability in 
measurements and interpretations of cardiac data. Two such technologies have dominated 
the research arena of echocardiography a) Doppler based tissue velocity measurements, 
and b) speckle tracking echocardiography (STE) on the basis of displacements (Mor-Avi et 
al., 2011). Guided by these expert consensus guidelines, upper limits of physiological cardiac 
adaptations have been assessed in highly trained athletes (Naylor et al., 2008, George et al., 
2011, Oxborough et al., 2012b, Spence et al., 2011).   
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2.5 Tissue-Doppler Velocity Imaging      
Tissue-Doppler echocardiography is based on the interrogation of high amplitude 
and low velocity reflected ultrasound signals from the myocardium Doppler signals from an 
echocardiographic region of interest (ROI). Tissue-Doppler velocity imaging applies different 
threshold algorithms using high/low pass filters to display myocardial velocities (Sutherland 
et al., 1999) and consequently can record both systolic and diastolic velocities within the 
myocardium (Figure 2.5) (Naguehet al., 1997, D’Andre et al., 2010). The velocity data can be 
obtained during pulsed- (Isaaz et al., 1989) and colour-Doppler techniques (McDicken et al., 
1992). Miyatake et al (1995) and Sutherland et al (1994) confirmed the clinical feasibility of 
TDI by demonstrating the potential for quantifying regional myocardial function (Sutherland 
et al., 1994, Miyatake et al., 1995).  
For instance, the assessment of myocardial function in the longitudinal plane has 
been documented to be more sensitive to discrete pathological changes (Price et al., 2000) 
primarily because longitudinal functional impairment precedes circumferential dysfunction 
(Vinereanu et al., 2001, Mädler et al., 2003). Numerous studies have reported that 
longitudinal plane excursion is directly related to global LV and RV function and important in 
assessing pathology (Kaul et al., 1984, Simonson and Schiller, 1989, Hammarström et al., 
1991, Mädler et al., 2003, Yu et al., 2007).  
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The image of Figure 2.5: Echocardiographic evaluation of athlete’s heart in an endurance 
trained athletes. (A) Standard echocardiography, apical four-chamber view: LV. (B) Trans-
mitral flow pattern: high early diastolic wave - E. (C) Pulsed tissue Doppler pattern: 
increased early diastolic myocardial velocity - E’. (D) Two-dimensional strain: normal 
myocardial longitudinal deformation originally presented here cannot be made freely 
available via LJMU Digital Collections because of copyright reasons. The image was sourced 
at D’ Andrea et al 2010, page 496 - http://www.ncbi.nlm.nih.gov/pubmed/20551250. 
One attraction of tissue Doppler velocity imaging (TDI) is that it can scan information 
obtained from echoes generated by a rapid succession of transmitted pulses in a single 
direction. With ease of alignment of longitudinal shortening with the ultrasound beam, TDI 
is less reliant on 2D image quality  and has a good reproducibility (Fleming et al., 1994, 
Ommen et al., 2000). Because TDI is dependent on angle of isonation, there is a limitation to 
discrete regions of the inter-ventricular septum (IVS) and posterior wall of the ventricles as  
 33 
  
well as the detrimental effects of translation, rotation and tethering of adjacent myocardial 
segments which can affect the accuracy of data (D'hooge et al., 2000, Sutherland et al., 
2004). 
TDI has been reported to be more load dependent (Sohn et al., 1997, Frommelt, 
1999) than originally proposed (Dumesnil et al., 2002, Andersen et al., 2004, Hart et al., 
2007). A surrogate of the ratio of early diastolic tissue velocity (E’) and late diastolic 
myocardial tissue velocity (A’) defined as E’/A’ was reported to be load–independent (Pelà 
et al., 2004) but this has been questioned during volume shifts associated with 
haemodialysis (Oğuzhan et al., 2005). Based on the principle that E’ is a more sensitive 
measure of LV relaxation and less influenced by left atrial (LA) pressure, Nagueh et al (1997) 
proposed E/E’ was as a surrogate of left atrial (LA) pressure which correlated with invasive 
measure of pulmonary wedge pressure in patients with diastolic dysfunction (Nagueh et al., 
1997). 
Numerous AH studies (Fagard et al., 1989, Caso et al., 2000, D'Andrea et al., 2002, 
Koc et al., 2007, Vinereanu et al., 2002, Florescu et al., 2010), and previous meta-analysis 
(Fagard, 1996) have reported that LV long-axis diastolic function is augmented in the hearts 
of endurance-trained compared with strength-trained athletes. Controversy exists in that 
some other studies (Pluim et al., 1999, Schannwell et al., 2002)  and meta-analysis (Pluim et 
al., 2000) found LV diastolic function to be similar in athletes and controls, whilst the most 
recent meta-analysis by Whyte et al (2004) reported enhanced stroke volume in athletes 
(Whyte et al., 2004a).  
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Emperical studies have demonstrated the clinical utility of Tissue Doppler indices as 
a non-invasive techniques for evaluating LV relaxation and estimation of filling pressures (Ha 
et al., 2004, Klein et al., 1994, Nagueh et al., 1997, Nagueh et al., 2009, Ruan et al., 2006). 
Disparate findings of normal LV relaxation (Firstenberg et al., 2000, González-Vilchez et al., 
2002) and decompensated heart failure patients (Mullens et al., 2009) warrants further 
research in select athlete groups to investigate whether training stimuli influences TDI 
derived functional parameters.  
2.6 Tissue-Doppler Strain Imaging        
Derived from colour Doppler technique, colour Doppler myocardial imaging is a relatively 
new technique that can resolve all mean velocities along its image lines (Sutherland et al., 
1994). One important attraction is the provision of a raw dataset for offline analysis, 
allowing samples to be placed on a region of interest (ROI) on the myocardium. By vector 
principles, a better description of regional myocardial function can be given by determining 
local deformation characteristics i.e. thickening and thinning or contraction and 
lengthening. The optimal regional myocardial function dataset defines deformation 
characteristics (Figure 2.6). Whereas grey scale M-mode provide unidirectional data for a 
limited ROI, tissue-Doppler strain imaging deformation characteristics of myocardial strain 
(ԑ) and strain rate (SR) are three-dimensional (3D) (D'hooge et al., 2000).    
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Figure 2.6: An examplar scan from a colour tissue-Doppler assessment of regional wall strain 
and strain rate in the apical four-chamber view (note the apical LV view and longitudinal 
tissue strain traces measured in the septal and free wall at the mid-wall level). 
 
Myocardial ԑ is a dimensionless quantity that defines the % change in deformation i.e. 
myocardial lengthening or shortening rather than movement as depicted by velocity data 
(Heimdal et al., 1998, Sutherland et al., 2004). Taken together, the rate of deformation per 
second, defined as SR, and ε have been reported to be an objective estimate of myocardial 
contractility and relaxation (Fleming et al., 1994, Yip et al., 2003). SR appears to correlate 
with rate of change in pressure (dP/dT) whereas ԑ correlates with regional EF (Marwick, 
2006). Following a combination of in vitro – phantoms (Heimdal et al., 1998) and in vivo 
ultrasonic crystal (Urheim et al., 2000) validity studies, a good correlation between TDI and 
CMR derived ԑ has been reported (Edvardsen et al., 2002, Amundsen et al., 2006). 
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Unlike tissue-Doppler velocities, ԑ is independent of motion artefacts from translation and 
tethering, however the quality of ԑ data is dependent on the underlining tissue velocity and 
therefore sensitive to noise and angle of isonation. Importantly, ԑ Values are less related to 
preload and after load (Andersen et al., 2004, Marwick, 2006, Yu et al., 2007). Regional 
systolic RV function could be estimated using TDI and has been used to demonstrate 
functional differences in athletes as compared with control subjects. Teske et al (2009) 
examined 180 individuals (61 healthy controls; 58 athletes and 63 elite endurance athletes) 
and demonstrated that LV and RV dimensions were significantly increased (p < 0.001) in 
both group of athletes compared with controls, however RV systolic velocities were not 
different between groups (Teske et al., 2009b).         
Similary, Pagourelias et al (2013) obsereved that different training modes induced different 
morphologic patterns, leading to greater RV dilatation in ET, with no significant diffences 
concerning TDI functional parameters between athlete groups and controls. Poulsen et al 
(2007) found comparable and normal longitudinal LV systolic function in a cross sectional 
study of 17 male ET, 15 male resistance athletes and 12 male controls (Poulsen et al., 2007). 
However, other studies have reported that regional systolic RV function estimated using TDI 
could be used to demonstrate functional differences in athletes as compared with control 
subjects (D'Andrea et al., 2003, Prakken et al., 2010). Baggish et al (2008) documented the 
relationship between competition level and RV parameters in a population of 40 athletes 
and found a significant enhancement of both RV systolic and diastolic function by TDI 
(Baggish et al., 2008). The physiological mechanism that underpins these various outcomes 
remains an area of considerable debate and warrants further investigations.   
 
 37 
  
  2.7 Myocardial Speckle Tracking Echocardiography: The Left Ventricle 
Speckle tracking is an echocardiographic method based on the tracking of characteristic 
speckle patterns created by constructive and destructive interference of ultrasound back 
scattered by structures smaller than the wavelength of the ultrasound beam in the 
myocardium (Amundsen et al., 2006, Mor-Avi et al., 2011). STE is an offline technique that is 
applied to previously acquired 2 D image files. The technique involves the use of speckle 
tracking algorithm that tracks the uniform motion of a speckle generating object (kernels). 
STE is angle independent and can assess radial, circumferential and longitudinal 
deformation (Andersen et al., 2004). 
The provision of a very good spatial resolution of 1 to 2 mm, provided potential application 
in measurement of myocardial ԑ and SR (D'hooge et al., 2000). STE derived measurements 
has been validated against sonomicrometry (Korinek et al., 2005, Sivesgaard et al., 2009) 
and CMR (Langeland et al., 2005, Amundsen et al., 2006) showing good reproducibility of 
longitudinal and circumferential ԑ, however it has been reported that at lower deformation 
magnitudes weakens the agreement by an over estimation of absolute values with STE 
(Korinek et al., 2005).  
Because MSTE allows for the measurement of temporal information throughout the cardiac 
cycle (Figure 2.7), the assessment of LV rotation and twist can establish rates of untwisting 
(Helle-Valle et al., 2005, Burns et al., 2009) which is an important factor in generating early 
diastolic intra ventricular pressure gradient (Burns et al., 2009) and extends knowledge of LV 
mechanics in both physiology  (Notomi et al., 2006, Nottin et al., 2009, Esch et al., 2010, 
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Burns et al., 2009) and pathology (Amundsen et al., 2006, Borg et al., 2008, Galderisi et al., 
2010, Leitman et al., 2010).  
 
Figure 2.7: An examplar scan of myocardial speckle tracking assessment of regional wall 
strain and strain rate in the para-sternal short-axis view (note the short axis LV view at the 
level of the papillary muscle and the circumferential strain traces from six LV wall 
segments). 
 
Nottin et al (2008) evaluated LV regional strain in 16 male elite cyclist and 23 controls. They 
reported that Apical radial strain (42.7±10.5% vs. 52.2±14.3%, P < 0.05) and LV torsion (6.0 ± 
1.8 degrees vs 9.2±3.2 degrees, P < 0.01) were lower in cyclists than in controls, respectively 
(Nottin et al., 2008). Quite recently, Monte et al (2014) studied 26 resistance trained, 40 
endurance athletes and 40 sedentary subjects and documented that LV mass indexed for 
BSA, IVSWT and PWT mean values were significantly increased in athletes (p < 0.001, 
p < 0.01 and p < 0.001, respectively). Despite a preserved mean value of LV ejection fraction 
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(LV EF) in all the groups, resistance trained athletes showed a significant reduction of strain 
in the longitudinal, radial and circumferential directions (p < 0.05 for all variables) (Monte et 
al., 2014).   
In contrast, Simsek et al (2013) demonstrated increased global longitudinal strain velocities 
in both resistance and endurance athletes greater than controls (p < 0.001) (Simsek et al., 
2013). Although the potential for STE in discriminating disease states and the association 
between LV function independent of LVH has been highlighted (Amundsen et al., 2006, Borg 
et al., 2008, Galderisi et al., 2010, Bellini et al., 2011), there are limited reports on the 
relationship between exercise training stimuli. This builds the rationale for further studies 
included in this thesis. 
   
2.8 Myocardial Speckle Tracking Echocardiography: The Right Ventricle   
The RV appears to have completely different cardiac mechanics in comparison to the LV. In 
contrast to the homogenously distributed deformation properties in the LV, the ԑ and SR 
values in the RV are less homogenously distributed (Weidemann et al., 2002) and show a 
reverse base to apex gradient reaching the highest values in the apical segments and 
outflow tract (Teske et al., 2009a) (Mor-Avi et al., 2011). This reverse gradient is attributed 
to the complex geometry and the thin walled crescent shape of the RV as well as the above 
mentioned less homogenously distribution of regional wall stress (Rudski et al., 2010, Mor-
Avi et al., 2011).  
Due to predominance of longitudinal fibres in a thinner RV wall, a simple quantitative 
approach to estimate RV function is Tricuspid Annular Plane Systolic Excursion (TAPSE) 
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(Kukulski et al., 2000). Longitudinal shortening is a major contributor to RV function with an 
equal contribution from the free wall and inter-ventricular septum (IVS). Similarly, 
longitudinal deformation is known to contribute significantly to RV SV (Pellerin et al., 2003, 
Rudski et al., 2010). The thinner RV chamber is associated with low pressure in the 
pulmonary circulation, which facilitates quick adaptation to changes in preload. 
Therefore, ε and SR abnormalities of the RV can be an early indicator of RV pathologies e.g. 
pulmonary hypertension (Borges et al., 2006), arhythmogenic RV cardiomyopathy (ARVC) 
(Teske et al., 2009a, Marcus et al., 2010, Meris et al., 2010) and hypertrophied 
cardiomyopathy (Mörner et al., 2008) with a potential to differentiate from physiologic RV 
remodelling to exercise. Teske et al (2009) demonstrated that strain and strain rate of the 
RV free wall were reduced in 63 highly trained athletes relative to controls (p < 0.001), 
particularly in the basal segments of athletes with RV dilatation. The authors proposed that 
this reflected normal physiological adaptation consequent upon a base to apex gradient in 
RV deformation (Teske et al., 2009b).  These findings were extended to the clinical 
population by D’ Andrea et al (2010) who demonstrated that RV global and regional 2D STE 
measurements were largely impaired in HCM compared to athletes. The authors also 
reported significant differences between athletes and control subjects. However, other 
studies have reported no between group difference in RV STE functional indices between 
athlete groups and control subjects (Prakken et al., 2010, Oxborough et al., 2012b, 
Pagourelias et al., 2013).  
These new techniques were not available more than a decade ago when the last meta-
analysis of the AH was conducted. Therefore, the studies included in this thesis are designed 
to apply these new techniques in a re-visit of the Morganroth’s hypothesis using a robust 
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carefully crossmatched and rigourously selected cross section of elite athletes where the 
exercise training stimulus (ET vs RT) simulates the participants of Morganroths seminal 
study.    
 
2.9 Body size influence on the athlete’s heart  
There is extensive evidence that cardiovascular structural and functional variables, along 
with other biological properties that span the range of organism size, scale with body size 
(Batterham et al., 1999, George et al., 2001, Dewey et al., 2008, Oxborough et al., 2009). 
Although technological advancements in cardiac imaging technology has greatly improved 
measurement accuracy, clinical decision based on these measurements are difficult when 
overlap is present between normal and abnormal ranges of cardiovascular variables (figure 
2.8) (Whyte et al., 2004b).  
Such areas of diagnostic uncertainty are common in pre-participation screening of athletes 
to differentiate the AH from cardiomyopathies.  Similarly, the interpretation of AH 
phenotypes in athletes with different body habitus is complex and controversial. These 
concepts of individual descision making and data interpretation in people of divergent body 
size underscores the necessity for appropriate scaling procedures (George et al., 2001).  
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The image of Figure 2.8. Diferential diagnosis of structural adaptations that occur with 
athletic conditioning, originally presented here cannot be made freely available via LJMU 
Digital Collections because of copyright reasons. The image was sourced at Dewey et al., 
2008, page 2280 http://circ.ahajournals.org/content/117/17/2279.short. 
 
Despite this, the practise of scaling cardiovascular measurements is poorly applied in the 
scientific literature. Scaling approaches, exclussively using ratiometric or linear relationships 
are popular in the AH literature. LV mass and LV cavity dimensions and volumes are often 
scaled via simple division by BSA i.e. adopting the per ratio standards (y/x) method of scaling 
(Morganroth et al., 1975, Maron et al., 1995, Pluim et al., 2000).  Empirical evidence in the 
normalization of cardiac data suggests that a curvilinear, allometric scaling model (y = axb) is 
the most appropriate scaling procedure for cardiac data (Tanner, 1949, De Simone et al., 
1992, Gutgesell and Rembold, 1990, Batterham et al., 1999, George et al., 2001, Dewey et 
al., 2008). 
In the first large sample (n = 464) analysis of the relationship between cardiac dimension 
and body size variables in male and female athletes, George et al 1991 demonstrated that 
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the calculated b exponent (y/xb) generally tend to be dimensionally consistent and agree 
with previous clinical data. However, the relationship between RV internal diameter was not 
geometrically consistent as was with the use of height (cm) as a body size scaling variable 
(George et al., 2001). 
Gutgesell and Rembold (1990) evaluated the relationship between cardiac dimension and 
BSA in 7 theoretical “subjects” spanning human age ranges whose cardiac and body 
dimensions were modelled by values obtained from several large studies of healthy 
individuals. The authors reported that linear cardiac dimension (LV, aortic and pulmonary 
artery diameter) were proportional to BSA raised to the power of 0.5 and that the 
relationship between BSA and LV volume was better modelled by allometric scaling in a 
dimensionally consistent manner than by ratiometric scaling (Gutgesell and Rembold, 1990).  
Similarly, Oxborough et al (2012) observed, in 102 endurance athletes, that RV size is 
allometrically related to BSA, therefore scaling for population specific b exponents is 
encouraged.  Considering that Morganroth et al (1975), and subsequent meta-analysis 
larglely adopted absolute or ratiometric scaling of data, in deriving the hypothesis of  a 
divergent cardiac adaptation to exercise training, a repeat of the MH, using new 
technologies and deploying appropriate scaling in the studies included in this thesis will be 
unique.  
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2.10 Ethnicity and the athlete’s heart    
To date the study of the AH and the definition of normal limits for cardiac structure 
and function included in clinical algorithms for cardiac screening have been largely based on 
data from Caucasian athletes. The increasing globalisation of sports has led to the 
development of elite athletes from a wide range of different nationalities and ethnicity. 
Recent data from studies examining the AH phenotype in Black athletes (Africans and Afro-
Caribbean descent) has demonstrated that black athletes (BA) develop more striking 
repolarization changes on the ECG and exhibit a greater magnitude of left ventricular 
hypertrophy (LVH) than white male athletes of similar age and size participating in identical 
sports (Basavarajaiah et al., 2008, Magalski et al., 2008, Rawlins et al., 2009, Sheikh et al., 
2013).  
In a male AH study, Basavarajaiah et al (2008) investigated 300 nationally ranked 
black athletes (mean age 20.5 years); 300 white athletes; 150 black and white subjects and 
reported that black athletes had greater LV wall thickness  and LV mass compared with 
whites (11.3 ± 1.6 mm vs. 10 ± 1.5 mm, p < 0.001); (286 ± 78 vs. 250 ± 62 g, p < 0.001) 
amounting to a 12% and 13% difference respectively. The authors demonstrated that in 
absolute terns, 54 black athletes (18%) had LV wall thickness > 12 mm compared to white 
athletes (4%) and 3% black athletes exhibited LV wall thickness ≥ 15 mm compared with 
none of the white athletes (Basavarajaiah et al., 2008). However, black athletes with LVH 
displayed an enlarged LV cavity and normal diastolic function. In comparison with white 
athletes, Black athletes with LVH exhibited a higher prevalence of voltage criteria for LVH 
(37 [68%] vs. 5 [40%]); displayed a higher prevalence of repolarisation changes specifically 
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ST – segment elevation (46 [85&] vs. 7 [62%], p < 0.001) and deep T – wave inversion (7 
[12%] vs. none [0%] p < 0.001).   
Similar to the study by Basavarajaiah et al (2008), Rawlins et al (2010) investigated 
240 nationally ranked black female athletes and compared their ECG (Electrocardiogram) 
and echocardiographic indices with 200 matched female athletes, the authors report that 
Black athletes demonstrate greater LV wall thickness and LV mass (9.2 ± 1.2 vs 8.6 ± 1.2 mm, 
p < 0.001) and (187.2 ± 42 vs. 172.3 ± 42 g, p = 0.008) than white athletes  (Rawlins et al., 
2010). Although all athletes revealed normal indices of systolic and diastolic function, black 
athletes ECG data revealed higher prevalence of T – wave inversion (14% vs 25, p < 0.001) 
and ST segment elevation (11% vs 1%, p < 0.001) respectively.  
Although in Rawlins et al’s (2010) study, black ethicity was determined by self report 
questionnaire and included terms such as black African, Afro-caribbean, black British and 
black French, the research confirmed that black ethnicity was the strongest independent 
predictor of maximal LV wall thickness (β = 0.263, CI 0.29 to 0.855, p < 0.006) but contrary 
to the MH, did not observe any relationship between sporting discipline and LVH (Rawlins et 
al., 2010).  
Ethnicity has emerged to be an important determinant of the electrical (Magalski et 
al., 2008) and structural manifestation of the AH (Basavarajaiah et al., 2008, Sheikh et al., 
2013, Rawlins et al., 2010). Importantly, in the development of cardiac screening 
procedures,  it has emerged that BA are more susceptible to sudden cardiac death (SCD),  
with a 2-fold higher incidence compared to Caucasian athletes (Maron and Pelliccia, 2006 , 
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Maron et al., 2009, Harmon et al., 2011). The issue of ethnicity and its impact on the AH 
phenotype is complex not least because of ethnic and genetic dispersal and mixing.   
Previous cross-sectional studies on BA have included Afro-Caribbean’s, African 
Americans, Black French, Black British (Basavarajaiah et al., 2008, Magalski et al., 2008, 
Rawlins et al., 2010, Magalski et al., 2011). Intra ethnic differences to cardiac adaptation 
based on ancestral origin exists within blacks. Basavarajaiah et al (2008) documented that 
50 (20%) of the 246 athletes of West African ancestry   (including caribbeans) exhibited LVH 
vs. 4 (7%) of 54 athletes of East African origin (p < 0.01). It is important to partition these 
athletes to ascertain whether these participants were first or second generation blacks 
because there is a potential for genetic mix in these populations over time which could have 
a significant influence of the AH phenotype (Dunn et al., 1983, Mayet et al., 1994, Bhopal, 
2004, Agyemang et al., 2005, Basavarajaiah et al., 2008).  
Previous studies have not specifically examined the training stimulus particularly 
with the impact of resistance training activity on the AH and how it relates to a homogenous 
group of West African athletes. Consequently, understanding the impact of resistance 
training and ethnicity on the AH phenotype requires substantially more work.  
As detailed earlier, technological advancements in echocardiography technology has 
enabled researchers to gain new insights of the AH. The few previous studies describing the 
AH in BA were limited to standard or ‘traditional’ echocardiography measurement 
techniques (Basavarajaiah et al., 2008, Rawlins et al., 2010, Magalski et al., 2011).   
Newer imaging modes such as tissue-Doppler imaging (TDI) and speckle tracking 
echocardiography (STE) estimation of strain and (ɛ) and strain rate (SR) can provide detailed 
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information related to global and regional function to partition any signficant influence of 
resistance training and black ethnicity on the AH phenotype. With these rationales in mind, 
an AH research on a homogenous group of West African RT athletes using novel 
echocardiographic techniques will provide valuable data with important implications for 
cardiovascular screening programmes routinely incorporating ECG and Echocardiography.   
 
2.11 Summary  
This review has defined, described and critically appraised the concept of both the AH and 
the MH, in light of developing databases, evolving techniques and awareness of key issues 
such as scaling and ethnicity. In the 4 decades since Morganroth’s initial study, the 
progressive evolution echocardiography, driven by researchers and ultrasound equipment 
manufacturers, has led to new insights and potential for further study of the AH. These 
overarching issues provide the broad rationale for studies in this thesis.  
Consequently, the studies in subsequent chapters will provide further evidence to support 
or refute different AH phenotypes, the importance of taking into account individual 
variability in body size as well as the value provided by new echocardiographic techniques 
describing regional cardiac function. Finally, the impact of ethnicity on the AH will be 
studied in a pilot trial of West African elite male resistance athletes.  
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CHAPTER 3 
MORPHOLOGY AND FUNCTION OF THE ATHLETE’S HEART: META-ANALYSIS 
EVALUATION OF THE IMPACT OF TRAINING MODE, IMAGING MODALITY AND 
BODY SIZE. 
This work has been presented as ‘Systematic review and meta-analysis of training mode, 
imaging modality and body size influences on the morphology and function of the male 
athlete’s heart’ at the 18th Annual Congress of the European College of Sport Science, 
Baarcellona, Spain. www.sport-science.org/index.php?option=com_content&view. 
Balagué, N., Torrents, C., Vilanova, A., Cadefau, J et al (2013): BOOK OF ABSTRACTS, 18th 
annual Congress of the EUROPEAN COLLEGE OF SPORT SCIENCE 26th - 29th June 2013, 
Barcelona – Spain, Page 325.          
This work has been published as ‘Systematic review and meta-analysis of training mode, 
imaging modality and body size influences on the morphology and function of the male 
athlete's heart’, Heart, 2013;99, 1727-1733.doi:10.1136/heartjnl-2012-303465. 
http://heart.bmj.com/content/99/23/1727.full.pdf+html?sid=6f368e01-ae3a-4592-9aed-
31c6d8ed5c07                 
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3.1 Introduction  
The Athlete’s heart (AH) has been extensively described in male athletes (George et al., 
2011). A cornerstone of this phenomenon has been the concept that cardiac structural 
adaptation follows a dichotomous course of eccentric hypertrophy (balanced increase in 
chamber and wall dimensions) with endurance training versus concentric hypertrophy 
(disproportionate increase in wall thickness) (Bardo et al., 2008), with resistance training,( 
(Morganroth et al., 1975, Pelliccia et al., 1991, Pluim et al., 2000).  It is hypothesised that 
these adaptations reflect differential hemodynamic loading during acute training (George et 
al., 1991). The 26th Bethesda Conference adopted training-specific changes in cardiac 
morphology as a base for its recommendations for cardiovascular screening (Maron et al., 
1994b) and this “hypothesis” has been broadly reported in textbooks and teaching.  
Despite this pervasive “knowledge”, contradictory evidence exists (Baggish et al., 2008, 
Spence et al., 2011) mainly reflecting a lack of concentric hypertrophy in resistance trained 
athletes (Haykowsky et al., 2000). Haykowksy et al (2001) suggested that the stimulus for 
concentric remodelling, a hemodynamic pressure overload on the LV, may not actually 
occur during heavy resistance training due to a simultaneous Valsalva (Haykowsky et al., 
2001). Allied to this on-going controversy, two specific technical issues warrant evaluation.   
Firstly, only echocardiographic AH studies were included in a previous meta-analysis (Pluim 
et al., 2000) Cardiac magnetic resonance imaging (CMR) has now become the gold standard 
tool for cardiac structural assessment.  Clinically significant differences between 
echocardiography and CMR have been reported (Bellenger et al., 2003). Whilst eccentric 
hypertrophy has been reported when CMR is used in endurance trained participants 
(LaGerche et al., 2011), no concentric adaptation has been noted in resistance-trained 
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athletes (Scharhag et al., 2002). Developments in CMR and echocardiography have also 
resulted in novel regional functional indices (i.e. tissue-Doppler analysis) as well as greater 
access to morphological and functional data from the right ventricle (RV) and left atrium 
(LA). 
A second issue of concern relates to the impact of body size on cardiac structure.  Pluim et 
al.,(2000) reported absolute cardiac dimensions in their between-group comparisons (Pluim 
et al., 2000).  Whilst informative, this does not account for potential differences in both 
body size and composition that occur between athlete and sedentary controls which could 
alter the interpretation of AH studies (George et al., 1998, Batterham et al., 1999, Dewey et 
al., 2008, Oxborough et al., 2012b). 
Consequently the aim of this systematic review and meta-analysis was to provide new 
insight in relation to: 1) cardiac adaptation to divergent training patterns in male athletes, 2) 
a developing research database using CMR in athletes; 3) functional data derived from 
tissue-Doppler analysis as well as RV and LA measurements in athletes; and 4) an awareness 
of the impact of body size on cardiac dimensions.  This study applied a quality-criteria 
guided approach to study selection, common in current meta-analyses, but not overtly 
applied in previous AH meta-analyses (Pluim et al., 2000, Whyte et al., 2004a).   
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3.2 Methods 
 
3.2.1 Search criteria and processes 
Our initial aim was to identify all echocardiographic and CMR studies examining the AH in 
male populations published between 1975 and 2012 using a number of electronic search 
engines (e.g. Pub Med, Medline, Scopus and ISI Web of knowledge scholarly data base). 
Relevant MeSH subject terms and keywords pertaining to the structure and function of the 
AH and Boolean operators were used in 2 separate searches for echocardiographic and CMR 
studies. The following search strings were employed:   
 
  “Cardi$ OR Ventric$ OR Atria$ AND Athlet$ AND Echocardio$” 
 “Cardi$ OR Ventric$ OR Atria$ AND Athlet$ AND Magnetic resonance imag$” 
 “Cardi$ OR Ventric$ OR Atria$ AND Athlet$ AND MRI$”  
 
As well as date limits we concentrated the search to human studies and those with an 
English language abstract.  Finally this initial search was extended by a thorough cross-
reference to reference lists from previous reviews and meta-analyses to find studies not 
cited in electronic databases. The search process identified 377 echocardiography and 41 
MRI records for potential inclusion. The filtration process from this point is detailed in Figure 
3.1.  
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The first stage of the filtration process reviewed titles and then abstracts.  This process was 
completed independently by two authors (VU, KG) who compared decision making and 
discussed disagreements. Inclusion criteria were: 1) male subjects, 2) aged 18 – 45 years, 3) 
elite athletes at international or national level of participation for at least 2 years, 4) clear 
ability to define athletes as endurance or resistance focused, 4) healthy with no history of 
cardiovascular disease, and 5) age-matched sedentary control group with low documented 
levels of physical activity.  We excluded review papers as well as trials on children, veteran 
athletes, female athletes, mixed-sex athlete groups, patient groups, steroid users and 
sporting groups with a cross-training focus (e.g. boxing). 
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Sixty-six records were excluded at the title level largely due to a non-athlete focus to the 
studies. Examination of the echocardiography records at the abstract filtration level 
identified and excluded 128 studies out of which 101 papers had no control group. A further 
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9 studies were rejected as athletes were not deemed to be elite.  Twelve CMR studies were 
excluded due to:  lack of control group (n=4); non-elite athletes (n=2); veteran athletes 
(n=2); no cardiac data (n=2) as well as case studies and reviews (n=2).  
All remaining records were obtained for the full record appraisal level. At this stage 115 
records were excluded on assessment of the full paper against the stated inclusion and 
exclusion criteria: female athletes (n=8); mixed-sex athlete data (n=23); non-English 
language (n=19); duplicate data sets (n=3); no absolute cardiac data (n=8). The remaining 
101 studies were then scored by a single researcher (VU) using a quality criteria checklist 
specifically compiled for this systematic review, (Appendix 9.4).   
This was adapted from the STROBE statement (von Elm et al., 2008) to improve the 
systematic appraisal of quality of observational studies.  Nine records were excluded due to 
low quality scores, largely based on missing data related to training or athlete status and/or 
a lack of reference to professional guidelines for assessment and measurement (Moher et 
al., 2009).  Consequently, 92 records (Appendix 9.5) were eligible for quantitative analysis 
including 185 echocardiographic and 41 MRI data sets.   
 
3.2.2 Data retrieval and meta-analysis  
All relevant cardiac and BSA data were extracted directly from individual trials into a 
spreadsheet (Excel 2010, Microsoft Corp).  Athlete groups and imaging modalities were 
coded discretely for each study.  Continuous data for BSA as well as LV, RV and LA 
morphology and functional data were recorded as group mean ± SD for each study.  For the 
LV we recorded LV mass, inter ventricular septal wall thickness (IVSWT), posterior wall 
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thickness (PWT), LV end-diastolic diameter (LVEDD), LV end-diastolic volume (LVEDV), stroke 
volume (LV SV), ejection fraction (LV EF), the ratio of peak early to atrial trans-mitral 
Doppler flow velocities (LV E/A), peak septal longitudinal tissue velocity in early diastole (LV 
E’), late diastole (LV A’) and systolic phase (LV S’). In the RV we recorded RV mass, RV end-
diastolic diameter (RVEDD), RV end-diastolic volume (RVEDV) and RV stroke volume (RVSV). 
Finally for the LA we recorded left atrial dimension (LAD). Other parameters were 
considered at initial screening but too few papers recorded these data (e.g. lateral LV wall 
tissue velocities).  
To explore the impact of training group on structural and function parameters of the AH, we 
applied a mixed effect random meta-analysis model (DerSimonian, 1986). To quantify study-
to-study heterogeneity a Q statistic at p<0.05 and I-square statistic >50% was deemed 
significant (Higgins et al., 2003). In further sub-group analyses we explored the impact of 
imaging modality upon AH data, again, using a mixed effect random meta-analysis model.  
Finally, we used a multiple meta-analysis regression model (Kendall’s non-parametric 
statistic) to explore the impact of the covariate, BSA, on LV mass, RV mass and LAD. All 
statistical analysis was carried out with Comprehensive Meta-analysis software version 2.0 
(Biostat, Englewood, NJ, USA) and Stata version 12 (Stata corp, college station, Texas, USA). 
Statistical significance was set at p≤0.05.  
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3.3 Results 
Across all studies the mean age of all male athletes and controls ranged from 18-38 years. 
The results of the impact of different training stimuli on various indices of LV structure and 
function are summarised in Table 3.1.  There were more data sets for endurance athletes 
and limited data prevented a mean pooled estimate for peak septal early diastolic tissue 
velocity in resistance athletes.  All LV structural parameters were increased in athletes 
compared to sedentary controls. Differences between athlete groups were only noted for 
LVEDD and LVEDV, which were larger in endurance compared to resistance athletes. There 
were no differences between athlete groups for IVSWT or PWT. The larger LV chamber 
accounted for a greater SV in endurance athletes compared to resistance athletes and 
controls but LV EF was not different between all groups. Both LV E/A and LV E’ were larger 
in endurance athletes than controls. 
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Table 3.1: Left ventricular structural and functional data in male endurance-trained, resistance-trained and sedentary control subjects. Data are mean (95% confidence 
intervals), [number of studies; number of participants]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parameter Endurance-Trained 
(ET) 
Resistance-
Trained (RT) 
Sedentary 
Controls (CT) 
P-value (All 
groups) 
Post-hoc 
Significant 
Differences  
Heterogeneity test 
Hetero-
geneity 
I squared 
(%) 
P value 
LV mass (g) 
 
232  
(200 to 260) 
[n=64; 1099] 
220  
(205 to 234) 
[n=25; 510] 
166  
(145 to 186) 
[n=59; 1239] 
P<0.001 ET, RT>CT 21 99.8% <0.001 
IVSWT (mm) 
 
11.0  
(10.8 to 11.3) 
[n=68; 1802] 
11.0  
(10.3 to 11.8) 
[n=19; 408] 
9.2  
(8.9 to 9.5) 
[n=63; 1352] 
P<0.001 ET, RT>CT 98 99.2% <0.001 
PWT (mm) 
 
10.6  
(10.3 to 10.9) 
[n=57; 1928] 
10.4  
(9.8 to 10.9) 
[n=14; 370] 
8.8  
(8.6 to 9.1) 
[n=53; 1433] 
P<0.001 ET,RT>CT 87 99.2% <0.001 
LVEDD 
(mm) 
 
54.8  
(54.1 to 55.6) 
[n=61; 1548] 
52.4  
(51.2 to 53.6) 
[n=17; 384] 
50.1  
(49.5 to 50.7) 
[n=56; 1174] 
P<0.001 ET>RT, CT 
RT>CT 
95 99.1% <0.001 
LVEDV (ml) 
 
171  
(157 to 185) 
[n=34; 493] 
131  
(120 to 142) 
[n=14; 189] 
135  
(125 to 145) 
[n=34; 539]  
P<0.001 ET>RT, CT 23 99.2% <0.001 
LV SV (ml) 
 
106  
(97 to 116) 
[n=28; 479] 
86  
(77 to 95) 
[n=9; 125] 
83  
(77 to 90) 
[n=27; 590] 
P<0.001 ET>RT, CT 
 
16 98.7% <0.001 
LV EF (%) 
 
63  
(61 to 64) 
[n=42; 1330] 
66  
(62 to 70) 
[n=7; 85] 
64  
(62 to 65) 
[n=37; 878] 
P=0.365 NS 2.0 97.7% <0.001 
LV E/A 
 
2.0  
(1.9 to 2.1) 
[n=34; 844] 
1.9  
(1.7 to 2.0) 
[n=8; 214] 
1.8  
(1.7 to 1.9) 
[n=34; 868] 
P=0.014 NS 8.5 98.8% <0.001 
LV E’ 
 
13.6  
(12.3 to 14.9) 
[n=7; 204] 
*  
 
 
11.0  
(9.4 to 12.6) 
[n=4; 183] 
P=0.014 NS 18 98.6% <0.001 
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LV-left ventricle, IVSWT-inter ventricular septal wall thickness, PWT-posterior wall thickness, EDD-end-diastolic dimension, EDV-end-diastolic 
volume, SV-stroke volume, EF-ejection fraction, E/A-peak early to atrial Doppler trans-mitral flow velocities, E’ peak septal early diastole 
longitudinal tissue velocity. One-way ANOVA analysis, P-value are significant at <0.05. 
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Table 3.2: Right ventricular structural and functional data as well as left atrial diameter in male endurance-trained, resistance-trained and 
sedentary control subjects, Data are mean (95% confidence intervals), [number of studies, number of participants]. 
  
 
 
 
 
 
 
 
 
 
 
 
RV-right ventricle, RVEDD-RV end diastolic diameter, RVEDV- RV end diastolic volume, RVSV- RV stroke volume, LAD-left atrial diameter, One-
way ANOVA analysis, P-value are significant at <0.05. 
Parameter Endurance-
Trained (ET) 
Resistance-
Trained (RT) 
Sedentary 
Controls (CT) 
P-value 
(All 
groups)  
Post hoc 
Significant 
Difference
s 
Heterogeneity test 
 
Heterogeneity I squared (%) P value 
RV mass (g) 
 
91  
(63 to 119) 
[5; 116] 
* 37  
(24 to 50) 
[4; 102] 
P<0.01 ET>CT 3.5 99.3% 0.174 
RVEDD 
(mm) 
 
33.5  
(21.0 to 46.0) 
[4; 140] 
* 26.1  
(16.1 to 36.1) 
[4; 95] 
P=0.347 NS 0.81 
 
99.7% 0.367 
RVEDV (ml) 
 
222  
(216 to 227) 
[6; 136] 
* 156  
(153 to 159) 
[6; 150] 
P=0.627 NS 2.8 99% 0.248 
RV SV (ml) 
 
114  
(11 to 122) 
[5; 66] 
* 94  
(92 to 98) 
[4; 66] 
P=0.415 NS 0.84 99.8% 0.657 
LAD (mm) 
 
39.2  
(35.9 to 42.5) 
[10; 206] 
31.9  
(29.7 to 34.1) 
[2; 58] 
34.9  
(31.9 to 37.9) 
[11; 243] 
P<0.001 ET>RT 13.2 98.1% <0.001 
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Table 3.2 contains between group comparisons for indices of RV structure and 
function as well as LAD.  Noticeably, fewer studies have reported these data in cross-
sectional athlete-controls comparisons and we could not generate pooled mean 
estimates for resistance-trained athletes in respect to RV data.  Mean RV mass, 
RVEDV and RV SV were greater in endurance athletes than controls.  Data for LAD 
were greater in endurance than resistance-trained athletes but not controls. 
For many LV and RV variables there was significant evidence of study-to-study 
heterogeneity (see Table 3.1 and 3.2).  This provided support for our a-priori 
rationale to assess subsidiary factors. Substantial differences between imaging mode 
were noted (Table 3.3).  Pooled mean estimates for LV mass, LV EF and LAD were 
higher when using echocardiography.  Conversely, pooled mean estimates for LVEDV 
and LV E/A were higher when using CMR. No imaging mode comparison was possible 
for the RV because of limited data using echocardiography. 
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Table 3.3: Left ventricular structural and functional data as well as left atrial 
diameter in male athletes measured using echocardiography and CMR, Data are 
mean (95% confidence intervals), [number of studies, number of participants]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
LV mass, Left ventricular mass; LVEDV, LV end-diastolic volume, LV EF, LV ejection 
fraction, LV E/A, Ratio of LV early diastolic and late diastolic velocity, LAD, Left atrial 
diameter. One-way ANOVA P-value are significant at <0.05. 
Across all studies the mean BSA ranged from 1.69 to 2.52. Multiple meta-analysis 
regression analysis resulted in significant and positive relationships between BSA and 
LV mass (b= 0.010; Tauˆ2 p>/z/ 0.01; CI 0.001-0.010), LAD (b= 0.001; Tauˆ2 p>/z/ 
0.001; CI 0.008-0.012) and RVM (b= 0.001; Tauˆ2 p>/z/ 0.001; CI 0.008-0.012) at 
p<0.05.  This suggests that as BSA increases across studies cardiac dimensions also 
increase. 
 
Parameter Echocardiography CMR P-value Post hoc  
Significant 
Differences 
LV mass (g) 
 
212  
(195 to 229) 
[118; 2403] 
173  
(156  to 190) 
[30; 445] 
P<0.001 Echo>CMR 
LVEDV (ml) 
 
135  
(128 to 142) 
[54; 791] 
178  
(162 to 194) 
[28; 430] 
P<0.001 CMR>Echo 
LV EF (%) 
 
64  
(63 to 66) 
[42; 1915] 
61  
(59 to 62) 
[26; 378] 
P<0.001 Echo>CMR 
LV E/A 
 
1.8  
(1.7 to 1.9) 
[69; 1806] 
2.3  
(2.0 to 2.6) 
[7; 120] 
P<0.001 CMR>Echo 
LAD (mm) 
 
36.9  
(34.6 to 39.2) 
[21; 436] 
32.7  
(29.8 to 35.6) 
[2; 71] 
P=0.026 NS 
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3.4 Discussion 
  The key findings from this systematic review and meta-analysis of the AH in 
male athletes are: 1) both endurance and resistance trained athletes demonstrate 
larger LV structures than sedentary controls with the greater dimensions in 
endurance athletes suggestive of an eccentric hypertrophy.  Similar LV wall thickness 
in the two athlete groups provides minimal support for a concentric hypertrophy in 
resistance athletes; 2) imaging mode has a significant, but inconsistent, effect on a 
range of LV indices and LAD; 3) Differences between endurance athletes and controls 
were noted for LV function, RV structure and LAD whilst limited resistance athlete 
data was available; and 4) BSA has a significant positive relationship with LV mass, 
RV mass and LAD.  These data should inform current knowledge of the AH and 
prompt on-going research. 
 
3.4.1 The impact of training group 
Both athlete groups had larger LV wall, chamber dimensions and mass than the 
control group, which supports the existence of a morphological AH (Pluim et al., 
2000).  The endurance-trained athletes had marginally larger LV mass and 
significantly greater LVEDD and LVEDV than resistance athletes, supporting the 
contention that endurance athletes tend to present with the largest LV dimensions 
(Naylor et al., 2008).  Furthermore, the pattern of LV morphology in the endurance-
trained athletes, a bigger LV chamber and proportionately larger LV walls, is 
commensurate with an eccentric LV hypertrophy first proposed by Morganroth and 
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co-workers (Morganroth et al., 1975).  The mechanism(s) underpinning training-
induced changes in LV morphology in endurance athletes are poorly understood but 
a hemodynamic volume overload is widely quoted (George et al., 1991).   
Endurance athletes had a larger LV SV than controls and resistance-trained athletes.  
This adaptation makes some teleological sense as an augmented LV SV is likely a key 
contributor to an enhanced endurance capacity (George et al., 2011).  The lack of 
difference in LV EF at rest between all groups confirms data from Pluim et al (2000), 
and suggests no between group differences in contractility at rest (Pluim et al., 
2000). Both the LV E/A and LV E’ were significantly greater in endurance athletes 
than controls.   
Although controversial, individual studies have reported an improved diastolic filling 
at rest in athletes (Pluim et al., 2000, D'Andrea et al., 2002) yet this has often been 
dependent upon the specific parameter assessed (George et al., 2010).  The 
potential importance of enhanced diastolic function in the development of maximal 
SV (Gledhill et al., 1994) as well as putative mechanisms (preload or intrinsic 
relaxation properties), requires further evaluation.  Finally it is interesting to note 
that the endurance-training related changes in LV morphology and function are quite 
closely mirrored in RV and LA data.  This supports a balanced cardiac hypertrophy 
that is assumed to be wholly physiological in nature. 
Whilst there are noticeable fewer resistance-training studies in the extant literature, 
the current data confirm the observation by Pluim et al (2000) that resistance 
athletes display some morphological characteristics of the AH (Pluim et al., 2000). 
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Both IVSWT and PWT were bigger in resistance-trained athlete’s controls and were 
similar to endurance athletes.  Cavity dimension, but not volume, data were greater 
in resistance athletes than controls but were smaller than endurance athletes.  
Pluim et al, (2000) noted some support for concentric hypertrophy in resistance 
athletes due to an increased wall to chamber ratio (relative wall thickness). Use of 
mean data from all groups in the current meta-analysis results in a relative wall 
thickness of 0.40 for endurance athletes compared to 0.41 in resistance athletes 
(Pluim et al., 2000).  These data are within normal ranges (Lang et al., 2005) and not 
meaningfully different.  As opposed to dichotomous cardiac structural responses to 
endurance and resistance-training, it could be argued that both athlete groups 
present with a similar qualitative cardiac adaptation on a continuum, with greater 
cardiac dimensions in endurance athletes reflecting a greater overall training 
volume.  
The lack of concentric-type hypertrophy in resistance athletes could be due to; (a) a 
limited exposure time to an elevated hemodynamic afterload as an increase in blood 
pressure only occurs sporadically during resistance training because of the 
intermittent nature of repetitions, sets and work-to-rest ratios (Naylor et al., 2008).  
The exposure to an elevated hemodynamic load during exercise is likely much more 
consistent and substantial during endurance training; (b) the absence of any real 
afterload stimulus when resistance training is performed with a valsalva manoeuvre 
(Haykowsky et al., 2002). The resistance-trained athletes demonstrated no increase 
in resting LV SV or either index of diastolic function, compared to controls.  Given 
that an enhanced SV is an unlikely contributor to resistance sports performance the 
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lack of difference between the controls and athletes is not surprising.  Data for RV 
and LA morphology and function are extremely limited in resistance-trained athletes 
and this requires further study.   
 
3.4.2 The impact of imaging mode 
There was strong evidence of study-to-study heterogeneity within the meta-analysis, 
suggesting that sub-factor analysis may be relevant in this area.  CMR is the gold 
standard tool for morphological assessment of cardiac chambers and mass due to its 
greater spatial resolution and 3-D data provision.  Recent, direct comparisons 
between echocardiography and MRI-derived measures of left ventricular (LV) mass 
and volume in athletes suggest that large absolute differences exist between these 
measurement modalities (DeCastro et al., 2006, Prakken et al., 2011a, Wernstedt et 
al., 2002).   
Measurement variability is also substantially greater with echocardiography 
(Bellenger et al., 2003).  In this study the use of CMR resulted in a higher LVEDV than 
echocardiography and this agrees with previous comparative studies (LaGerche et 
al., 2011, Petersen et al., 2005, Caselli et al., 2011, Scharhag et al., 2010). The 
difference is likely due to the biplane Simpson’s technique that uses estimation and 
geometric modelling allied to poorer lateral resolution that makes clear delineation 
of the endocardium difficult.  
Conversely, LV mass, was greater in echocardiography in comparison to MRI which 
supports previous work by Prakken et al.,(2011) but contradicts other work 
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(DeCastro et al., 2006). Because CMR provides a more accurate and precise 
measurement of LV mass (Armstrong et al., 2012) we can assume that 
echocardiography over-estimates, again likely due to the limitations of geometric 
assumptions (Missouris et al., 1996) possibly compounded by the nature of any 
eccentric LV enlargement in endurance athletes.  
These results, allied to the modality-related differences in LAD and LV function, 
highlight that imaging modalities should not be used interchangeably (Bottini et al., 
1995). For training studies or other within subject testing at multiple epochs, a single 
modality should be used. Given the higher variability in echocardiographic estimates 
of LV dimensions, compared to CMR, some caution is warranted in the interpretation 
of small-sample echocardiographic AH studies.  Further CMR studies in resistance 
athletes, or focusing on the RV and LA, are required.  
 
3.4.3 The impact of BSA 
Finally, we sought to explore the effect of between-study differences in BSA on LV 
mass, RV mass and LAD. Multiple meta-regression data clearly demonstrated that as 
BSA increased so did measures of cardiac structure.  Consequently, it is likely that 
some portion of the between-group difference in LV mass, RV mass and LAD are 
explained by those with larger cardiac dimensions having larger body dimensions.  
Whether this reflects a higher total body mass or more specifically a higher lean 
body mass in the athlete groups is impossible to determine from the use of BSA 
alone. 
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The importance of body size on cardiac dimensions has been demonstrated in a 
number of empirical studies (De Simone et al., 1992, George et al., 1998, Oxborough 
et al., 2012b) and has been highlighted in review articles (Batterham et al., 1999, 
Dewey et al., 2008). The current data provide further support that between 
individual or group comparisons of cardiac dimensions must take account of 
individual variability in body size otherwise data interpretation and conclusions could 
be flawed.   
The current study does not determine the best body size scaling index (mass, BSA, 
lean mass) or the most appropriate approach to scaling (ratio standards, allometry).  
These issues have been debated before (Batterham et al., 1999, Dewey et al., 2008) 
and further empirical work is required. It is of critical importance that future AH 
studies report anthropometrics and/or scaled data. 
 
3.5 Implications, limitations and future research 
Strong evidence supports an “eccentric-type” hypertrophy of the LV, RV and LA in 
endurance athletes.  Resistance-trained athletes do not present with concentric LV 
hypertrophy.  This data prompts a re-evaluation of the long held belief that different 
exercise training produces divergent cardiac adaptation (Morganroth et al., 1975). A 
caveat is important here; we report substantial numbers of endurance athlete 
groups but fewer resistance athlete groups.  This issue is magnified for studies of RV 
and LA structure and function in athletes. It is clear from this met-analysis data set 
that further cross-sectional athlete-control studies are required to develop the 
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database for resistance-trained athletes generally and with new imaging 
technologies specifically.  It would also be pertinent to extend a similar endurance-
resistance study specifically to investigate “old” and “new” imaging tools with 
respect to the RV and atria.   
The current findings also provide relevant information for those interested in the 
nature of the upper limits of human cardiac, physiological adaptation to training.  It 
is likely that the upper limits for chamber dimensions will be observed in endurance 
athletes. This knowledge will inform cardiac screening and the differential diagnosis 
of AH from pathological adaptation.  Further, it is unlikely that the upper limits of LV 
wall dimensions will be exclusively observed in resistance athletes. It is also 
important to highlight that absolute wall thicknesses and the LV end diastolic 
dimension, although increased when compared to sedentary controls, do not fall 
within the pathological range seen in hypertrophic or dilated cardiomyopathy in 
either resistance or endurance trained athletes.  This knowledge will further aid the 
diagnostic challenges associated with pre-participation screening of the competitive 
athlete.  
In this meta-analysis, we examined the influence of BSA on sample differences in 
cardiac dimensions via a multiple meta-regression approach. Whilst this analysis 
goes some way in partitioning out the influence of BSA on the cardiac dimension 
estimates, ideally proper allometric scaling approaches should be applied at the 
individual study level. Unfortunately, this analysis approach is rare at present. It 
would be pertinent to include this as a secondary focus in further studies in this 
thesis addressing athlete group comparisons for various LV and RV structural data.  
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The current study has some limitations.  As already noted, data for resistance 
athletes is relatively scarce.  Functional measures in high quality case-control series 
studies are largely limited to global echocardiographic parameters i.e. LV EF, SV and 
E/A. The current study excluded older athletes and all female athlete studies.  These 
limitations prompt on-going evaluation in this area.   
 
3.6 Conclusions  
This large scale systematic review and meta-analysis in male athletes 
provides strong evidence of LV, RV and LA hypertrophy with athletic training that is 
not dichotomous in form, but quantitatively greater with endurance training.  
Significant evidence of study-to-study heterogeneity was noted that could be due to 
the use of different imaging modalities as well as the approach to scaling (or 
indexing) cardiac structural data for individual differences in body size.  
Consequently, this meta-analysis provides a useful re-evaluation of concepts and 
models in the AH literature. 
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CHAPTER 4 
 A COMPREHENSIVE TECHNICAL ASSESSMENT OF THE 
ATHLETE’S HEART: THE “MORGANROTH HYPOTHESIS” RE-
VISITED 
 This work has been presented as ‘a comprehensive technical assessment of the 
athlete’s heart: the “morganroth hypothesis” re-visited’ at the 19th Annual Congress 
of the European College of Sport Science, Amsterdam, The Netherlands.     
De Haan, A., De Ruiter, C. J., Tsolakidis, E et al 2014: BOOK OF ABSTRACTS, 19th 
annual Congress of the EUROPEAN COLLEGE OF SPORT SCIENCE, 2nd - 5th July 2014, 
Amsterdam – The Netherlands, Page 173. 
This work has been published as 'Predominance of normal left ventricular geometry 
in the male athlete's heart'. Heart 2014;0:1–8.doi:10.1136/heartjnl-2014-305904. 
http://heart.bmj.com/content/100/16/1264.full      
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4.1 Introduction 
A landmark assessment of the left ventricle (LV) was undertaken by Morganroth and 
colleagues (Morganroth et al., 1975) in a small sample of highly-trained endurance 
(15 swimmers and 15 long distance runners) and resistance-trained athletes (12 
wrestlers and 4 shot putters). Despite limited details related to training-related 
haemodynamic loading on the LV a dichotomous morphology was observed with an 
eccentric hypertrophy (balanced increase in chamber and wall dimensions) in 
endurance athletes versus a concentric hypertrophy (disproportionate increase in 
wall thickness) in resistance athletes.  
It is hypothesised that these adaptations reflect differential haemodynamic loading 
during acute training (Grossman et al., 1975). This differential adaptation of the 
athlete’s heart (AH) has been referred to as the “Morganroth Hypothesis” (MH) and 
has been widely adopted in textbooks, scientific papers and professional guidelines 
(Rudski et al., 2010) including the 26th Bethesda Conference: Recommendation for 
cardiovascular screening among athletes (Mitchell et al., 1994). Despite the 
pervasive nature of the MH, continuous evaluation of the AH phenotype is clinically 
important (George et al., 1991).  
A plethora of original AH research papers, supplemented by numerous reviews and 
meta-analyses have raised specific questions related to the nature of cardiac 
adaptation to resistance training (Haykowsky et al., 2001).  The meta-analysis 
conducted in the previous chapter confirmed only an eccentric-type cardiac 
phenotype in endurance athletes with limited adaptation in resistance trained 
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athletes, with significant caveats about limited data sets and the requirement for 
further study.  
Inconsistency in AH research may be related to multiple factors including; 1) on-
going developments in non-invasive imaging, and 2) the importance of appropriate 
scaling for between subject differences in body size. Morganroth et al (1975) 
employed “ice pick” M-mode echocardiography and since then technological 
advancements have included improved spatial resolution as well as two- and three-
dimensional imaging that provide more accurate estimates of cardiac structure and 
function (Mor-Avi et al., 2011).  
Newer imaging modes such as tissue-Doppler imaging (TDI) and speckle tracking 
echocardiography (STE) estimation of strain (ԑ) and strain rate (SR), can  provide 
detailed information related to global and regional function in the AH.  Although 
used in a small number of cross-sectional athlete-control studies (La Gerche et al., 
2011) they have not specifically evaluated the MH with very limited data available in 
resistance trained athletes (Utomi et al., 2013).   
The association between body size and cardiac morphology is well known 
(Batterham et al., 1999, Dewey et al., 2008) but inconsistently applied. The use of 
simple linear ratio-standard scaling of cardiac structures is popular in the published 
literature despite the fact that a large number of cardiovascular variables relate to 
body size in a non-linear fashion (George et al., 2001). Appropriate scaling in a re-
evaluation of the MH would be unique.  
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The following hypotheses were tested: A) Dichotomous LV structural adaption is not 
apparent in elite male endurance and resistance-trained athletes, B) modern imaging 
technologies will determine training-specific adaptation in global and regional LV 
function, and C) indexing LV data for individual variance in body size will have a 
significant impact on the interpretation of the AH. 
 
4.2 Methods 
 
4.2.1 Study design and procedures 
A prospective cross-sectional study design was employed with data acquired in a 
resting state at a single testing session. All subjects were advised to abstain from 
caffeine, exercise training and alcohol consumption at least 3 hours prior to the 
investigation. Height and body mass were assessed using a stadiometer and digital 
weighing machine (SECA 764, Birmingham, UK) and body surface area (BSA) was 
calculated. After 5 minutes of supine rest, brachial artery blood pressure was 
assessed with an automated sphygmomanometer (DINAMAP 300, GE Medical 
Systems, Milwaukee, Wisconsin).  
 
4.2.2 Echocardiographic assessment 
A standard echocardiographic investigation was performed using a Vivid Q 
ultrasound machine (GE Medical System, Horten, Norway) with a 2.5-5 MHz 
transducer. All acquisitions were made with the subject lying in the left lateral 
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decubitus position by the same experienced echocardiographer using a standard 
echocardiography-protocol in accordance with American Society of 
Echocardiography (ASE) guidelines (Lang et al., 2005). Offline analysis was performed 
using commercially available software (EchoPAC Version 7.0; GE Vingmed Ultrasound, 
Horten, Norway). 
4.2.3 Conventional 2D and Doppler / Tissue-Doppler  
Inter-ventricular septal wall thickness (IVSW), LV internal diameter (LVID) and LV 
posterior wall thickness (PWT) were measured at end-diastole (IVSWd, LVIDd and 
PWTd), using 2D imaging and LV mass was calculated.  In order to establish LV 
geometry, relative wall thickness (RWT) was calculated using the general formula 
(RWT = (IVSWd + PWTd) / LVIDd) and participants were classified as eccentric 
hypertrophy, concentric hypertrophy, concentric remodelling or normal geometry 
(Lang et al., 2005). LV volumes, stroke volume (SV) and ejection fraction (EF) were 
calculated using Simpson’s biplane method (Otto and Pearlman, 2004).  
Doppler assessment of trans-mitral flow allowed the measurement of peak early 
diastolic (E), late diastolic (A) flow velocities, E deceleration time (Edecel) and 
isovolumic relaxation time (IVRT). Pulsed-wave TDI was undertaken with 
assessments of the basal septum and lateral wall where peak early diastolic (E’), late 
diastolic (A’) and systolic (S’) myocardial velocities were obtained. The ratio E/E’ was 
calculated as a surrogate measure of LA pressure.  
All LV structural variables were scaled to individual differences in BSA.  This was 
achieved by the linear ratiometric method by simple division of the structural 
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variable by BSA. Scaling was also performed allometrically according to the laws of 
geometric similarity (i.e. linear dimensions were scaled to BSA0.5, volume and mass 
measurements were scaled to BSA1.5 and area measurements to BSA1.0) as well as LV 
mass being scaled to height2.7. TDI data were also scaled linearly to LV length as 
previously demonstrated (George et al., 2001).  
4.2.4 Speckle tracking echocardiography (STE)  
The apical 4-chamber view was used for the assessment of longitudinal LV ε and SR. 
For the assessment of LV basal circumferential ε, SR and rotation a parasternal short 
axis views was acquired at the tips of the mitral valve. The parasternal short axis at 
the apex defined as the level just above the point of systolic cavity obliteration was 
acquired to allow the assessment of apical rotation.  
For offline analysis and assessment of longitudinal function, the region of interest 
(ROI) was placed around the LV basal septum through to basal lateral wall 
encompassing the mid and apical wall segments. Peak global LV ε and SR were 
obtained as the average of the base, mid and apical wall segments. The SR curves 
provided peak measures of systolic SR (SRS), early diastolic SR (SRE) and late diastolic 
SR (SRA). Peak global LV circumferential ε, SR and rotation were averaged from six 
myocardial segments with the ROI placed around the circumference of the LV at 
basal and apical levels.  Left ventricular twist was calculated as the net difference 
between apical and basal rotation.  
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Intra class coefficient for LV ԑ for our laboratory are good to very good (0.714-0.807) 
with coefficient of variation for LV peak circumferential and longitudinal ԑ (7% and 
6%), basal rotation (21%) and twist (10%) (Oxborough et al., 2012a). 
4.2.5 Statistical analysis 
Statistical analyses were performed using SPSS, version 20.0, for Windows (SPSS, 
Chicago, IL, USA) and the critical alpha was set at p < 0.05. Data are presented as 
mean ± SD [Range], and were analysed between groups using one-way ANOVA and 
Bonferoni correction for the post hoc test for multiple comparison to estimate 
differences between groups. A priori, a sample size of 15 from each target 
population (CT, ET and RT) was prospectively determined to achieve 80% statistical 
power, accommodate data variability in the study population and detect the 
minimum difference of 3 mm in LV chamber dimension between groups (Minitab 16, 
Minitab ltd, Coventry, United kingdom). 
4.3 Results  
4.3.1 Study population 
A total of 54 males provided written informed consent to participate in the study. 
We recruited elite athletes (competitive at a national or international level) of which 
18 were endurance (ET) athletes recruited from an international field at the 100-mile 
Western States Endurance Run (California, USA), and 19 were resistance trained (RT) 
athletes recruited from national Weightlifting and Aikido squads. The ET and RT were 
matched for accumulated mean training years, training hours per week and training 
days per week of (11 yrs., 12 hours/wk. and 6 days/wk.) and (12 yrs., 11 hours/wk. 
and 6 days/wk.), respectively. In addition, 17 sedentary controls (CT) were recruited 
from a university staff/student population in a similar age range. The CT were 
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healthy individuals who were not engaged in systematic sport-related training and 
engaged in less than 3 hours recreational activity per week. All participants self-
reported being healthy and free from any known cardiovascular disease, and were 
not currently taking any form of prescribed medication (Appendix 9.6 – participant 
information ship; 9.7 - Consent form and 9.8 - Health questionnaire).  The study 
conformed to the ‘STROBE STATEMENT: Guidelines for reporting observational 
studies’ (Appendix 9.9) (von Elm et al., 2008) and to the standards set by the 
Declaration of Helsinki and ethical approval was granted by the Ethics Committee of 
Liverpool John Moores University (Appendix 9.10). The demographic characteristics 
of all participants are presented in Table 4.1.  
Table 4.1: Demographic and resting cardiovascular data of male endurance-trained 
(ET), resistance-trained (RT) and sedentary control (CT) subjects, Data are mean ± SD 
(Range).   
Parameter ET RT CT 
Sample Size (n) 18 19 17 
Age (yrs) 34±5 (23 to 41)† 29 ± 8 (18 to 44)  27 ± 8 (20 to 43)  
Body Mass (kg) 74 ± 9 (59 to 87) 83 ± 14 (61 to 111)  76 ± 10 (61 to 91)  
Height (m) 1.8 ± 0.1 (1.5 to 1.9)  1.8 ± 0.1 (1.7 to 1.9)  1.8 ± 0.1 (1.6:1.9) 
BSA (kg/m2) 2.1 ± 0.2 (1.7 to 2.4)  2.3 ± 0.3 (1.8 to 2.9)  2.1 ± 0.2 (1.7 to 2.5)  
Heart rate 
(beats.min-1) 
56 ± 11 (40 to 80) 70 ± 11 (56 to 98) ‡ 63 ± 10 (53 to 84)  
Systolic BP 
(mmHg) 
132 ± 10 (110 to 142)  134 ± 9 (110 to 145) 128 ± 12 (104 to 140) 
Diastolic BP 
(mmHg) 
78 ± 11 (58 to 90) 76 ± 7 (59 to 89) 75 ± 8 (59 to 89) 
SA – Body surface area; BP – Blood pressure; † P<0.05 vs CT and ‡ P<0.05 vs. ET (Post 
hoc statistical significance at P<0.05).    
Body mass, height, BSA and resting blood pressure were similar between groups. ET 
had a lower heart rate than the RT (P<0.05) but not the CT group (Table 1). Mean age 
was slightly higher in ET and greater than CT (P<0.05).  
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4.3.2 2D- Echocardiography  
LV structural data are contained in Figure 4.1. and Table 4.2. Higher LVIDd, LVEDV 
and LV mass were observed in the ET, compared to both RT and CT, irrespective of 
scaling approach. 
 
 
Figure 4.1: Box and whisker plots for selected LV structural parameters. The whiskers 
represent the minimum and maximum data value, the box represents the 1st and 3rd 
percentile while the Band within the box represents the median statistic (a) mean 
wall thickness, (b) LV end diastolic volume (LVEDV), (c) absolute LV mass, (d) LV mass 
index, and functional data (e) stroke volume (SV), and (f) early diastolic tissue 
velocity (TDI E’).         
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 There was no between-group difference in absolute LV wall thickness; 
however after ratiometric and allometric scaling, LV wall thicknesses were higher in 
ET than RT and CT.   
Parameter   ET RT CT 
IVSWTd (mm) 10 ± 1 (9 to 13) 10 ± 1 (8 to 12) 9 ± 1 (8 to 12) 
IVSWTd (mm/m2)  4.8 ± 0.5 (4 to 5) 4.3 ± 0.6 (3 to 5)‡ 4.5 ± 0.6 (3 to 5) 
IVSWTd (mm/m0.5) 6.3 ± 0.8 (5.1 to 7.1)  5.9 ± 0.7 (4.8 to 7.4) 5.9 ± 0.6 (5.0 to 7.1) 
LVIDd (mm) 56 ± 2 (53 to 59)† 53 ± 2 (50 to 57)‡ 51 ± 2 (48 to 55)  
LVIDd (mm/m2) 27 ± 3 (24 to 32)† 24 ± 3 (19 to 29)‡ 25 ± 3 (21 to 29) 
LVIDd (mm/m0.33) 42.1 ± 2.4 (38 to 46)† 39.5 ± 3.2 (33 to 46)‡ 38.8 ± 2.3 (34 to 42) 
PWTd (mm) 9 ± 1 (8 to 12) 9 ± 1 (8 to 11) 9 ± 1 (7 to 11) 
PWTd (mm/m2) 4.9 ± 0.6 (3 to 5) 4.3 ± 0.7 (3 to 5)‡ 4.6 ± 0.5 (3 to 5) 
PWTd (mm/m0.5) 6.4 ± 0.8 (5 to 8) 6.2 ± 0.6 (5 to 7) 6.3 ± 0.6 (5 to 8) 
LV mass (g) 200 ± 34 (154 to 254)† 187 ± 31 (133 to 247) 165 ± 32 (131 to 247) 
LV mass (g/ m2) 98 ± 15 (70 to 124)† 78 ± 15 (53 to 107)‡ 74 ± 11 (54 to 97) 
LV mass (g/m2.7) 29.8 ± 6.6 (17 to 41) 25.4 ± 8.7 (15 to 48) 25.9 ± 6.5 (13 to 38) 
LVEDV (ml) 141 ± 12 (120 to 158)† 120 ± 17 (100 to 158)‡ 116 ± 18 (92 to 152) 
LVEDV (ml/m2) 68 ± 7 (53 to 80)† 54 ± 8 (42 to 70)‡ 55 ± 7 (44 to 69) 
LVEDV (ml/m1.5) 43.7 ± 6.8 (32 to 58)† 34.2 ± 7.4 (24 to 52)‡ 32.5 ± 8.9 (18 to 47) 
LV length (mm) 91 ± 7 (78 to 100) 87 ± 10 (76 to 110) 86 ± 7 (74 to 98) 
LV length (mm/m2) 44 ± 4 (36 to 50) 39 ± 6 (29 to 50)‡ 41 ± 3 (33 to 46) 
LV length (mm/m0.5) 62.9 ± 3.8 (53 to 70) 57.5 ± 6.9 (47 to 71)‡ 59.6 ± 3.1 (52 to 65) 
 
Table 4.2: Left ventricular structural parameters measured using 2D 
echocardiography in male endurance-trained (ET), resistance-trained (RT) and 
sedentary control (CT) subjects. Data are mean ± SD (Range). 
                                                                                                                                                     
LV-left ventricle, IVSWT-inter ventricular septal wall thickness, d-at end-diastole, s-at 
end-systole, PWT-posterior wall thickness, LVIDd - LV internal diameter, LVEDV- LV 
end-diastolic volume.  Post-hoc analysis from one-way ANOVA at † p<0.05 vs. CT; ‡ 
P<0.05 vs. ET; **P<0.05 vs. RT. 
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Normal geometry was present in most participants, with eccentric hypertrophy 
evident in only 30% of ET and no concentric hypertrophy in RT (Figure 4.2). 
 
Figure 4.2 Comparison of the individual distribution of relative wall thickness (RWT) 
and LV mass index in all athletes. Normal geometry (LV mass ≤115 g/m2 with RWT 
≤0.42), concentric remodelling (LV mass ≤115 g/m2 with RWT >0.42), concentric 
hypertrophy (LV mass >115 g/m2 with RWT >0.42) or eccentric hypertrophy (LV mass 
>115 g/m2 with RWT ≤0.42) as described by Lang et al (2005). 
Global LV functional data are presented in Table 4.3a and 4.3b. SV was higher in ET 
compared to both RT and CT but there was no between-group difference in any 
other global measure of systolic or diastolic function.  Likewise there were no 
between-group differences in regional TDI data.  
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Table 4.3a: Left ventricular systolic functional data in male endurance-trained (ET), 
resistance-trained (RT) and sedentary control (CT) subjects, data are mean ± SD 
(Range).  
 
SV-stroke volume, EF-ejection fraction, E-early ventricular filling, A-late atrial 
contraction, Edecl-E deceleration time, IVRT-Isovolemic relaxation time, VTI-velocity 
time integral, AV max-aortic valve maximum velocity, TDI-tissue Doppler imaging, 
Sep-septal, Lat-lateral, S’-systolic tissue velocity, E’-early diastolic tissue velocity, A’-
late atrial diastolic tissue velocity. Post-hoc analysis from one-way ANOVA, † P value 
<0.05 vs. CT; ‡ P value < 0.05 vs. ET. 
 
 
 
 
 
 
Parameter ET RT CT 
Systolic function 
LVSV (ml) 80 ± 17(48 to 113)† 62 ± 20(37 to 106)‡ 63 ± 17(37  to 93) 
LVSV(ml/ m2) 38 ± 8(26 to 56)† 28 ± 9(15 to 46)‡ 30 ± 6 (20 to 40) 
EF (%) 59 ± 3(54 to 66) 57 ± 4(50 to 65) 59 ± 2(54 to 63) 
LV VTI (cm) 25 ± 3(19 to 29)† 20 ± 2(17 to 25)‡ 22 ± 3(17 to 25) 
Sep S’(cm/s) 10 ± 1(8 to 13) 10 ± 2(7 to 12) 10 ± 2(7 to 13) 
Sep S’/LV 
length 
1.1 ± 0.2(1.1 to 1.4) 1.2 ± 0.2(0.9  to 1.6) 1.1 ± 0.2(0.9 to 1.5) 
Lat S’(cm/s) 12 ± 2(9 to 16) 13 ± 4(8 to 21) 12 ± 2(7 to 15) 
Lat S’/LV length 1.4 ± 0.2(1.1 to 1.9) 1.5 ± 0.4(0.8 to 2.1) 1.5 ± 0.3(1.1 to 2.1) 
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Table 4.3b: Left ventricular diastolic functional data in male endurance-trained (ET), 
resistance-trained (RT) and sedentary control (CT) subjects, data are mean ± SD 
(Range). 
 
 
 
SV-stroke volume, EF-ejection fraction, E-early ventricular filling, A-late atrial 
contraction, Edecl-E deceleration time, IVRT-Isovolemic relaxation time, VTI-velocity 
time integral, AV max-aortic valve maximum velocity, TDI-tissue Doppler imaging, 
Sep-septal, Lat-lateral, S’-systolic tissue velocity, E’-early diastolic tissue velocity, A’-
late atrial diastolic tissue velocity. Post-hoc analysis from one-way ANOVA,† P value 
<0.05 vs. CT; ‡ P value < 0.05 vs. ET 
 
Parameter ET RT CT 
Diastolic function 
IVRT (ms) 71 ± 9(54 to 88) 76 ± 11(53 to 98) 77 ± 11(53 to 95) 
E (m/s) 0.8 ± 0.2(0.6 to 1.2) 0.7 ± 0.2(0.5 to 1.0) 0.8 ± 0.2(0.5 to 1.0) 
A (m/s) 0.5 ± 0.1(0.4 to 0.6) 0.5 ± 0.1(0.3 to 0.7) 0.5 ± 0.1(0.3 to 0.8] 
E/A 1.7 ± 0.3(1.4 to 2.50 1.5 ± 0.5(0.9 to 2.7) 1.7 ± 0.4(1.2 to 2.5) 
Edecl (ms) 140 ± 16([118 to 165] 141 ± 24 (102 to 178) 141 ± 49(99 to 190) 
Sep E’(cm/s) 13 ± 2(10 to 15) 13 ± 3(6 to 18) 13 ± 2(9 to 17) 
Sep A(cm/s)’ 9 ± 2(6 to 11) 8 ± 2(4 to 13) 9 ± 1(6 to 11) 
Lat E’(cm/s) 17 ± 4(8 to 23) 16 ± 4(8 to 24) 17 ± 3(13 to 23) 
Lat A’(cm/s) 8 ± 1(6 to 10) 8 ± 2(4 to 13) 8 ± 2(6 to 14) 
Sep E’/LV length 1.0 ± 0.2(0.6 to 1.3) 1.0 ± 0.3(0.4 to 1.7) 1.0 ± 0.2(0.7 to 1.3) 
Sep A’/LV length 1.3 ± 0.2(0.9 to 1.8) 1.2 ± 0.5(0.9 to 1.9) 1.3 ± 0.3(0.9 to 1.8) 
Lat E’/LV length 1.9 ± 0.5(0.9 to 2.7) 1.9 ± 0.5(1.0 to 2.7) 1.9 ± 0.3(1.5 to 2.5) 
Lat A’/LV length 0.9 ± 0.2(0.6 to 1.2) 1.0 ± 0.3(0.5 to 1.4) 1.0 ± 0.2(0.7 to 1.5) 
E/E’ 5.5 ± 1(3.9 to 7.5) 4.9 ± 1.3(3.2 to 7.2) 5.3 ± 1.1(3.4 to 7.0) 
 - 83 - 
  
4.3.3 2D-STE   
Longitudinal and basal circumferential ԑ were not different between ET and CT but 
were significantly lower in RT compared to ET (Table 4.4). Likewise, basal 
circumferential SRS was significantly lower in RT than the ET (Figure 4.3). 
Longitudinal SRE and SRA were significantly lower in the RT group compared to the 
CT group. There was no significant between-group difference in basal and apical 
rotation and derived LV twist. 
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Table 4.4: Descriptive cohort data for two-dimensional STE derived LV strain (ԑ) and strain rate (SR S
-1
), data are mean ± SD (range). 
Strain (ԑ), SRS-strain rate in systole, SRE-strain rate in early diastole, SRA-strain rate in late diastole. Post-hoc analysis from one-way ANOVA, ‡P<0.05 vs RT
Parameter ET RT CT 
Longitudinal 
Peak ԑ (%) -18.6 ± 2.2 (-22.9 to -14.4)‡ -16.2 ± 1.7 (-20 to -12) -17.7 ± 2.1 (-21.9 to -14.7) 
Peak SRS (S
-1
) -0.9 ± 0.1 (-1.2 to -0.8) -0.9 ± 0.1 (-1.1 to -0.7) -0.9 ± 0.1 (-1.2 to -0.7) 
Peak SRE (S
-1
) 1.31 ± 0.21 (1.0 to 1.9) 1.14 ± 0.24 (0.8 to 1.6) 1.29 ± 0.19 (0.9 to 1.7) 
Peak SRA (S
-1
) 0.7 ± 0.1 (0.5 to 0.9) 0.7 ± 0.2 (0.4 to 0.8) 0.7 ± 0.1 (0.5 to 0.8) 
Basal circumferential 
Peak ԑ (%) -18.5 ± 3.4 (-22.5 to -12)‡ -13.5 ± 3.3 (-21.4 to -9.8) -15.8 ± 2.9 (-20.8 to -11.6) 
Peak SRS (S
-1
)
 
 -1.15 ± 0.20 (-1.7 to -0.9)‡ -0.90 ± 0.19 (-1.3 to -0.7) -1.1 ± 0.2 (-1.5 to -0.8) 
Peak SRE (S
-1
) 1.7 ± 0.4 (1.2 to 2.3) 1.2 ± 0.4 (0.8 to 2.0) 1.3 ± 0.4 (0.9 to 2.1) 
Peak SRA (S
-1
) 0.4 ± 0.1 (0.2 to 0.6) 0.5 ± 0.2 (0.2 to 0.7) 0.4 ± 0.1 (0.2 to 0.9) 
Rotation 
Peak apical rotation (
o
) 9.8 ± 3.1 (3.8 to 16.6) 8.2 ± 3.2 (3.8 to 14.5) 10.8 ± 3.5 (3.1 to 15.1) 
Peak basal rotation (
o
) -5.8 ± 2.3 (-10.4 to -2.8) -4.7 ± 2.2 (-9.1 to -2.1) -3.8 ± 2.1 (7.1 to -2.1) 
Peak twist (
o
) 15.3 ± 4.4 (5.1 to 22.7) 12.5 ± 4.8 (5.9 to 22.1) 14.50 ± 3.9 (9.8 to 21.5) 
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4.4 Discussion 
The key outcomes from this study were; 1) A normal geometry was predominant 
across all groups with only 30% of ET demonstrating an eccentric hypertrophy and 
no concentric hypertrophy in RT, 2) global LV function and TDI data were comparable 
between groups, but peak longitudinal and basal circumferential ԑ was lower in RT 
than ET, 3) indexing of LV structures for BSA uncovered increased wall thickness 
dimensions in ET compared to both RT and CT groups. 
4.4.1 The Morganroth Hypothesis 
The present study demonstrated that ET is associated with increased LV volume and 
mass but the geometry remained normal in the majority and eccentric hypertrophy 
in only 30% athletes. These finding partially conform to the MH as well as 
subsequent studies and reviews (Utomi et al., 2013, Pluim et al., 2000, Pelliccia et al., 
1991, Baggish et al., 2008, Haykowsky et al., 2000) but suggests that the degree of 
hypertrophy  is limited and varies between individuals. Endurance sporting activity 
entails a sustained high oxygen demand. An increased cardiovascular preload (La 
Gerche et al., 2011) and a haemodynamic volume overload is suggested as the 
primary stimulus for LV adaptation in ET (George et al., 1991).  
Teleologically, an increase in LV volume and mass should contribute to a higher SV 
and cardiac output, thus underpinning an elevated performance capacity. Review of 
the 30% of ET with an eccentric hypertrophy revealed no systematic association with 
age, BSA, performance times and/or training history that could explain this 
adaptation.  
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There was no concentric hypertrophy in RT. This confirms previous cross-sectional 
data (George et al., 1999) and meta-analysis (Utomi et al., 2013) but conflicts with 
the MH. The lack of concentric adaptation in RT could be due to limited exposure to 
an increased haemodynamic afterload during resistance exercise training, or the 
potential lack of any afterload stimulus due to the fact that wall stress is not 
elevated during lifting when a brief phase 1 Valsalva manoeuvre is performed 
(Haykowsky et al., 2001).  
A key take home message for clinicians is that normal cardiac geometry is 
predominant across all groups, and that the upper limits of LV wall thickness and 
cavity dimensions were within published normal limits (Lang et al., 2005) and 
recorded in ET athletes. These data, confirm current practice in relation to the 
cardiovascular pre-participation screening of athletes and the differential diagnosis 
of the AH from pathology. 
 
4.4.2 Left ventricular function  
A larger SV in ET has been reported in most athlete-control studies (Pelliccia et al., 
1991) with no difference between RT and CT (Utomi et al., 2013).  The current study 
confirms this pattern.  The larger SV in ET is partially due to the larger LV dimensions 
at rest. Current data and previous studies (Utomi et al., 2013, Pelliccia et al., 1991, 
George et al., 1999) have demonstrated that LV EF is normal in athletes.  This 
suggests that resting contractility in athletes is not augmented. 
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The assessment of diastolic flow yielded no significant between-group difference. 
Some individual studies have reported improved diastolic filling at rest in athletes 
(Florescu et al., 2010) but this observation is not consistent. It is possible that the 
important adaptation in LV diastolic filling in athletes is not apparent at rest but 
noticeable during exercise (Batterham et al., 2008). 
 
4.4.3 Novel techniques  
We did not observe any significant between group differences in systolic and/or 
diastolic LV TDI velocities. This supports some previous data (Baggish et al., 2008)  
but contradicts study by Florescu and colleagues, who observed significantly higher 
longitudinal velocities in ET in comparison to CT. One possible reason for the 
contradictory outcomes between studies in relation to TDI data could be the 
inconsistent approach to scaling tissue velocities (Florescu et al., 2010).  Batterham 
et al documented that S’ and E’ were proportional to LV length, providing empirical 
support for the scaling procedures adapted by Pela et al and the current study 
(Batterham et al., 1999, Pela et al., 2004). 
Despite the lack of between group differences in TDI data, we observed that highly 
trained RT had a lower peak longitudinal ԑ and peak SRS than ET, although neither RT 
or ET were significantly different from CT. Whilst there is limited data related to STE 
in athletes, the current ET data agrees with Stefani et al who reported no differences 
in LV STE measurements between 20 endurance athletes and 18 controls (Stefani et 
al., 2009). Similarly, Nottin et al documented that longitudinal ԑ, S’, E’ and A’ did not 
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differ between endurance-trained cyclists (n=16) and controls (n=23) (Nottin et al., 
2009).  In contrast, Simsek et al reported higher ԑ values at rest in marathon runners 
compared to sedentary subjects (Simsek et al., 2013). These disparate findings 
warrants further evaluation as it calls the reliability of segmental ԑ to question.  
Whilst there were no differences in STE data between ET and CT we noted lower ε 
data in RT.  This data is at odds with a previous study by Simsek et al who 
documented higher systolic ԑ and SR in both runners and wrestlers compared to 
sedentary individuals (Simsek et al., 2013). The observation of lower ԑ in RT, 
compared to ET, requires further study and we cannot determine the mechanism(s) 
underpinning this data from the current cross-sectional study.  It is, however, 
unlikely that this data represents an increased ԑ reserve in RT (Akagawa E et al., 
2007) as this type of adaptation would serve no purpose to the RT sporting activity.   
As well, it is unlikely to reflect a higher resting HR in RT as ԑ tends to increase with 
HR under inotropic stimulation (Gutgesell and Rembold, 1990). Whilst STE data in RT 
is limited, it is interesting to note that in a longitudinal training study, Baggish and 
colleagues documented a significant reduction in LV early and late diastolic tissue 
velocities in participants who undertook strength-training. Baggish et al speculated 
that training-related changes in LV afterload and increased peripheral vascular 
resistance could be implicated in these changes (Baggish et al., 2008). The current 
data prompt continuing research in this area. 
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4.4.4 Impact of body composition on the athlete’s heart phenotype  
Differences in absolute LV chamber size between the ET and both RT and CT were 
maintained with both ratio and allometric scaling for individual differences in BSA. 
Indexing of LV wall thickness for BSA did ‘uncover’ a higher LV wall thickness index in 
ET compared to RT. Scaling has been observed to alter data interpretation in a small 
number of previous studies (George et al., 1999) and the current data partially 
support this.  
On the basis of the current data and previous theoretical (Gutgesell and Rembold, 
1990) and empirical (George et al., 2001, De Simone et al., 1995) research we would 
argue that interpretation of absolute cardiac dimensions must take account of body 
size differences.  Further, ratio scaling can be misleading and thus should always be 
empirically supported within the sample being studied, alongside an exploration of 
other potentially allometric approaches to determine which index is indeed size-
independent (Batterham et al., 1999, George et al., 2001, Dewey et al., 2008).  
 
4.5 Limitations and future research 
This cross-sectional study, as well as the previous meta-analysis cannot directly 
support a “cause-effect” relationship between exercise mode and physiological 
cardiac remodelling.  Significantly, our study is limited to the LV in adult male 
athletes. The assessment of RV and atrial structure and function in various athlete 
groups, with novel technologies, requires substantial development and is particularly 
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relevant to interpretation of clinical data and should form the focus of the next study 
in this thesis.    
 
4.6 Conclusions 
Although ET express an AH phenotype with an increased LV chamber size, the overall 
LV geometry was normal in the majority of athletes. Highly-trained RT do not display 
concentric LV hypertrophy suggesting that the MH requires revision.  Whilst global 
cardiac function and TDI data were largely similar between all groups there was 
some evidence of lower LV ԑ in RT. Finally, appropriate scaling of LV structural data 
for within subject differences in BSA can alter between group comparisons and 
should be adopted in future research. 
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CHAPTER 5 
 
DOES TRAINING TYPE RESULT IN A DICHOTOMOUS RIGHT 
VENTRICULAR ATHLETIC HEART PHENOTYPE IN MALE 
ATHLETES  
 
This chapter has been published as ‘Does training type result in a dichotomous right 
ventricular athletic heart phenotype in male athletes’ in Eur J Appl Physiol DOI 
10.1007/s00421-015-3147-3. http://link.springer.com/article/10.1007/s00421-015-
3147-3. 
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5.1 Introduction 
Regular intense sporting activity can lead to physiological hypertrophy of the left 
ventricle (LV) that was initially proposed to be training dependent (Morganroth et 
al., 1975). The training-dependent dichotomous athletic heart phenotype was linked 
to differential haemodynamic loading during acute exercise (George et al., 1991) 
resulting in eccentric hypertrophy (balanced increase in chamber and wall 
dimension) with endurance training versus concentric hypertrophy (disproportionate 
increase in wall thickness) with resistance training.  Evidence from a cross-sectional 
study in the previous chapter and a meta-analysis in Chapter 2 suggests adaptation 
in endurance-trained athletes (ET) but casts doubt over the degree and pattern of 
adaptation in resistance-trained athletes (RT). 
Whether the right ventricle (RV) demonstrates a training-dependent athletic heart 
phenotype has received less attention (Utomi et al., 2014).  This may be partially due 
to the complexity of non-invasive imaging of the RV but technological advancements 
have resulted in a standardised assessment protocol for the RV (Rudski et al., 2010). 
These recent developments have prompted renewed interest in the RV of athletes 
and the ability to differentiate RV physiological hypertrophy from pathological 
changes associated with congenital diseases such as arrhythmogenic RV 
cardiomyopathy (ARVC) (Maron et al., 2007). 
A small number of studies have described greater RV structural parameters in ET 
compared to controls (Baggish et al., 2008, Teske et al., 2009a, Oxborough et al., 
2012b, D'Andrea et al., 2013) but limited evidence has assessed the impact of 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The description originally presented here cannot be made freely available via LJMU Digital 
Collections because of ‘copyright’ reason. The text was sourced at Eur J Appl Physiol DOI 
10.1007/s00421-015-3147-3. http://link.springer.com/article/10.1007/s00421-015-3147-3. 
 - 93 - 
  
different training on the RV d (D'Andrea et al., 2013, Koc et al., 2007, Pagourelias et 
al., 2013, King et al., 2013). In addition it is well established that taking into account 
differences in body size can alter the interpretation of LV athletic heart data (Dewey 
et al., 2008) but little attention has been given to the scaling of RV dimensions 
(Oxborough et al., 2012b).  This is, however, important in any RV data interpretation 
and could have implications for improving the sensitivity and specificity of existing 
upper normal limits for RV dimensions (Oxborough et al., 2012b).  
Finally, available global and regional functional data in the RV of athletes is also 
limited. RV strain (ε) data in athletes are controversial with reduced resting 
deformation in some (King et al., 2013, Teske et al., 2009a, La Gerche et al., 2012) 
but not all studies (Oxborough et al., 2012b, Pagourelias et al., 2013). Given the 
potential value of deformation parameters to improve the discrimination of normal 
and pathologic adaptation (Teske et al., 2009a, Marcus et al., 2010), further 
evaluation in different athlete groups will be unique. 
This study tests the hypotheses that; 1) global RV adaptation to exercise is mediated 
by training type; 2) the scaling of RV structural data will alter data interpretation, 
and 3) global and regional RV function will be training-type dependent.  
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5.2 Methods 
 
5.2.1 Study design and procedures 
A prospective cross-sectional study design was employed with data acquired in a 
resting state at a single testing session. All subjects were advised to abstain from 
exercise training, caffeine and alcohol consumption at least 3 hours prior to the 
investigation. After a detailed explanation of the test protocol, subjects were initially 
issued with a medical questionnaire and then assessed for basic anthropometrics.  
Height and body mass were assessed using a stadiometer and digital weighing 
machine (SECA 764, Birmingham, UK) and body surface area (BSA) was calculated 
(Dubois and Dubois, 1916). After 5 minutes of supine rest, brachial artery systolic 
and diastolic blood pressures as well as resting heart rate were assessed with an 
automated sphygmomanometer (DINAMAP 300, GE Medical Systems, Milwaukee, 
USA).  
 
5.2.2 Echocardiographic assessment 
Standard echocardiographic investigation was performed using a Vivid Q ultrasound 
machine (GE Medical System, Horten, Norway) with a 1.7-4 MHz transducer. All 
acquisitions were made with the subject lying in the left lateral decubitus position by 
the same experienced echocardiographer using a standard echo-protocol in 
accordance with the American Society of Echocardiography (ASE) (Lang et al., 2005). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The description originally presented here cannot be made freely available via LJMU Digital 
Collections because of ‘copyright’ reason. The text was sourced at Eur J Appl Physiol DOI 
10.1007/s00421-015-3147-3. http://link.springer.com/article/10.1007/s00421-015-3147-3. 
 - 95 - 
  
Standard 2D echocardiographic parameters were obtained from parasternal and 
modified apical acoustic windows (Rudski et al., 2010). Images were recorded to DVD 
in a raw Digital Imaging and Communications in Medicine (DICOM) format. Further 
offline analysis was performed using commercially available software (EchoPAC 
Version 7.0; GE Vingmed Ultrasound, Horten, Norway). 
   
5.2.3 Conventional 2D and Doppler / Tissue Doppler 
In accordance with ASE guidelines, RV size was measured at end-diastole from the 
proximal RV out flow tract at the level of the aortic valve (PLAX RVOT and RVOT1), 
and at the pulmonary valve annulus (RVOT2) using a parasternal short-axis (PSAX) 
orientation. RV free wall was measured in diastole from the subcostal view and RV 
cavity dimensions at the basal RV inflow (RVD1), mid-level (RVD2) and RV length 
(RVD3) were measured from the modified apical 4-chamber orientation. RV diastolic 
and systolic areas were calculated by tracing around the endocardium from a 
modified apical 4-chamber orientation, and RV fractional area change (RV FAC) was 
calculated (Rudski et al., 2010).  
Tricuspid annular plane excursion (TAPSE) was obtained as a measure of RV 
longitudinal function. RV stroke volume (RVSV) was calculated using the general 
formula RVSV = π (RVOT/2)*2 x VTI, RV velocity time integral (VTI) was measured 
from the Doppler spectral envelop derived from a 4mm sample volume placed at the 
RV outflow in the PSAX view (Lang et al., 2005, Rudski et al., 2010). All RV structural 
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variables were allometrically scaled for individual differences in BSA according to 
laws of geometric similarity (Dewey et al., 2008).  
Pulsed wave TDI was used to assess RV myocardial velocities with a 4mm sample 
volume positioned in the lateral aspect of the tricuspid annulus of the RV lateral wall 
and peak velocities in systole (RVS’), early diastole (RVE’) and late diastole (RVA’) 
were measured.  Tissue velocity data were scaled to RV length (Batterham et al., 
2008). 
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5.2.4 Speckle tracking echocardiography (STE) 
The modified apical 4-chamber orientation was used for the assessment of 
longitudinal RV ԑ and strain rate (SR). During off-line analysis, the region of interest 
(ROI) was placed around the RV lateral wall from the base to apex. A priori, each 
segment was visually inspected, and the ROI adjusted to track in synchrony before 
approval. Regional peak values were obtained at the base, mid and apical RV wall 
and a base-to-apex gradient was calculated.  
Global peak values were calculated as an average of all 3 myocardial segments. 
Indices obtained included peak RV ε and SR during ventricular systole (SRS) and 
during early and late ventricular diastole (SRE and SRA).  Intra-observer variation for 
RV structural and functional data in our laboratory demonstrated no systematic bias 
for peak ε or indices of SR (P < 0.05) with intraclass correlation coefficients of 0.834 
and 0.610, respectively (Oxborough et al., 2012b). 
5.2.5 Data analysis and statistics 
All analyses were performed using SPSS, version 20.0, for Windows (SPSS, Chicago, 
IL, USA) and the critical alpha was set at p ≤ 0.05. Absolute data were extracted from 
DICOM file format. Data are presented as mean ± SD, and were analysed between 
groups using one-way ANOVA and Bonferoni post hoc test for multiple comparison 
to estimate differences between groups. A priori, a sample size of 15 from each 
target population (CT, ET and RT) was prospectively determined to achieve 80% 
statistical power, accommodate data variability in the study population and detect 
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the minimum difference of 3 mm in RV chamber dimension between groups 
(Minitab 16, Minitab ltd, Coventry, United kingdom). 
 
 
 
 
 
 
 
 
 
 
5.3 Results 
 
5.3.1 Study population 
After institutional Ethics Committee approval, 61 males provided written informed 
consent to participate in the study. We recruited elite athletes (competitive at a 
national or international level).  Specifically, 19 were elite ET recruited from an 
international field at the 100-mile Western States Endurance Run (California, USA)  
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 Table 5.1: Demographic data of male endurance-trained (ET), resistance-trained 
(RT) and sedentary control (CT) subjects. 
Parameter ET RT CT 
Sample Size 
(n) 
19 21 21 
Age (yrs) 34±5(23 to 41)* 29 ± 8(18 to 44) 
[18:44] 
27 ± 8(20 to 43) 
[20:43] Body Mass 
(kg) 
74 ± 9(59 to 87) 83 ± 14(61 to 111) 
[61:111] 
76 ± 10(61 to 91) 
[61:91] Height (m) 1.8 ± 0.1(1.5 to 1.9) 
[1.5:1.9] 
1.8 ± 0.1(1.7 to 1.9) 
[1.7:1.9] 
1.8 ± 0.1 (1.6:1.9) 
BSA (kg/m2) 2.1 ± 0.2(1.7 to 2.4) 
[1.7:2.4] 
2.3 ± 0.3(1.8 to 2.9) 
[1.8:2.9] 
2.1 ± 0.2(1.7 to 2.5) 
[1.7:2.5] Heart rate 
(beats.min-1) 
56 ± 11(40 to 80)† 
[40:80] 
70 ± 11(56 to 98) 
[56:98] ‡ 
63 ± 10(53 to 84) 
[53:84] Systolic BP 
(mmHg) 
132 ± 10(110 to 142) 
[110:142] 
134 ± 9(110 to 145) 128 ± 12(104 to 
140) Diastolic BP 
(mmHg) 
78 ± 11(58 to 90) 76 ± 7(59 to 89) 75 ± 8(59 to 89) 
Data are mean ± SD with [range]. BSA – Body surface area; One-way ANOVA 
significant at *P<0.05 versus CT and †p< 0.05 versus RT. 
 
5.3.3 2D-Echocardiography: Right ventricular structure 
RV structural data (absolute and allometrically scaled) are contained in Table 5.2. 
Higher absolute values for RVD1, RVD3, RV areas and RV free wall thickness were 
observed in the ET compared to CT. Absolute RVD1 was also higher in ET than RT.  
When these variables were scaled allometrically, all remained significant except 
RVD3 (between ET and CT) and RVD1 (between ET and RT). There were no 
differences in absolute or scaled RV structural data between RT and CT. 
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Table 5.2: Absolute and allometrically scaled right ventricular structural data in male 
endurance-trained (ET), resistance-trained (RT) and sedentary control (CT) subjects. 
 
Data are mean ± SD with [range]. RV-Right ventricle, RVOT PLAX-RV outflow tract dimension 
parasternal long axis, RVOT1-basal parasternal short axis, RVOT2-distal parasternal short 
axis, RVD1-basal dimension, RVD2-mid cavity dimension, RVD3-longitudinal dimension,  
One-way ANOVA significant at * p<0.05 versus CT and †P<0.05 versus RT. 
Table 5.3 shows the % of subjects in each group that fulfilled the structural 
component of the major and minor revised ASE Taskforce Criteria for the diagnosis 
of ARVC in the absence of RV dysfunction across groups (Marcus et al., 2010). 
 
Table 5.3: Percentage of participants in each group who met specific ASE revised 
task force criteria for diagnosis of ARVC (Marcus et al 2010). 
Parameter ET RT CT 
Right heart standard 2-Dimensional echocardiographic  parameters 
RVOT Plax (mm) 31 ± 4.3 (23 to 37) 29 ± 3.8 (22 to 35) 30 ± 4.3 (23 to 38) 
RVOT1 (mm) 32 ± 4.9 (24 to 40) 31 ± 4.5 (22 to 42) 33 ± 3.2 (23 to 36) 
RVOT2 (mm) 27 ± 5.0 (22 to 39) 25 ± 3.2 (20 to 32) 26 ± 2.9 (20 to 31) 
RVD1 (mm) 45 ± 4.9 (39 to 57)† 40 ± 5.1 (32 to 51) 39 ± 4.3 (31 to 45) 
RVD2 (mm) 30 ± 3.0 (25 to 35) 30 ± 4.0 (24 to 38) 29 ± 3.1 (20 to 32) 
RVD3 (mm) 88 ± 8.8 (72 to 106) 84 ± 9.6 (69 to 1.2) 81 ± 10.0 (64 to 98) 
RV diastolic area 
(cm2) 
27 ± 3.8 (23 to 35)† 24 ± 4.8 (17 to 36) 22 ± 3.9 (15 to 29) 
RV systolic area (cm2) 14 ± 2.2 (10 to 18)† 13 ± 2.9 (8 to 18) 11 ± 3.3 (7 to 18) 
RV thickness (mm) 4 ± 0.6 (3 to 5)† 4 ± 0.5 (3 to 5)  3 ± 0.5 (2 to 4) 
RA major (mm) 50 ± 5.3 (41 to 59)† 48 ± 7.1 (33 to 54) 47 ± 6.8 (35 to 54) 
RA minor (mm) 45 ± 4.9 (38 to 52) 44 ± 5.7 (40 to 48) 43 ± 5.8 (35 to 51) 
RA area (cm2) 19 ± 3.5 (15 to 26)† 16 ± 4.1 (9 to 24)‡ 16 ± 2.7 (11 to 21) 
RV/LV 0.9 ± 0.1 (0.8 to 1.0) 0.8 ± 0.1 (0.7 to 1.0) 0.9 ± 0.9 (0.7 to 1.0) 
PA Diameter (mm) 22 ± 2.1 (20 to 26) 21 ± 2.1 (19 to 22) 22 ± 1.9 (20 to 25) 
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ASE-American Society of Echocardiography, PLAX-parasternal long axis, PSAX-
parasternal short axis, BSA-body surface area, RV-right ventricle, RVOT-RV out flow 
tract and FAC-fractional area change.  
 
 
 
5.3.4 Global and regional right ventricular function 
Global RV functional data are presented in Table 5.4. There was no statistically 
significant difference (p<0.05) in standard RV functional parameters between all 
groups. Global RV ԑ, SRS as well as segmental ԑ did not significantly differ between 
the three groups. The base-to-apex gradient for ε was not different between groups 
(Table 5.5). 
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Table 5.5: STE-derived RV longitudinal ε and SR 
 
Data are mean ± SD with (range). ε-strain, SRS - strain rate in systole, SRE - strain rate in early diastole and SRA - strain rate in late diastole.
 
RV Parameters ET  RT CT 
Peak global RV ε (%) -26.9 ± 4.3 (-34.7 to -21.3) -27.4 ± 4.9 (-36.6 to -21.8) -28.4 ± 2.7 (-37.0 to -25.0) 
Peak basal wall ε (%) -26.2 ± 3.4 (-32.9 to -20.7) -26.5 ± 3.2 (-32.6 to -20.7) -28.2 ± 3.0 (-34.8 to -24.5) 
Peak mid wall ε (%) -26.4 ± 5.2 (-33.2 to -20.4) -27.5 ±2.5 (-33.6 to -23.6) -28.4 ± 4.6 (-37.9 to -22.0) 
Peak apical wall ε (%) -30.7 ± 4.1 (-38.8 to  -23.5) -31.3 ± 3.3 (-36.6 to -26.2) -32.6 ± 3.0 (-38.8 to -23.5) 
Base to apex ε gradient (%) -4.6 ± 2.5 (-9.4 to  -0.8) -4.7 ± 2.5 (-8.3 to -1.0) -4.4 ±2.9 (-9.1 to -1.9) 
Peak global RV SRS (s-1)  -1.4 ± 0.2 (-2.0 to -1.1) -1.5 ± 0.3 (-2.1 to -1.0) -1.5 ± 0.2 (-2.0 to -1.2) 
Peak global RV SRE (s-1 ) 1.2 ± 0.5 (1.1 to 2.8) 1.8 ± 0.5 (1.2 to 2.8) 1.9 ± 0.5 (1.2 to 2.8) 
Peak global RV SRA (s-1)  1.1 ± 0.2 (0.8 to 1.6) 1.1 ± 0.3 (0.5 to 1.6) 1.0 ± 0.3 (0.5 to 1.4) 
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5.4 Discussion  
The key findings from this study were that 1) RV chamber and wall thickness were greater in 
ET compared to CT but with no differences noted between RT and CT, 2) scaling or 
indexation of RV structural data for individual differences in BSA can significantly alter data 
interpretation for some variables, and 3) neither ET nor RT altered RV global and regional 
function compared to CT.  
5.4.1 Right ventricular morphology 
This study provides additional evidence that physiological remodelling can occur in the RV of 
ET. Overall, the higher RV diameters and areas in ET support previous studies (Oxborough et 
al., 2012b, D'Andrea et al., 2013).  Cross-sectional athlete data were supported by a 
prospective study of ET (Koc et al., 2007), where a progressive increase in training load over 
12 weeks resulted in evidence of RV dilatation.  A greater RV wall thickness was also 
observed in the ET compared to CT and this finding confirms some previous data (Koc et al., 
2007, King et al., 2013).  
The putative mechanism(s) involved in RV adaptation to ET remain controversial and poorly 
understood.  Haemodynamic theories of adaptation previously applied to the LV have been 
purported to play a similar role in the RV such that ET activity places a prolonged but 
intermittent haemodynamic volume overload that initiates structural adaptation to 
normalise wall stress (Grossman et al., 1975). It was demonstrated recently that a 
disproportionate haemodynamic afterload is placed on the RV, compared with the LV, 
during intense ET due to a greater relative increase in pulmonary artery systolic pressure 
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(PASP) vs. systemic pressure (LaGerche et al., 2011) and this may partially explain the 
increase in RV wall size in the ET. 
Of note in the current study was the lack of difference in RV structural data between RT and 
CT, especially in relation to wall thickness. This lack of adaptation mirrors recent LV data 
(D'Andrea et al., 2013, Pagourelias et al., 2013, Utomi et al., 2013) as well as an athlete-
control cross-sectional examination of the LV (Utomi et al., 2014). Further, a lack of RV 
adaptation was noted in prospective data collected before and after a progressive increase 
in RT training load (Baggish et al., 2008).  Potential reasons for the lack of adaptation in the 
RV of elite RT may relate to the limited time exposure to any haemodynamic overload, 
compared to the long-term steady state haemodynamic conditions associated with 
endurance training. Additionally, the lack of any significant haemodynamic pressure 
overload stimulus in the presence of a Valsalva manoeuvre often performed by RT could 
also contribute (Haykowsky et al., 2001).   
The present study also demonstrated that when absolute RV data are scaled for individual 
differences in body size (here BSA scaled allometrically) alterations in statistical comparisons 
can occur which fundamentally changes data interpretation. Whilst not a consistent affect 
across all variables, this should be noted carefully.  The importance of body size on cardiac 
dimension has been demonstrated in previous LV studies (George et al., 1998, Utomi et al., 
2014) and a recent meta-analysis (Utomi et al., 2013). The current data add to this 
knowledge base specifically with respect to the interpretation of RV data in athletes but 
further work should produce normative data for large athlete groups using this allometric 
approach. 
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5.4.2 Global and regional right ventricular function 
Similar to the study by King et al (2013), RV FAC and TAPSE as well as a range of other global 
parameters were not different between ET, RT and CT. Conversely, Teske et al (2009b) 
reported a higher TAPSE in ET (26 ± 5 mm) than CT (24 ± 3 mm). Whilst the absolute mean 
data are not dissimilar to our study (ET: 24 ± 3 mm; CT 25 ± 2 mm) the heterogeneity in 
statistical outcomes between studies may be due to sample size, differences in age, training 
levels and echocardiographic vendor/quality.  We also observed no between group 
differences in RV diastolic Doppler-flow parameters which confirms past work (Prakken et 
al., 2010, Oxborough et al., 2012b, Pagourelias et al., 2013) but disagrees with Teske et al 
(2009a & 2009b). Overall there seems to be little evidence to support training induced 
changes in global RV systolic and diastolic function, including prospective data from Baggish 
et al (2008), and this would suggest that resting RV function is normal in athletes.  
In addition to global function we observed no between group differences in regional RV 
function using tissue-Doppler and STE. This confirms previous TDI data in athlete-control 
comparisons (Pelà et al., 2004, Krol et al., 2011, D'Andrea et al., 2013). Of note global and 
regional longitudinal RV Ԑ and SR were not different between groups and were also not 
diminished in any athletes meeting the RV structural indices of the ARVC ASE revised Task 
Force criteria (Marcus et al., 2010). This observation contrasts with the report by Teske et al 
(2009) who demonstrated that Ԑ and SR of the RV free wall were reduced in 63 highly 
trained athletes relative to controls, particularly in the basal segments of athletes with RV 
dilatation. The authors proposed that this reflected normal physiological adaptation that 
resulted in a base-to-apex gradient in RV deformation (Teske et al., 2009a).  
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 Whilst we observed a base-to-apex gradient in deformation, this was not different between 
groups. It is speculated that because RV volume is greatest at the base, a smaller degree of 
deformation may be required to generate the same stroke volume, if contractility is 
preserved which consequently produces a base-to-apex gradient (La Gerche et al., 2012). It 
is also possible that any functional adaptation in the athletic heart is not apparent at rest, 
but may be noticeable during exercise (La Gerche et al., 2012). Further assessment of global 
and regional RV function at peak exercise could provide further insight to allow for 
distinction between athletes, control participants and those with RV pathology. 
 
5.5 Clinical Implications: The ASE revised criteria for the diagnosis of ARVC 
We applied the revised Task Force diagnostic criteria for ARVC (Marcus et al., 2010) to RV 
data in all groups. Major and minor RV structural criteria were observed in all groups but 
generally the higher percentages occurred in ET.  The highest prevalence of any single 
criteria was for RVOT dimension measured in the PLAX, with lower expression in the PSAX 
suggesting that the imaging window should be taken into account in any data 
interpretation. In 50% of ET, absolute PLAX RVOT fulfilled the major echocardiographic 
diagnostic criteria (≥ 32 mm) and 16% met the minor criteria (≥ 29 mm but ≤ 32 mm) for 
ARVC, although when these data were scaled (ratio) to BSA the prevalence dropped 
markedly and again reflects the importance of scaling RV structural data. These findings are 
consistent with previous reports from our group (Oxborough et al., 2012b) and others 
(Teske et al., 2009a, Prakken et al., 2010). The important point, from a clinical perspective is 
that no individual participant met either the major or minor ARVC criteria of poor RV 
function (Marcus et al., 2010).  
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5.6 Limitations and future research 
This was a cross-sectional study in small but highly trained cohorts of male Caucasian 
athletes. Further work should expand the participant base as well as development of a 
prospective cohort designs. For example the study of different ethnic groups is becoming 
more relevant and there is limited data specifically studying different training groups in 
separate ethnic populations.  This is important to develop the application of these data 
around the globe. Future studies should describe the upper limits of atrial structure and 
function in elite athlete groups as well as develop data on the acute exercise response of 
cardiac function in the athletic heart. 
 
5.7 Conclusion 
This study observed greater RV dimensions in elite ET compared to CT with no evidence of 
physiological RV hypertrophy in RT.  Most of the ET met at least one major or minor 
criterion for ARVC but these data, as well as Statistical significant  between group 
comparisons, were ameliorated by scaling or indexing of absolute data. Global and regional 
RV function were not different between both athlete groups and CT.   
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CHAPTER 6 
 
THE ATHLETE’S HEART PHENOTYPE IN WEST AFRICAN RESISTANCE-
TRAINED ATHLETES: AN EXPLORATORY STUDY   
 110 
  
6.1 Introduction 
The “athlete’s heart” (AH) reflects a complex range of structural, functional and electrical 
adaptations to prolonged periods of training (Morganroth et al., 1975).  The AH has been 
the focus of substantial enquiry to determine; 1) how the heart adapts to training, 2) 
whether this adaptation is obligatory for enhanced athletic performance, and 3) how we can 
easily differentiate the athlete’s heart from hereditary disease states like hypertrophic 
cardiomyopathy (HCM) and arrythmogenic right ventricular cardiomyopathy (ARVC). These 
pathologies can present with phenotypes similar to the AH and place the athlete at risk of 
sudden cardiac death (SCD) (Maron and Pelliccia, 2006 ).  As a consequence, the AH has 
been extensively described (George et al., 2011) in an attempt to develop rigorous clinical 
algorithms to identify at risk individuals.   
Following from the systematic review and meta-analysis, and the 2 cross-sectional studies 
included in the earlier chapters of this thesis, the study of the AH and the definition of 
normal limits for cardiac structure and function included in clinical algorithms have been 
largely based on data from Caucasian athletes. The study of other ethnic groups is essential 
especially when one considers that Black athletes (BA) have a 2-fold higher incidence of SCD 
compared to Caucasian athletes (Maron and Pelliccia, 2006 , Magalski et al., 2011).  
Description of the AH in BA has developed recently, with evidence of greater LV wall 
thickness and elevated LV mass in generalised cross sectional groups of BA compared to 
Caucasian athletes (Basavarajaiah et al., 2008, Rawlins et al., 2010).  These authors 
concluded that ethnicity was the strongest predictor of maximal LV wall thickness (LVWT).  
Other recent studies have described an increased prevalence of repolarisation abnormalities 
on ECG in BA (Corrado et al., 2009, Magalski et al., 2011, Drezner et al., 2013b) The updated 
 111 
  
“Seattle ECG criteria for athlete screening” recognises these ethnic differences as normal 
ECG patterns in BA population (Appendix 9.11 & 9.12) (Drezner et al., 2013a).  
Current ECG and echocardiographic studies in BA have largely ignored training type/mode 
as a specific issue of interest.  This is despite recent data in Caucasian athletes that have 
questioned the existence of an AH phenotype in elite Caucasian resistance trained (RT) 
athletes (Haykowsky et al., 2001, Utomi et al., 2013, Utomi et al., 2014).  Magalski et al 
(2011) reported that black ethnicity was a statistically significant predictor of distinctly 
abnormal ECGs (relative risk 1.82, 95% confidence interval, 1.22-2.73; P<0.01), however 
clinically important racial differences in cardiac structures were not apparent in their study 
on collegiate athletes(Magalski et al., 2011). Perhaps, there could be more insight on the AH 
phenotype if the data in their study was stratified into training groups. The effect of 
resistance training in BA has not been investigated comprehensively.  
Finally, although informative the large-scale AH studies in BA by Basavarajaih et al (2008) 
and Rawlins et al (2010) were limited to standard or ‘traditional’ echocardiography 
measurement techniques (Basavarajaiah et al., 2008, Rawlins et al., 2010).  Newer imaging 
modes such as tissue-Doppler imaging (TDI) and speckle tracking echocardiography (STE) 
estimation of strain and (ɛ) and strain rate (SR) can provide detailed information related to 
global and regional function in RT. TDI and STE have been used in a small number of cross-
sectional athlete control studies in Caucasian athletes (CA) but never before in BA of West 
African origin.   
Using ECG and novel echocardiographic technologies in a pilot study design, we proposed to 
define global and regional cardiac structure and function in elite West African resistance 
trained athletes (WRT).  This data was compared to sedentary West African controls (WCT) 
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as well as Caucasian RT athletes (CRT) and sedentary controls (CCT). Previous cross sectional 
studies on Black athletes were not homogenous. They included Afro Caribbean’s, African 
Americans, Black French, Black British descents that were determined through self-report 
questionnaire (Basavarajaiah et al. 2008, Magalski et al. 2008, Rawlins et al. 2010, Magalski 
et al. 2011). Whether these participants were first or second generation blacks and the 
potential for genetic mix in these populations over time could be significant. Secondly, 
empirical studies have demonstrated that significant genetically mediated differences exist 
between, Black Asians, East Africans and West Africans (Dunn et al., 1983, Mayet et al., 
1994, Bhopal, 2004, Agyemang et al., 2005).  
Consequently, the purpose of this pilot study was to characterise the AH phenotype in a 
homogenous population of elite RT athletes of West African origin using state-of-the-art 
imaging technology. In a case control / cross sectional design, this study will provide new 
insight in relation to: 1) Cardiac adaptation to RT in elite WRT; 2) ECG characteristics in WRT 
in comparison with CRT; 3) functional data derived from tissue Doppler imaging (TDI) and 
speckle tracking echocardiography (STE).   
  
6.2 Methods  
6.2.1 Study design and procedures 
A prospective cross-sectional study design was employed with data acquired in a resting 
state at a single testing session. All subjects were advised to abstain from caffeine ingestion 
and exercise training at least 3 hours prior to the investigation. Height and body mass were 
assessed using a stadiometer and digital weighing machine (SECA 764, Birmingham, UK) and 
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body surface area (BSA) was calculated (Dubois and Dubois 1916). After 5 minutes of supine 
rest, brachial artery blood pressure was assessed with an automated sphygmomanometer 
(DINAMAP 300, GE Medical Systems, Milwaukee, Wisconsin).  
6.2.2 Echocardiographic assessment 
A standard echocardiographic investigation was performed using a Vivid Q ultrasound 
machine (GE Medical System, Horten, Norway) with a 2.5-5 MHz transducer. All acquisitions 
were made with the subject lying in the left lateral decubitus position by the same 
experienced echocardiographer using a standard echocardiography-protocol in accordance 
with American Society of Echocardiography (ASE) guidelines (Lang et al. 2005). Offline 
analysis was performed using commercially available software (EchoPAC Version 7.0; GE 
Vingmed Ultrasound, Horten, Norway). 
6.2.2.1 Conventional 2D and Doppler / Tissue Doppler: Left ventricule 
Inter-ventricular septal wall thickness (IVSW), LV internal diameter (LVID) and LV posterior 
wall thickness (PWT) were measured at end-diastole (IVSWd, LVIDd and PWTd), using 2D 
imaging and LV mass was calculated (Lang et al. 2005). LV volumes, stroke volume (SV) and 
ejection fraction (EF) were calculated using Simpson’s biplane method (Lang et al. 2005).  
Doppler assessment of trans-mitral flow allowed the measurement of peak early diastolic 
(E), late diastolic (A) flow velocities, E deceleration time (Edecel) and isovolumic relaxation 
time (IVRT). Pulsed-wave TDI was undertaken with assessments of the basal septum and 
lateral wall where peak early diastolic (E’), late diastolic (A’) and systolic (S’) myocardial 
velocities were obtained. The ratio E/E’ was calculated as a surrogate measure of LA 
pressure (Nagueh et al. 1997, Burgess et al. 2006, George et al. 2010).  
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All LV structural variables were scaled to individual differences in BSA.  This was achieved by 
allometrically according to the laws of geometric similarity (i.e. linear dimensions were 
scaled to BSA0.5, LVIDd was scaled to BSA0.33 and mass measurements were scaled to BSA1.5 
and area measurements to BSA1.0) as well as LV mass being scaled to height2.7 (Batterham et 
al. 1999, George et al. 2001).  TDI data were also scaled linearly to LV length as previously 
demonstrated (Pela et al. 2004). 
6.2.2.2 Conventional 2D and Doppler / Tissue Doppler: Right ventricle 
In accordance with ASE guidelines, RV size was measured at end-diastole from the proximal 
RV out flow tract at the level of the aortic valve (PLAX RVOT and RVOT1), and at the 
pulmonary valve annulus (RVOT2) using a parasternal short-axis (PSAX) orientation. RV free 
wall was measures in diastole from the subcostal view and RV cavity dimensions at the basal 
RV inflow (RVD1), mid-level (RVD2) and RV length (RVD3) were measured from the modified 
apical 4-chamber orientation. RV diastolic and systolic areas were assessed by tracing 
around the endocardium from a modified apical 4-chamber orientation, and RV fractional 
area change (RV FAC %) was calculated (Rudski et al. 2010).  
Tricuspid annular plane excursion (TAPSE) was obtained as a measure of RV longitudinal 
function. RV stroke volume (RVSV) was calculated using the general formula RVSV = π 
(RVOT/2)*2 x VTI, RV velocity time integral (VTI) was measured from the Doppler spectral 
envelop derived from a 4 mm sample volume placed at the RV outflow in the PSAX view 
(Rudski et al. 2010). All RV structural variables were allometrically scaled for individual 
differences in BSA according to laws of geometric similarity (Batterham et al. 1999). Pulsed 
wave TDI was used to assess RV myocardial velocities with a 4mm sample volume 
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positioned in the lateral aspect of the tricuspid annulus of the RV lateral wall and peak 
velocities in systole (RVS’), early diastole (RVE’) and late diastole (RVA’) were measured.  
Tissue velocity data were scaled to RV length (Pela et al. 2004). 
6.2.2.3 Speckle tracking echocardiography (STE): Left ventricle 
The apical 4-chamber view was used for the assessment of longitudinal LV ԑ and SR. For the 
assessment of LV circumferential, radial ԑ, SR and rotation, parasternal short axis views were 
acquired at the tips of the mitral valve (basal) and at the apex defined as the level just above 
the point of systolic cavity obliteration.  
For offline analysis and assessment of longitudinal function, the region of interest (ROI) was 
placed around the LV basal septum through to basal lateral wall encompassing the mid and 
apical wall segments. Peak global LV ԑ and SR were obtained as the average of the base, mid 
and apical wall segments. A priori, each segment was visually inspected, and the ROI 
adjusted to track wall synchrony before approval. The SR curves provided peak measures of 
systolic SR (SRS), early diastolic SR (SRE) and late diastolic SR (SRA). Peak global LV 
circumferential, radial ԑ, SR and rotation were averaged from six myocardial segments with 
the ROI placed around the circumference of the LV at basal and apical levels.  Left 
ventricular twist was calculated as the net difference between apical and basal rotation.  
6.2.2.4 Speckle tracking echocardiography (STE): Right ventricle 
The modified apical 4-chamber orientation was used for the assessment of longitudinal RV ԑ 
and strain rate (SR). During off-line analysis, the region of interest (ROI) was placed around 
the RV lateral wall from the base to apex. A priori, each segment was visually inspected, and 
the ROI adjusted to track wall synchrony before approval. Regional peak values were 
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obtained at the base, mid and apical RV wall and a base-to-apex gradient was calculated. 
Global peak values were calculated as an average of all 3 myocardial segments. Indices 
obtained included peak RV ԑ and SR during ventricular systole (SRS) and during early and 
late ventricular diastole (SRE and SRA).   
Intra class coefficient for LV ԑ for our laboratory are good to very good (0.714-0.807) with 
coefficient of variation for LV peak circumferential and longitudinal ԑ (7% and 6%), basal 
rotation (21%) and twist (10%). For the RV, Intra-observer variation for structural and 
functional data demonstrated no systematic bias for peak ε or indices of SR (P < 0.05) with 
intra-class correlation coefficients of 0.834 and 0.610, respectively (Oxborough et al. 2012). 
6.2.2.5 Electrocardiography (ECG) 
A standard 12 lead Electrcardiogram (ECG) was performed after 5 minutes of rest in suppine 
position with an automated ECG machine (Cardioexpress SL3, Spacelabs Healthcare ltd. 
Hertford, United Kingdom).  ECG tracings recorded the magnitude of electrical potentials 
through the cardiac cycle for P – wave (atrial depolarization). A tall or peaked P-wave 
indicates Right atrial hypertyrophy present in Tricuspid valve stenosis and also in pulmonary 
hypertension. A wide QRS complex (Ventricular depolarization) greater than normal values 
of 120s is suggestive of bundle branch block or extra-systole beat. The T-wave (ventricular 
repolarization) abnormality is be seen in ventricular hypertrophy, cardiac ischaemia and also 
in bundle branch block. The begining of the P-wave to begining of the QRS complex 
recorded the time interval of atrial contraction (PR-interva). Greater than normal value of 
PR interval 200ms suggests some degree of heart block. Whilst the begining of Q-wave to 
the end of T wave is the time interval for Ventricular replolarisation (QT interval) and 
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corrected for variations in heart rate (QTc interval). Abnormalities in QTc interval is 
suggestive of repolarisation abnormalities and channelopathies like Bruggada’s syndrome 
and long QT syndrome. 
6.2.3 Statistical analysis 
Statistical analyses were performed using SPSS, version 20.0, for Windows (SPSS, Chicago, IL, 
USA) and the critical alpha was set at p < 0.05. Data are presented as mean ± SD [Range], 
and were analysed between groups using two-way ANOVA and Bonferoni correction for the 
post hoc test for multiple comparison to estimate differences between groups. A priori, a 
sample size of 15 from each target population (CT, and RT) was prospectively determined to 
achieve 80% statistical power, accommodate data variability in the study population and 
detect the minimum difference of 3 mm in LV/RV chamber dimension between groups 
(Minitab 16, Minitab ltd, Coventry, United kingdom).  
  
6.3 Results 
 
6.3.1 Study population 
A total of 66 males provided written informed consent to participate in the study. We 
recruited elite athletes (competitive at a national or international level) of which 19 were 
resistance trained Caucasian athletes (CRT) recruited from British national Weightlifting and 
Aikido squads, 6 were international West African black RT athletes (WRT) recruited from the 
- Nigerian track and field team at the London Olympics 2012. The CRT and WRT were 
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matched for accumulated mean training years, training hours per week and training days 
per week of (12 yrs., 11 hours/wk. and 6 days/wk.), and (11 yrs., 11 hours/wk. and 6 
days/wk.), respectively. In addition, 17 Caucasian sedentary controls (CCT) and 24 West 
African sedentary controls (WCT) were recruited from a university staff/student population 
in a similar age range.  
The CT’s were healthy individuals who were not engaged in systematic sport-related training 
and performing less than 3 hour’s recreational activity per week. All participants self-
reported being healthy and free from any known cardiovascular disease, and were not 
currently taking any form of prescribed medication (Appendix 9.6, 9.7, 9.8 and 9.9).  The 
study conformed to the ‘STROBE STATEMENT: Guidelines for reporting observational 
studies’ (von Elm et al., 2008) and to the standards set by the Declaration of Helsinki. Ethical 
approval was granted by the Ethics Committee of Liverpool John Moores University 
(Appendix 9.10). The demographic characteristics of all participants are presented in Table 
6.1. 
6.3.2 Demographic characteristics of the study population 
The four groups were comparable for body mass, height, BSA, heart rate and systolic blood 
pressure. WRT had a lower diastolic blood pressure than CRT (P< 0.05) but not significantly 
different from WCT and CCT groups (Table 6.1). Mean age were not significantly different 
between groups. 
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Table 6.1: Demographic and resting cardiovascular data of male resistance trained (RT) and sedentary control (CT) subjects. Data are mean ± SD (range). 
 
 
SA, body surface area; BP, blood pressure; WA, West Africans; WRT, West African resistance trained athletes; WCT, West African control subjects; CA, 
Caucasians; CRT, Caucasian resistance trained athletes; CCT, Caucasian control subjects. P values from 2-way ANOVA with main effects for ethnicity and 
sport. 
 
Parameters West Africans (WA) Caucasians (CA) 2 Way ANOVA 
Ethnicity 
(WA vs CA) 
Sport (RT 
vs CT) 
Interaction 
Sample size (n) WRT (6) WCT (24) CRT (19) CCT (17)    
Age (years) 25 ± 4 (21 to 31) 25 ± 6 (18 to 40) 29 ± 8 (18 to 44) 27 ± 8 (20 to 43) 0.19 0.66 0.53 
Heart rate 
(beats.min-1) 
60 ± 9 (47 to 74) 65  ± 8 (48 to 84) 70 ± 11 (56 to 98) 63 ± 10 (53 to 84) 0.19 0.71 0.85 
Systolic  BP 
(mm Hg) 
126 ± 8 (117 to 
139) 
127 ± 6 (116 to 136) 135 ±  9 (119 to 150) 129 ± 12 (107 to 150) 0.81 0.48 0.14 
Diastolic BP 
(mm Hg) 
67 ± 10 (51 to 82) 74 ± 8 (62 to 90) 76 ±  7 (59 to 89) 75 ± 8 (59 to 89) 0.03            
WA <  CA  
0.12 0.09 
Body Mass (kg) 81 ± 5 (75 to 89) 77 ±  14 (54 to 105) 83 ± 14 (61 to 111) 76 ± 11 (61 to 91) 0.87 0.12 0.64 
Height (m) 1.8 ± 0.1 (1.7 to 
1.9) 
1.7  ± 0.1 (1.6 to 1.9) 1.8 ± 0.1 (1.7 to 1.9) 1.8 ± 0.1 (1.6 to 1.9) 0.88 0.17 0.16 
BSA (Kg/m2) 2.2 ± 0.1 (2.1 to 
2.4) 
2.1  ± 0.3 (1.6 to 2.7) 2.3 ± 0.3 (1.8 to 2.8) 2.1 ± 0.2 (1.7 to 2.5) 0.9 0.06 0.97 
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6.3.3 2D Echocardiography: Left ventricle 
LV structural data are contained in Table 6.2. Whereas absolute LV wall thickness (IVSWT 
and PWT) were similar between groups, allometric scaling uncovered an ethnicity effect 
(post-hocs p=0.01) of IVSWT. Although no significant differences were noted between 
athletes and controls. In contrast, scaling tended to decrease athlete-control differences in 
LV cavity (LVIDd), LV volume (LVEDV) and LV mass. Absolute LV length was similar across 
groups and was not altered by scaling. Global LV functional data are presented in Table 6.3. 
LVSV, EF (%) and other systolic functional parameters were similar across all groups (6.3a). 
IVRT, E/A, and other diastolic functional parameters derived by standard 2D 
echocardiographic assessment were not different between groups (Table 6.3b). TDI indices 
of   diastolic function were not statistically different (post-hocs p < 0.05) within and between 
groups. 
 
6.3.4 2D Echocardiography: Right ventricle 
In Table 6.4 RV structural data (absolute and scaled) were mostly similar between groups 
with the exception of a training effect on absolute RV mid cavity dimension (RVD2) which 
was higher (p = 0.01) in both athlete groups (WRT and CRT). The observed difference was 
abolished with allometric scaling. We should also note that, absolute and scaled RV free wall 
thickness were higher in the athletes (post-hocs p = 0.01) than CT but there was no 
significant difference between both athlete groups. Table 6.5 presents results of RV global 
and regional functional indices. RVFAC (%), TAPSE and tissue Doppler parameters were not 
statistically different (post-hocs p<0.05) within and between study cohorts.  
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6.3.5 Speckle tracking echocardiography (STE) 
LV longitudinal and circumferential ԑ and SR data were not statistically different between all 
groups (Table 6.6). Similarly, LV peak apical/basal rotation and peak twist parameters did 
not demonstrate between-group differences. Global RV ԑ, SRS as well as segmental ԑ did not 
differ between groups (Table 6.7). The base-to-apex gradient for ε was not statistically 
different (post-hocs p < 0.05) between groups. 
 
6.3.6 Electrocardiography (ECG) 
A statistically significant ethnicity was noted for PR interval (p = 0.04) with a greater PR 
interval in WRT/WCT (Table 6.8).  WRT had the highest 156 (16.2%) QTc with a significant 
interaction (p=0.05).  
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Table 6.2: LV structural parameters measured using 2D echocardiography in male resistance trained (RT) and sedentary control (CT) subjects. Data are mean ± SD (range).    
LV, left ventricle; IVSWT, interventricular septal wall thickness;  LVIDd, LV internal diameter at end diastole; PWT, posterior wall thickness; LVEDV, LV end diastolic volume. 
Post-hoc 2 way ANOVA P < 0.05. 
 
Parameter West Africans (WA) Caucasians (CA) 2 Way ANOVA 
Sample size (n) WRT (6) WCT (24) CRT (19) CCT (17) Ethnicity (WA 
vs CA) 
Sport (RT vs 
CT) 
Interaction 
IVSWT 
 (mm) 
10 ± 1 (8 to 110 9 ± 1 (7 to 11) 9 ± 1 (7 to 11) 8 ± 1 (7 to 10) 0.99 0.47 0.32 
IVSWT (mm/m
0.5
)  6.5 ± 0.7 (5.6 to 7.5) 6.2 ± 0.9 (4.6 to 7.7) 5.7 ± 0.7 (4.5 to 7.4) 5.6 ± 0.5 (4.7 to 6.5) 0.01           
WA > CA 
0.36 0.87 
LVIDd  
(mm) 
54 ± 3 (49 to 58) 51 ± 3 (44 to 56) 53 ± 2 (50 to 57) 51 ± 2 (48 to 55) 0.09 0.01    WRT & 
CRT > WCT & 
CCT 
0.07 
 
LVIDd  (mm/m
0.33
) 41 ± 2 (39 to 43) 40 ± 3 (33 to 43) 41 ± 3 (37 to 44) 40 ± 2 (36 to 42) 0.83 0.11 0.48 
PWT  
(mm) 
9 ± 1 (8 to 9) 9 ± 1 (7 to 11) 9 ± 1 (8 to 10) 9 ± 1 (7 to 11) 0.59 0.41 0.93 
PWT 
 (mm/m
0.5
) 
5.8 ± 0.3 (5.4 to 6.1) 6 ± 1 (4.3 to 8.3) 5.9 ± 0.6 (4.7 to 7.3) 5.9 ± 0.6 (5.0 to 7.1) 0.92 0.52 0.66 
LV Mass  
(g) 
190 ± 32 (158 to 254) 178 ± 27 (134 to 240) 186 ± 41 (152 to 252) 176 ± 31 (137 to 246) 0.07 0.03    WRT & 
CRT > WCT & 
CCT 
0.15 
LV Mass  
(g/m
 2.7
) 
25 ± 2 (17 to 23) 24 ± 8 (11 to 32) 25 ± 9 (15 to 42) 26 ± 7 (13 to 38) 0.08 0.54 0.07 
LVEDV 
 (mL) 
131 ± 14 (115 to 152) 115 ± 18 (91 to 151) 120 ± 17 (100 to 158) 116 ± 18 (92 to 152) 0.01           
WRT > CRT 
0.01   WRT & 
CRT > WCT & 
CCT 
0.01 
LVEDV   
(mL/m
1.5
) 
42 ± 5 (36 to 52) 39 ± 10 (23 to  62) 36 ± 7 (26 to 47) 38 ± 6 (30 to 52) 0.92 0.29 0.46 
LV Length  
(mm) 
84 ± 7 (75 to 96) 87 ± 7 (70 to 97) 86 ± 10 (76 to 104) 86 ± 9 (74 to 98) 0.69 0.69 0.55 
LV Length 
(mm/m
0.5
) 
56 ± 5 (52 to 65) 60 ± 6 (50 to 73) 58 ± 7 (47 to 74) 59 ± 9 (52 to 65) 0.79 0.07 0.57 
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Table 6.3a: LV functional parameters measured using 2D echocardiography in male resistance trained (RT) and sedentary control (CT) subjects. 
Data are mean ± SD (range). 
        
 
 
 
 
 
 
 
 
                           
 
 
SV, stroke volume; EF, ejection fraction; LV, left ventricle; LV VTI, LV velocity time integral; Sep, septal; Lat, lateral; S’, systolic tissue velocity; IVRT, 
Isovolemic relaxation time; E, early ventricular filling; A, late atrial contraction; Edecl, E deceleration time; E’, early diastolic tissue velocity; A’, late atrial 
diastolic tissue velocity. P values from 2-way ANOVA with main effects for ethnicity and sport. 
 
 
Parameter West Africans (WA) Caucasians (CA) 2 Way ANOVA 
Sample size (n) WRT (6) WCT (24) CRT (19) CCT (17) 
Ethnicity (WA 
vs CA) 
Sport (RT vs 
CT) 
Interaction 
Systolic function 
LVSV 66 ± 11 
 (54 to 94) 
65 ± 16 
 (38 to 109) 
64 ± 19 
 (37 to 106) 
63 ± 17  
(37 to 93) 
0.96 0.89 0.65 
(mL) 
LVSV 30 ± 6  
(22 to 38) 
31 ± 8  
(20 to 40) 
29 ± 8 
 (15 to 42) 
30 ± 7  
(20 to 41) 
0.78 0.25 0.6 
(mL/m2) 
EF 58 ± 3  
(52 to 62) 
57 ± 2  
(51 to 62) 
57 ± 4 
 (51 to 63) 
58 ± 3 
 (54 to 63) 
0.58 0.93 0.09 
(%) 
LV VTI 22 ± 2  
(20 to 25) 
20 ± 4 
 (11 to 26) 
20 ± 2  
(17 to 26) 
21 ± 3 
 (17 to 25) 
0.84 0.43 0.23 
(cm) 
Sep S' 9 ± 1 
 (8 to 11) 
10 ± 2  
(7 to 12) 
10 ± 2  
(7 to 12) 
10 ± 2 
 (7 to 13) 
0.37 0.59 0.21 
(cm/s) 
Sep S'/LV 
length 
1.1 ± 0.2 
 (0.8 to 1.4) 
1.1 ± 0.2 
 (0.8 to 1.4) 
1.1 ± 0.2  
(0.9 to 1.6) 
1.1 ± 0.2 
 (0.9 to 1.5) 
0.26 0.25 0.13 
Lat S' 11 ± 1  
(8 to 13) 
11 ± 2 
 (7 to 14) 
13 ± 2 
 (7 to 14) 
12 ± 2 
 (7 to 14) 
0.42 0.67 0.26 
(cm/s) 
Lat S' cm/LV 
length 
1.1 ± 0.2 
 (0.8 to 1.6) 
1.1 ± 0.2 
 (0.8 to 1.7) 
1.1 ± 0.2 
 (0.9 to 1.8) 
1.1 ± 0.2 
 (0.9 to 1.7) 
0.21 0.23 0.19 
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Table 6.3b: LV functional parameters measured using 2D echocardiography in male resistance trained (RT) and sedentary control (CT) subjects. Data are mean ± SD (range).  
Parameter West Africans (WA) Caucasians (CA) 2 Way ANOVA 
Sample size (n) WRT (6) WCT (24) CRT (19) CCT (17) Ethnicity (WA vs 
CA) 
Sport  
(RT vs CT) 
Interaction 
Diastolic function 
IVRT (ms) 69 ± 11 
(65 to 74) 
76 ± 11 
(58 to 99) 
74 ± 10 
(53 to 88) 
77 ± 11 
(53 to 95) 
0.34 0.08 0.56 
E (m/s) 0.9 ± 0.2 
(0.6 to 1.2) 
0.8 ± 0.1 
(0.5 to 1.0) 
0.7 ± 0.2 
(0.5 to 1.1) 
0.8 ± 0.2 
(0.5 to 1.0) 
0.14 0.45 0.08 
A (m/s) 0.5 ± 0.2 
(0.3 to 0.8) 
0.5 ± 0.1 
(0.3 to 0.7) 
0.5 ± 0.1 
(0.3 to 0.7) 
0.5 ± 0.1 
(0.3 to 0.8) 
0.48 0.6 0.43 
E/A 1.8 ± 0.5 
(1.4 to 2.8) 
1.6 ± 0.3 
(1.1 to 2.3) 
1.5 ± 0.1 
(0.9 to 2.7) 
1.7 ± 0.4 
(1.2 to 2.5) 
0.31 0.46 0.78 
Edecl(ms) 141 ± 9 
(128 to 156) 
142 ± 14 
(108 to 161) 
141 ± 24 
(102 to 170) 
141 ± 21 
(99 to 160) 
0.86 0.92 0.94 
Sep E' (cm/s) 12 ± 2 
(9 to 15) 
13 ± 2 
(7 to 18) 
12 ± 3 
(6 to 16) 
13 ± 2 
(9 to 17) 
0.55 0.36 0.65 
Sep A' (cm/s) 8 ±  2 
(6 to 11) 
8 ± 1 
(6 to 11) 
9 ± 2 
(4 to 12) 
9 ± 2 
(6 to 11) 
0.33 0.59 0.78 
Lat E' (cm/s) 18 ±  3 
(15 to 23) 
16 ± 3 
(9 to 24) 
16 ± 4 
(8 to 24) 
17 ± 3 
(13 to 23) 
0.52 0.41 0.16 
Lat A' (cm/s) 8 ±  2 
(5 to 11) 
8 ± 2 
(5 to 13) 
8 ± 3 
(4 to 13) 
8 ± 2 
(6 to 14) 
0.65 0.58 0.72 
Sep E'/LV length 1.4 ±  0.3 
(1.0 to 1.9) 
1.5 ± 0.3 
(0.8 to 2.3) 
1.3 ± 0.6 
(0.1 to 2.1) 
1.5 ± 0.3 
(1.1 to 2.1) 
0.64 0.53 0.88 
Sep A'/LV length 1.0 ± 0.3 
(0.6 to 1.3) 
0.9 ± 0.2 
(0.6 to 1.3) 
1.0 ± 0.3 
(0.4 to 1.7) 
1.0 ± 0.2 
(0.7 to 1.3) 
0.37 0.84 0.74 
Lat E'/LV length) 2.2 ± 0.4 
(1.8 to 2.9) 
1.8 ± 0.3 
(1.1 to 2.6) 
1.7 ± 0.8 
(0.1 to 1.4) 
2.0 ± 0.3 
(1.5 to 2.5) 
0.41 0.19 0.08 
Lat A'/LV length) 0.9 ± 0.2 
(0.6 to 1.3) 
1.0 ± 0.2 
(0.5 to 1.4) 
0.9 ± 0.4 
(0.1 to 1.4) 
1.0 ± 0.2 
(0.7 to 1.5) 
0.59 0.69 0.57 
E/E' 5.1 ± 1.1 
(3.4 to 6.2) 
5.4 ± 1.3 
(3.4 to 7.8) 
5.1 ± 1.2 
(3.5 to 7.2) 
5.3 ± 1.1 
(3.4 to 7.0) 
0.9 0.46 0.94 
SV, stroke volume; EF, ejection fraction; LV, left ventricle; LV VTI, LV velocity time integral; Sep, septal; Lat, lateral; S’, systolic tissue velocity; IVRT, Isovolemic relaxation 
time; E, early ventricular filling; A, late atrial contraction; Edecl, E deceleration time; E’, early diastolic tissue velocity; A’, late atrial diastolic tissue velocity. P values from 2-
way ANOVA with main effects for ethnicity and sport. 
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Table 6.4: RV structural parameters measured using 2D echocardiography in male resistance trained (RT) and sedentary control (CT) subjects. 
Data are mean ± SD (range). 
 
Parameter 
Sample size (n) 
West Africans (WA) Caucasians (CA) 2 Way ANOVA 
Parameter WRT (6) WCT (24) CRT (19) CCT (17) Ethnicity (WA 
vs CA) 
Sport (RT 
vs CT) 
Interaction 
PLAX RVOT 
(mm) 
29 ± 4 (24 to 33) 30 ± 3 (24 to 35) 29 ± 4 (22 to 35) 30 ± 4 (23 to 38) 0.55 0.18 0.92 
PLAX RVOT 
(mm/[m2]0.5) 
20 ± 3 (15 to 23) 21 ± 2 (16 to 24) 20 ± 3 (16 to 24) 21 ± 2 (17 to 25) 0.62 0.12 0.85 
RVOT1  
(mm) 
31 ± 4 (27 to 38) 30 ± 4 (22 to 35) 31 ± 4 (22 to 42) 34 ± 4 (23 to 42) 0.07 0.59 0.10 
RVOT 1 
(mm/[m2]0.5) 
21 ± 3 (17 to 25) 21 ± 3 (15 to 25) 21 ± 3 (16 to 26) 23 ± 3 (17 to 27) 0.06 0.11 0.75 
RVOT2  
(mm) 
27 ± 2 (25 to 30) 27 ± 3 (21 to 35) 26 ± 3 (20 to 32) 27 ± 4 (20 to 34) 0.44 0.12 0.19 
RVOT2  
(mm/[m2]0.5) 
18 ± 1 (17 to 20) 18 ± 2 (16 to 24) 18 ± 2 (13 to 20) 19 ± 2 (15 to 24) 0.43 0.10 0.18 
RVD1 (mm) 43 ± 5 (34 to 49) 40 ± 5 (30 to 49) 39  ± 5 (32 to 49) 39 ± 4 (31 to 44) 0.08 0.35 0.29 
RVD1  
(mm/[m2]0.5) 
29 ± 3 24 to 32) 28 ± 3 (21 to 33) 27  ± 4 (24 to 38) 27 ± 3 (22 to 34) 0.10 0.91 0.34 
RVD2 
 (mm) 
32 ± 5 (25 to 37) 28 ± 4 (19 to 34) 30  ± 4 (24 to 38) 29 ± 3 (20 to 32) 0.41 0.01 
RT > CT 
0.19 
RVD2  
(mm/[m2]0.5) 
21 ± 3 (17 to 25) 19 ± 3 (13 to 25) 20  ± 3 (16 to 27) 20 ± 2 (15 to 23) 0.53 0.18 0.33 
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RV, Right ventricle; RVOT PLAX, RV outflow tract dimension parasternal long axis; RVOT1, basal parasternal short axis; RVOT2, distal parasternal short axis; 
RVD1, basal dimension; RVD2, mid cavity dimension and RVD3, longitudinal dimension. P values from 2-way ANOVA with main effects for ethnicity and 
sport. Post-hoc signficant was P < 0.05. 
RVD3 (mm) 84 ± 8 (77 to 98) 82 ± 6 (73 to 98) 84  ± 9 (69 to 102) 81 ± 10 (64 to 98) 0.88 0.45 0.78 
RVD3  
(mm/[m2]0.5) 
56 ± 5 (51 to 65) 57 ± 5 (48 to 67) 56  ± 6 (44 to 71) 56 ± 7 (46 to 69) 0.85 0.65 0.77 
RV diastolic 
area (cm2) 
25 ± 6 (15 to 32) 23 ± 4 (17 to 33) 23 ± 5 (17 to 36) 22 ± 4 (15 to 29) 0.23 0.16 0.71 
RV diastolic 
area (cm2/m2) 
11 ± 2 (7 to 14) 11 ± 2 (8 to 15) 10 ± 3 (7 to 16) 10 ± 2 (7 to 14) 0.28 0.98 0.74 
RV Systolic area 
(cm2) 
13 ± 3 (8 to 16) 13 ± 3 (9 to 20) 12 ± 3 (8 to 19) 11 ± 2 (7 to 18) 0.08 0.15 0.47 
RV Systolic area 
(cm2/m2) 
6 ± 1.1 (4 to 7) 6 ± 1.3 (4 to 9) 6 ± 2 (3 to 9) 5 ± 1.5 (3 to 9) 0.10 0.78 0.45 
RV wall 
thickness  (mm) 
4 ± 0.5 (3 to 4) 3.5 ± 0.5 (3 to 5) 4 ± 0.5 (3 to 5) 3.1 ± 0.5 (2 to 4) 0.98 0.01 
RT > CT 
0.02 
WRT > WCT & CCT 
WCT> CCT, 
WRT=CRT. 
RV wall 
thickness  
(mm/[m2]0.5) 
2.4 ± 0.3 (1.9 to 
2.7) 
2.4 ± 0.4 (1.8 to 3.1) 2.7 ± 0.3 (1.8 to 3.4) 2.2 ± 0.3 (1.5 to 
2.9) 
0.99 0.01 
RT > CT 
0.02 
RT > CT, 
CRT > CCT, 
WRT = WCT. 
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Table 6.5: RV functional parameters measured using 2D echocardiography in male resistance trained (RT) and sedentary control (CT) subjects. Data are mean ± SD 
(range). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
  RV FAC, RV fractional area change; TAPSE, tricuspid annular plane systolic excursion; RVSV, RV stroke volume; RVS’, RV lateral wall peak systolic tissue 
velocity;  RVE’, RV lateral wall peak early diastolic tissue velocity;  RVA’, RV lateral wall peak late diastolic tissue velocity, RVS’, RV E’ and RVA’ were scaled to 
RV length. P values from 2-way ANOVA with main effects for ethnicity and sport.
Parameter West Africans (WA)  Caucasians (CA)  2 Way ANOVA 
Sample size (n) WRT (6) WCT (24) CRT (19) CCT (17) Ethnicity  
(WA vs CA) 
Sport  
(RT vs CT) 
Interaction 
        
RVFAC (%) 47 ± 3 
(42 to 50) 
44 ± 6 
(35 to 58) 
46 ± 6 
(37 to 56) 
51 ± 8 
(36 to 62) 
0.16 0.38 0.64 
TAPSE 23 ± 2 
(21 to 26) 
21 ± 3 
(16 to 26) 
21 ± 4 
(14 to 27) 
23 ± 3 
(17 to 27) 
0.99 0.77 0.08 
RVOT VTI 18 ± 2 
(16 to 22) 
16 ± 3 
(12 to 23) 
18 ± 2 
(13 to 23) 
17 ± 3 
(10 to 22 
0.61 0.07 0.82 
RVSV (mL) 101 ± 14  
(86 to 119) 
92 ± 21  
(64 to 122) 
84 ± 27  
(48 to 132) 
99 ± 33 
(42 to 129) 
0.65 0.85 0.08 
RVSV (mL/[m2]1.5) 30 ± 6 
(23 to 36) 
31 ± 14 
(20 to 68) 
25 ± 7 
(14 to 52) 
32 ± 11 
(16 to 55) 
0.57 0.19 0.17 
RVS' cm/s 12 ± 3 
(6 to 14) 
15 ± 2 
(12 to 17) 
14 ± 3 
(10 to 19) 
14 ± 2 
(9 to 17) 
0.08 0.08 0.07 
RVS' ([cm/s]/cm) 0.4 ± 0.1 
(0.2 to 0.6) 
0.5 ± 0.2 
(0.2 to 0.8) 
0.8 ± 0.4 
(0.3 to 1.1) 
0.5 ± 0.2 
(0.2 to 0.9) 
0.12 0.99 0.06 
RVE' (cm/s) 11 ± 3 
(7 to 14) 
12 ± 2 
(8 to 16) 
14 ± 4 
(9 to 20) 
13 ± 3 
(8 to 18) 
0.08 0.54 0.39 
RVE' ([cm/s]/cm) 1.0 ± 0.6 
(0.6 to 2.1) 
0.8 ± 0.2 
(0.6 to 1.1) 
1.0 ± 0.3 
(0.4 to 1.4) 
1.0 ± 0.2 
(0.6 to 1.3) 
0.56 0.19 0.36 
RVA' cm/s 12 ± 4 
(8 to 18) 
11 ± 3  
(8 to 18) 
11 ± 3 
 (7 to 18 
11 ± 2  
(6 to 14) 
0.45 0.64 0.39 
RVA' ([cm/s]/cm) 0.4 ± 0.2 
(0.2 to 0.7) 
0.4 ± 0.2 
(0.1 to 1.0) 
0.6 ± 0.3 
(0.2 to 0.8) 
0.4 ± 0.2 
(0.1 to 0.8) 
0.96 0.58 0.94 
 128 
  
Table 6.6: Descriptive cohort data for two-dimensional STE derived LV strain (ԑ) and SR parameters in male resistance trained (RT) and sedentary control 
(CT) subjects. Data are mean ± SD (range), 2-way ANOVA with Post-hoc analysis of main effects for ethnicity and sport significant at P < 0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ԑ-strain, SRS -strain rates in systole, SRE- strain rate in early diastole, SRA- strain rate in late diastole. 
Parameter West Africans (WA) Caucasians (CA) 2 Way ANOVA 
Sample size 
(n) 
WRT (6) WCT (24) CRT (19) CCT (17) Ethnicity (WA 
vs CA) 
Sport  
(RT vs CT) 
Interaction 
Peak ԑ (%) -17.6 ±1.2  
(-20.0 to -16.7) 
-17.2 ± 2.1 
 (-21.9 to -13.9) 
-16.8 ± 1.7  
(-20 to -12) 
-17.7 ± 2.1 
 (-21.9 to -14.7) 
0.24 0.36 0.15 
Peak SRS (S-1) - 1.0 ± 0.1  
(-1.1 to -0.7) 
-0.9 ± 0.2  
(-0.2 to -0.7) 
-0.9 ± 0.1  
(-1.1 to -0.7) 
-0.9 ± 0.1  
(-1.2 to -0.7) 
0.18 0.16 0.48 
Peak SRE (S-1) 1.5 ± 0.2  
(1.2 to 1.8) 
1.4 ± 0.3  
(0.9 to 1.9) 
1.14 ± 0.24  
(0.8: 1.6) 
1.29 ± 0.19  
(0.9 to 1.7) 
0.46 0.32 0.18 
Peak SRA (S-
1) 
0.7 ± 0.1  
(0.5 to 1.0) 
0.7 ± 0.1  
(0.5 to 1.1) 
0.7 ± 0.2 
(0.4: 0.8) 
0.7 ± 0.1  
(0.5 to 0.8) 
0.22 0.48 0.22 
Peak ԑ (%) -17.2 ± 3.1  
(-23.2 to -15.1) 
- 16.8 ± 2.8  
(-23.2 to -13.7) 
-15.5 ± 3.3 
 (-21.4 to -9.8) 
-15.8 ± 2.9 
 (-20.8 to -11.6) 
0.18 0.12 0.42 
Peak SRS (S-1) -1.2 ± 0.3  
(-1.7 to -0.9) 
-1.2 ± 0.3  
(-1.7 to -0.9) 
-0.90 ± 0.19  
(-1.3 to -0.7) 
-1.1 ± 0.2  
(-1.5 to -0.8) 
0.42 0.28 0.2 
Peak SRE (S-1) 1.8 ± 0.5  
(1.0 to 2.4) 
1.5 ± 0.5 
 (0.8 to 2.6) 
1.2 ± 0.4  
(0.8 to 2.0) 
1.3 ± 0.4  
(0.9 to 2.1) 
0.12 0.54 0.44 
Peak SRA (S-
1) 
0.5 ± 0.1  
(0.4 to 0.8) 
0.6 ± 0.2 
 (0.3 to  1.0) 
0.5 ± 0.2  
(0.2 to 0.7) 
0.4 ± 0.1 
 (0.2 to 0.9) 
0.68 0.44 0.28 
Peak apical 
rotation (o) 
8.8 ± 2.1  
(7.4 to 9.3) 
10.0 ± 3.1  
(4.3 to 14) 
8.2 ± 3.2 
 (3.8 to 14.5) 
10.8 ± 3.5  
(3.1 to 15.1) 
0.14 0.92 0.66 
Peak basal 
rotation (o) 
-3.8  1.3  
(-6.2 to -1.5) 
-5.3  1.9  
(-7.6 to -2.0) 
-4.7 ± 2.2  
(-9.1 to -2.1) 
-3.8 ± 2.1  
(7.1 to -2.1) 
0.08 0.48 0.14 
Peak twist (o) 13.8 ± 2  
(8.8 to 18.2) 
14.2 ± 3.2  
(8.9 to 21.4) 
12.5 ± 4.8  
(5.9 to 22.1) 
14.50 ± 3.9 
 (9.8 to 21.5) 
0.22 0.64 0.32 
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Table 6.7: Descriptive cohort data for two-dimensional STE derived RV strain (ԑ) and SR parameters in male resistance trained (RT) and 
sedentary control (CT) subjects. Data are mean ± SD (range). 
 
 
 
 
 
 
 
 
 
 
 
 
WA, West African; WRT, WA resistance trained athletes; WCT, WA control subjects; CA, Caucasians; CRT, Caucasian resistance trained athletes; 
CCT, Caucasian control subjects; ԑ, strain; SRS, strain rates in systole; SRE, strain rate in early diastole and SRA, strain rate in late diastole. 2-way 
ANOVA with Post-hoc analysis of main effects for ethnicity and sport significant at P < 0.05. 
Parameter 
 
West Africans (WA) Caucasians (CA) 2 Way ANOVA 
Sample size (n) WRT (6) WCT (24) CRT (19) CCT (17) Ethnicity 
(WA vs CA) 
Sport (RT 
vs CT) 
Interaction 
Peak global ԑ  
(%) 
-28.8 ±2.1 
(-33.2 to -25.1) 
-27.4 ± 3.2  
(-33.8 to -22.4) 
-27.4 ± 4.9  
(-36.6 to -21.8) 
-28.4 ± 2.7  
(-37.0 to -25.0) 0.46 0.48 0.25 
Peak basal ԑ  
(%) 
-27.5 ± 1.7  
(-30.6 to -24.8) 
-25.7 ±3.2  
(-32.7 to -20.6) 
-26.5 ± 3.2 
 (-32.6 to -20.7) 
-28.2 ± 3.0  
(-34.8 to -24.5) 0.19 0.09 0.52 
Peak mid wall ԑ  
(%) 
-28.1 ±1.7  
(-31.0 to -24.0) 
-27.6 ± 3.8  
(-35.4 to -23.3) 
-27.5 ±2.5  
(-33.6 to -23.6) 
-28.4 ± 4.6 
 (-37.9 to -22.0) 0.56 0.29 0.22 
Peak apical wall ԑ 
(%) 
-31.3 ± 2  
(-34.6 to -26.4) 
-30.9 ±3.4  
(-37.7 to -25.5) 
-31.3 ± 3.3  
(-36.6 to -26.2) 
-32.6 ± 3.0 
 (-38.8 to -23.5) 0.09 0.51 0.64 
Base to apex ԑ 
gradient (%) 
-4.3 ±2.9  
(-9 to - 2.4) 
-5.3 ± 2.4  
(-9.3 to -1.8) 
-4.7 ± 2.5  
[-8.3 to -1.0) 
-4.4 ±2.9  
(-9.1 to -1.9) 0.98 0.64 0.58 
Peak global SRS  
(s-1) 
-1.5 ±0.2  
[-1.8 to -1.1) 
-1.4 ± 0.2 
(-1.7 to -1.0) 
-1.5 ± 0.3  
(-2.1 to -1.0) 
-1.5 ± 0.2 
 (-2.0 to -1.2) 0.09 0.92 0.96 
Peak global SRE  
(s-1 ) 
1.6 ±0.4  
(0.9 to 2.3) 
1.6 ± 0.5  
(0.2 to 2.3) 
1.8 ± 0.5  
(1.2 to 2.8) 
1.9 ± 0.5 
 (1.2 to 2.8) 0.15 0.43 0.75 
Peak global SRA 
(s-1) 
0.9 ± 0.2  
(0.7 to 1.4) 
1.1 ± 0.2 
 (0.8 to 1.9) 
1.1 ± 0.3  
(0.5 to 1.6) 
1.0 ± 0.3 
 (0.5 to 1.4) 
0.82 0.84 0.44 
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Table 6.8: Descriptive cohort data for 12 lead ECG in male resistance trained (RT) and sedentary control (CT) subjects. Data are mean ± SD (range), 2 way 
ANOVA p-values < 0.05. 
 
HR-Heart rate, RT-Resistance trained athletes, CT-Sedentary control subjects, WRT-West African RT, WCT-West African CT, CRT-Caucasian RT, CCT- 
Caucasian CT, P wave – Atrial depolarization, QRS-Ventricular depolarization, T wave- Ventricular repolarization.  2-way ANOVA with main effects for 
ethnicity and sport, Post-hoc analysis significant at P < 0.05. 
Parameter 
 
West Africans (WA) Caucasians (CA) 2 Way Anova 
Sample size 
(n) 
WRT (6) WCT (24) CRT (19) CCT (17) Ethnicity (WA 
vs CA) 
Sport 
(RT vs CT) 
Interaction 
HR 60 ± 9 
(47 to 74) 
63 ± 8 
(48 to 84) 
78 ± 20 
(46 to 108) 
63 ± 10 
(9 to 84) 
0.07 0.33 0.07 
P-Wave 109 ± 4 
(102 to 112) 
110 ± 9 
(90 to 126) 
103 ± 22 
(83 to 183) 
103 ± 6 
(4 to 114) 
0.12 0.96 0.71 
PR 168 ± 13 
(150 to 184) 
169 ± 23 
(119 to 221) 
157 ± 20 
(112 to 205) 
150 ± 17 
(13 to 118) 
0.04 0.32 0.26 (WRT/WCT) 
<(CRT/CCT) 
QRS 93 ± 7 
(82 to 102) 
93 ± 9 
(71 to 109) 
93 ± 11 
(69 to 113) 
95 ± 9 
(7 to 118) 
0.55 0.72 0.71 
QT 405 ± 28 
(366 to 450) 
363 ± 24 
(326 to 404) 
356 ± 36 
(302 to 413) 
373 ± 25 
(28 to 415) 
0.03 0.07 0.01 
(WRT > WCT), (CRT < 
CCT), (WRT > CRT) 
QTc 407 ± 13 
(393 to 4224) 
374 ± 17 
(330 to 400) 
399 ± 26 
(359 to 467) 
381 ± 10 
(13 to 402) 
0.43 0.01 0.05 
(WRT > WCT), (CRT >  
CCT),(WRT = CRT) 
P-axis 41 ± 26 
(10 to 73) 
50 ± 19 
(-6 to 78) 
54 ± 23 
(-6 to 76) 
51 ± 15 
(10 to 76) 
0.32 0.47 0.36 
QRS-axis 51 ± 11 
(35 to 63) 
45 ± 30 
(-35 to 83) 
58 ± 22 
(25 to 92) 
58 ± 36 
(-12 to 111) 
0.14 0.41 0.78 
T-axis 28 ± 22 
(2 to 60) 
36 ± 20 
(2to 71) 
33 ± 20 
(-1 to 72) 
39 ± 16 
(2 ± 69) 
0.41 0.21 0.83 
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6.4 Discussion 
The key outcomes of this exploratory study were; (1) there were few athlete vs. 
control or WA vs. Caucasian differences in LV structure, (2) some differences were 
mediated by the impact of body size; (3) RV structural parameters were largely 
similar across all groups, (3) Global LV and RV function, TDI data and longitudinal and 
segmental strain and strain rates were comparable within and between groups, and 
(4) athletes of WA ethnicity demonstrated longer PR and QT intervals than 
Caucasians but were well within normal Group 1 changes of the ‘Seattle’ ECG 
criteria. 
 
6.4.1 The impact of resistance training on athlete’s heart phenotype: Left Ventricle  
Recent evidence from individual studies, meta-analysis and studies included in 
previous chapters supports the existence of an athletic heart phenotype in 
endurance trained athletes but casts doubt over the nature of any cardiac 
adaptation in RT (Pelliccia et al. 1991, Haykowsky et al. 2000, Utomi et al. 2013, 
Utomi et al. 2014a). The current study supports recent data in Caucasians and 
extends this to WA RT athletes, albeit in a small but very elite cohort of Olympians. 
Similar to reports by Basavarajaiah et al 2008, WRT/CRT demonstrated a slightly 
higher absolute LV mass (post-hoc p = 0.03) than WCT/CCT, however, this difference 
was removed after appropriate body size scaling of LV mass.  There was no evidence 
of concentric LV hypertrophy in any RT athlete.  
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There is empirical evidence to suggest that the lack of concentric cardiac adaptation 
in RT could be due to limited exposure to an increased haemodynamic afterload 
during resistance exercise training (George et al. 2011) and the potential lack of any 
afterload stimulus due to the fact that wall stress is not elevated during lifting when 
a brief phase 1 Valsalva manoeuvre is performed (Haykowsky et al. 2000).  This 
conceptual idea would also apply to WA RT athletes undergoing similar training 
regimes although it is unclear if there is any substantive ethnic difference in acute 
haemodynamic response to resistance exercise.   
As was noted with the LV mass data scaling of LV structural data, in some cases, 
altered the interpretation of specific between group comparisons. Though absolute 
septal wall thickness was similar across all cohorts, scaling uncovered a higher IVSWT 
(post-hoc p = 0.01) in WRT. Conversely, higher cavity dimension (p = 0.01) and LV 
mass (post-hoc p = 0.03) were removed after scaling for differences in BSA. The 
importance of taking individual body size to account in quantitative cardiac 
assessment has been demonstrated in a number of empirical studies (George et al. 
1999, Batterham et al. 1999), and the current data supports this.  
 
6.4.2 The impact of resistance training on athlete’s heart phenotype: Right 
ventricle  
Few studies have examined the impact of RT and ethnicity on RV structure 
(Pagourelias et al. 2013, Utomi et al. 2013). Similar to previous reports by Baggish et 
al (2008) and Pagourelias et al (2013), RVD2 was higher in athlete groups (p = 0.01), 
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but other than that, few between group differences were apparent.  RV wall 
thickness and cavity dimension did not demonstrate a consistent hypertrophic 
change in comparison to the control subjects (Baggish et al. 2008, Pagourelias et al. 
2013).  
It is likely that haemodynamic theories used to explain the lack of adaptation in the 
LV of RT athletes is a potential reason for the general lack of RV remodelling and 
again this can now be extended to WA RT athletes. The proposed theory of 
disproportionate haemodynamic overload on the RV during exercise (LaGerche et al. 
2011) is not clear with respect to RT where there might not be any significant and 
sustained increase in pulmonary artery systolic pressure that could initiate structural 
adaptation to normalise wall stress (Grossman et al. 1975).  
 
6.4.3 The impact of resistance training on left and right ventricular function 
Both LV and RV function were largely similar between all groups. This supports data 
from the three previous studies in this thesis in Caucasian RT athletes and extends 
this to WA RT athletes. Given the absence of any regional wall motion abnormality as 
well as the fact that FAC was consistently > 40% in all subjects,  none of the subjects 
met the revised ARVC criteria (Marcus et al. 2010). We did not observe any 
significant within and between group differences in systolic and/or diastolic TDI 
velocities, strain and strain rate values. This supports some previous data 
(Pagourelias et al. 2013) but contradicts studies by Baggish et al (2008) (Baggish et al. 
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2008). Whilst we observed a base to apex gradient in deformation, the trend was not 
different between all groups.  
 
6.4.4 The impact of ethnicity on the athelete’s heart phenotype  
Previous studies have demonstrated that Black or African ethnicity is associated with 
greater prevalence of morphological and electrical cardiac alterations in response to 
exercise training than in white individuals (Mayet et al. 1994, Drazner et al. 2005, 
Basavarajaiah et al. 2008, Rawlins et al. 2010, Zaidi et al. 2013). This concept has 
rarely been specifically applied to RT athletes of different ethnicity. Whether RT 
exaggerates the degree of structural remodelling in WA similar to the exaggerated 
effects of hypertension in black patients (Mayet et al. 1994) is of key importance 
sports cardiology and CVS screening of BA to identify at risk individuals and 
ultimately to prevent sudden cardiac death (SCD).  
In a study of 300 black and 300 white athletes, Basavarajaiah et al (2008) reported a 
greater mean wall thickness (11.3 ± 1.6mm vs 10.0 ± 1.5mm; p<0.01) and prevalence 
of LV hypertrophy ≥ 13mm (18% vs 4%; p 0.001) in the black athletes (Basavarajaiah 
et al. 2008). Similar outcomes have been demonstrated by others, although to a 
lesser extent (Rawlins et al. 2009, Papadakis et al. 2012, Sheikh et al. 2013).  Our 
data does not support important role for WA ethnicity in mediating cardiac 
morphological adaptation in RT athletes. 
Key differences in ECG have been reported in athletes of black ethnicity. T-wave 
changes on the ECG were reported in over 10% of blacks and recent studies have 
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demonstrated a higher prevalence of marked repolarization changes and voltage 
criteria for left ventricular hypertrophy (LVH) when compared to Caucasian subjects 
(Xie et al. 1994, Papadakis et al. 2012, Chandra et al. 2012, Basavarajaiah et al. 
2008). Magalski et al (2008) reported that ST elevation, consistent with early 
repolarization was 2.5 times more common in Blacks athletes than Caucasians 
athletes, and further identified black race as statistically significant predictor of 
distinctly abnormal ECGs [RR 1.82, 95% CI: 1.22 to 2.73, p = 0.01] (Magalski et al. 
2008); [RR, 2.03, 95% CI: 1.56 to 2.64, p < 0.0001] (Magalski et al. 2011). 
 Further investigations (Holter monitoring and CMR) of abnormal ECG changes in BA 
subjects on a case-by-case basis have shown that these changes may be 
physiological adaptation to exercise rather than pathological, albeit more 
exaggerated in BA (Basavarajaiah et al. 2008, Chandra et al. 2012).  The current study 
did not identify any significant T-wave inversion but this may reflect a small sample 
size.  Fifty percent of BA, compared to less than 10% of Caucasian RT athletes, 
demonstrated early repolarization changes and isolated voltage criteria for LVH. 
Whilst it is thought that these are innocuous finding in BA, there is on-going 
controversies over the  suggestion that racial predilection for BA to develop LVH in 
response to exercise is a combination of genetic (Barley et al. 1996, Mayet et al. 
1994), endocrine and haemodynamic factors (Ekelund et al. 1990, Schmidt et al. 
1993, Diet et al. 2001). 
The definitive mechanisms remains unclear, and warrants further investigations. The 
current study did demonstrate higher PR interval (p = 0.04) and QT (p = 0.03) in BA 
and is similar to past work (Drezner et al. 2013c).  A sports specific effect was also 
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noted with higher QTc (p = 0.01) in both athlete groups. Similar to Wilson et al 
(2010), none of the subjects of this study demonstrated abnormal group 2 / 
uncommon ECG changes as defined in ESC and the Seattle Criteria (Drezner et al. 
2013b).  
 
6.5 Limitations and future research 
This was an exploratory cross-sectional study in a very small but highly trained 
cohort of male WA and Caucasian RT athletes. Further work should expand the 
participant base; to increase the sample size and therefore adequate statistical 
power, include female subjects as well as a development of a prospective cohort 
design. Another important limitation is that ECG and Echocardiographic post 
processing, though performed by experienced research scientists, were not blinded 
to participant identity, therefore the potential for bias exists.  
 
6.6 Implications 
 The results of this exploratory study provides relevant information on the ethnic 
differences in the upper limits of human cardiac adaptation to training and also 
provides foundations for the development of a pragmatic clinical algorithm for 
identifying the AH phenotype in BA. This knowledge will inform cardiac screening in 
the emerging population of BA to differentiate the electrical and morphological 
changes from cardiac pathologies like HCM, ARVC and Ion channelopathies.  
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6.7 Conclusions 
This exploratory study observed no evidence of an exaggerated AH phenotype in WA 
RT athletes.  LV and RV structural and functional parameters were largely similar 
across all groups including data derived from new echocardiographic techniques. 
Participants of Black ethnicity demonstrated longer PR and QTc intervals on ECG. 
These findings have important implications with regards to developing a wholly 
encompassing global screening algorithm to accommodate ethnic WA athletes.  
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CHAPTER 7 
 
GENERAL DISCUSSION 
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7.1 Brief summary of findings 
 
The following hypotheses were stated at the beginning of the thesis.  
1) I hypothesize that training mode, imaging modality and body size influence 
the morphology and function of the male AH. 
2) I hypothesize that LV structure and function will follow a dichotomous 
training specific adaptation.    
3) I hypothesize that global RV adaptation to exercise will follow a dichotomous 
training specific adaptation. 
4) I hypothesize that elite male West African resistance trained athletes will not 
present with a concentric AH pattern.  
 
The following responses are made in reflection of the data collected. 
1) This hypothesis was partially supported in that only endurance training had a 
significant impact upon cardiac structure and function in this meta-analysis.  
Resistance training did not result in a major impact upon cardiac structure 
and function.  Imaging mode and body size significantly influence cardiac 
structural data in the large meta-analysis data set. 
2) Within the cross-sectional study the impact of endurance training was more 
marked than that of resistance training which partially supported the 
hypothesis and confirmed the data trend reported from the meta-analysis.  
The addition of new imaging modalities provided extra descriptive insight 
 - 140 - 
  
into the AH but were largely similar between all groups. Of note most 
individuals were still presenting with “normal” LV geometry questioning the 
broadly accepted view that endurance athletes develop an eccentric 
hypertrophy.  
3) We partially accept the hypotheses as stated in that endurance training and 
body size did mediate RV structure and, to a lesser extent, function.  
Resistance training had no effect on RV structure and function. 
4) We can largely accept the hypothesis as stated. In a small sample, 
pilot/exploratory study of West African resistance-trained athletes we did not 
observe any significant structural, functional or electrical features of the AH.  
 
7.2 Overarching issues     
Overall the results of this thesis provide a useful re-evaluation of concepts and 
models in the AH literature. The findings have expanded our understanding of the 
impact of training type, new imaging technologies and the influence of body size 
upon cardiac structures.  These images have “resonated” across all the studies, 
validating the assertion that data interpretation should carefully consider all of these 
issues in scientific research and clinical decision making.  
The novel findings of this thesis; the predominance of a normal geometry in male 
athletes; the lack of concentric pattern of LV hypertrophy in resistance athletes; the 
limited expression of the AH in the right ventricle; and the importance of appropriate 
scaling are all worthy of an overarching discussion as these outcomes have 
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significant clinical implications for the sports cardiologist and should inform cardiac 
screening of athletes to identify those at risk of sudden cardiac death. 
 
7.2.1 Lack of evidence of a distinctly divergent cardiac adaptation to different 
training stimuli  
Across the meta-analysis and first two cross-sectional studies we noted some 
morphological features of the male AH in both athlete groups and in both the LV and 
the RV.  It is, however, important to state that a dichotomous training–specific 
pattern of cardiac adaptation did not fit with previous descriptions of the MH.  Most 
notable was that concentric hypertrophy was not discerned in RT in any of the first 
data chapters in this thesis. The meta-analysis and cross-sectional findings when 
looked at together should, at the very least, prompt a re-evaluation of the long-held 
belief that different exercise training produces distinctly divergent cardiac 
adaptation as expounded in the MH.  
The explanation for substantial difference in cardiac dimension between ET and RT is 
probably complex. The observed greater cardiac dimension in ET possibly reflects 
substantial hemodynamic burden (volume overload) engendered by a greater overall 
training volume (George et al., 2011). Conversely, the lack of a concentric pattern of 
hypertrophy in RT is likely related to the fact that RT may not acutely increase LV 
afterload and end systolic wall stress when resistance exercise is performed with a 
brief phase 1 Valsalva manoeuvre (Haykowsky et al., 2001).  
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The set-to-set repetitive pattern of resistance exercise activity also appears to 
negate any sustained increase in stroke volume that could remotely exert any 
substantial hemodynamic burden of volume overload to the LV (George et al., 2001).  
The lack of substantially increased LV wall thickness in male RT athletes actually can 
make cardiac screening somewhat easier.  If concentric hypertrophy is seen in any 
athlete this may represent a “red flag” and prompt further evaluation of the athlete. 
As a consequence of data in studies 1-3 in this thesis, the upper limits of chamber 
dimension and wall thickness are generally expressed in ET. Whilst we alluded to the 
lack of data on RT athletes in the meta-analysis, our cross-sectional studies clearly 
agree with the overall outcomes of the meta-analysis and consolidate our 
conclusions. Further care is required when utilising imaging tools to employ 
appropriately powered studies and choose validated novel techniques to fully 
describe the athletic heart phenotype.  
An unexpected finding from the first cross-sectional study was the relative lack of 
eccentric hypertrophy in endurance-trained male athletes.  The meta-analysis and 
the first cross-sectional study confirmed that endurance-trained athletes do present 
with larger LV chamber dimensions than controls and resistance-trained athletes 
that supports the MH and other previous work (Naylor et al., 2008, George et al., 
2011).  Despite this the degree of adaptation was, overall, quite small with the 
balance of wall and chamber adaptation still placing the majority of endurance-
trained athletes in the “normal geometry” categorisation (Utomi et al., 2014).  This 
would suggest that LV adaptation in endurance athletes is both highly individually 
variable and largely modest in nature.  Again this has implications for screening 
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programmes to the point where multiple athletes presenting outside the normal 
ranges in a small sample might be statistically rare. 
It is important to note that the LV adaptation in ETT in the meta- analysis was not 
specifically mediated by age, performance times or training history. Based on the 
new findings of this study, it appears that the MH does not hold true for RT and only 
about a third of the time in ET. It might be that the MH does not manifest in the RV 
in the same way as just described in the LV. Whilst the RV of the ET presented with 
some structural characteristics of the AH this was limited to some, but not all, 
chamber dimensions. Again, the RT did not demonstrate any substantial RV 
adaptation and was not significantly different from control subjects. Again the 
potential explanation for this could easily be drawn from the hypothetical 
mechanisms that underpin LV adaptation and the lack of a meaningful 
haemodynamic stimulus on the RV during resistance exercise. In summary, the 
overarching opinion is that RT leads to very little cardiac adaptation in elite athletes 
and ET has an effect, largely on chamber dimensions, that is quite muted, compared 
to past literature and highly variable between individuals. These finding, individually 
and in combination, provide a substantial challenge to the MH in male athletes. 
 
7.2.2 Scaling cardiac dimension to body size is crucial in the interprtation of 
cardiovascular measurements 
Scaling is an issue that permeates across all the studies in this thesis. As a backdrop 
we have observed (a) non-application of scaling models, (b) a rising popularity of 
linear scaling and (c) scant application of allometric scaling models in the AH 
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literature over the 40 years’ since Morganroth and colleagues seminal work (George 
et al., 1991, Naylor et al., 2008).  Of note was the general lack of attention in 
previous meta-analyses (Fagard, 1996, Pluim et al., 2000, Whyte et al., 2004a).   
The meta-analysis, explored the effect of between-study differences in BSA on LV 
mass, RV mass and LAD using a meta-regression approach that is different to any 
scaling application in original, cross-sectional studies (Batterham et al., 1999). 
Multiple meta-regression data clearly demonstrated that as BSA increased so did 
measures of cardiac structure.  Consequently, it is likely that some portion of the 
between-group difference in LV mass, RV mass and LAD are explained by those with 
larger cardiac dimensions having larger body dimensions. Whether this reflects a 
higher total body mass or more specifically a higher lean body mass in the athlete 
groups is impossible to determine from the use of BSA alone in a meta-analysis.  
The remaining studies in this thesis further support and re-enforce the assertion that 
appropriate scaling can alter data interpretation in LV and RV measurements, given 
that allometric scaling uncovered higher wall thickness index in ET compared to RT. 
In the final study we noted that allometric scaling of LV and RV structural data again, 
in some cases, altered the interpretation of within group comparisons. Though 
absolute LVSWT was similar across all cohorts, allometric scaling uncovered a higher 
IVSWT (post-hoc p = 0.01) in WRT. Conversely, higher cavity dimension (post-hoc p = 
0.01) and LV mass (post-hoc p = 0.03) were removed after scaling for differences in 
BSA.  This supports previous theoretical and empirical work form our laboratory 
(Batterham et al., 1999, George et al., 2011). 
 - 145 - 
  
Clearly, it makes good sense to take account of body size differences in the 
interpretation of absolute cardiac dimension within athlete populations who via 
their training may see huge changes in body morphology. From our analysis, we 
argue that ratio scaling can be misleading and thus should always be supported 
within the sample being studied alongside an exploration of other potentially 
allometric approaches to determine which index is indeed size-independent.   
 
7.2.3 Black vs. white differences in the athlete’s heart of resistance trained 
athletes: ‘fact or fiction’  
A recent ethnicity study by Riding et al (2013) documented that Arabic athletes have 
significant, yet modest increases in cardiac dimensions compared with Arab controls; 
yet cardiac dimensions in all parameters were significantly smaller than Black African 
and Caucasian athletes (Riding et al., 2013). Although highly powered (n=600), the 
caveat here is that the participants of their study were not clearly partitioned into ET 
and RT, and as well, the black African athletes of their study were from nine African 
countries (Sudan, Somalia, Ghana, Nigeria, Chad, Ivory Coast, Senegal, Cameroon 
and Ethiopia). Clearly, there is a significant racial and demographic difference among 
people of African descent (Chandra et al., 2012). For instance, it may be erroneous to 
group the East Africans (Ethiopian, Somalia) with West Africans (Nigeria, Ivory coast, 
Ghana), considering the proven pedigree of endurance sporting excellence in the 
former.  
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Because of the key differences in ECG and the higher incidence of SCD in Black 
athletes when compared to Caucasian athletes (Xie et al., 1994), the rising presence 
of  Black sportsmen in the international sporting arena has brought attention to the 
fairness of  applying existing Cardiovascular (CVS) screening criteria on Black 
athletes. It is still contentious whether applying the existing CVS screening criteria 
(Weiner et al., 2011, Drezner et al., 2013a) is scientifically justifiable. Black athletes 
are known to exhibit a high prevalence of additional repolarization patterns that are 
usually categorised as abnormal in white athletes and often associated with 
cardiomyopathies and SCD (Corrado et al., 2010).   
A great deal of evidence indicates that in the general population and in cohorts of 
patients with hypertension, Black individuals present with a greater magnitude of 
LVH compared to patients from other ethnic backgrounds (Chapman et al., 1999, 
Mayet et al., 1994). These observations advanced the probable hypothesis that 
exercise associated alterations in cardiac preload and afterload might exaggerate the 
degree and probably pattern of electrical and morphological adaptation in Black 
athletes (Drazner et al., 2005, Weiner et al., 2011, Harmon et al., 2011).  
In a small sample pilot/exploratory study we observed some form of training 
mediated structural adaptation, given that the athlete groups had larger LV mass (P 
= 0.03) and RVD2 (P = 0.01) than control subjects.  This observation was, however, 
quite limited across multiple LV and RV variables and was not distinct between 
ethnicities. Like previous studies in the thesis we did not observe higher values for 
cavity and wall dimensions in Black or Caucasian elite resistance-trained athletes.  
Drawing from our current understanding of hypothetical physiological mechanisms 
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that underpin expression of a predominantly normal geometry in male athletes 
(Utomi et al., 2014) and the unexpected lack of concentric hypertrophy in healthy 
resistance trained athletes (Utomi et al., 2013) it would seem that resistance training 
in Black athletes presents no meaningful stimulus for cardiac adaptation.  
ECG data from our study is also limited by sample size but data do follow previous 
athlete data patterns. For instance, 50% of BA in our study, compared to < 10% of 
Caucasian RT demonstrated early repolarization changes. These data are likely part 
of a normal “training-related” adaptation (Corrado et al., 2010). The Sports 
Cardiologist would normally align individual ECG indices to the recently revised 
recommendations on normal (Appendix 5) and abnormal (Appendix 6) ‘Seattle’ 
screening criteria (Drezner et al., 2013a).  
Allied to this, there is a growing interest in the RV component of the AH, considering 
that the high prevalence of T-wave inversion in the right pre cordial lead (V1-V3) 
invariably raises suspicion of ARVC (Basso et al., 2009, Marcus et al., 2010, Drezner 
et al., 2013b). More studies are needed to investigate the ‘facts and fictions’ of the 
impact of Black ethnicity on the AH and shed more light on the prospects of applying 
the current diagnostic criteria derived from disparate cohorts to BA.     
    
 
7.3 Technical considerations – Pros and Cons of new techniques 
Although we are beginning to see the emergence of a substantive database using TDI 
in athletes, we report some rudimentary data in our meta-analysis, there are a 
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number of important points with respect to the potential superiority of MST over TDI 
derived data and ԑ parameters in particular. Firstly, the accuracy of MST is 
dependent on image quality (Geyer et al., 2010) and depth (Sivesgaard et al., 2009). 
Secondly low fame rates creates an unstable speckle pattern and inaccurate peak ԑ 
values whereas high frame rates induce noise and reduce image resolution (Geyer et 
al., 2010).  
Although MSTE is technically known to be angle independent, movement parallel to 
the ultrasound bean provides greater accuracy which explains the superior axial 
resolution (Grabskaya et al., 2010). This implies a more robust and reproducible 
dataset in the longitudinal plane, in comparison to radial and circumferential planes 
(Jenkins et al., 2006, Mor-Avi et al., 2011).  
Because the dynamic LV moves longitudinally through a stationary ultrasound beam, 
as the base of the LV descends towards the apex in systole the ROI is at a slightly 
different level throughout the cardiac cycle. This can result in out of plane motion 
which is particularly important in radial and circumferential ԑ (Zhou et al., 2010, Mor-
Avi et al., 2011). Another important limitation is its sensitivity to acoustic shadowing 
and reverberation which can result in underestimation of ԑ and SR.  
 
7.4 Implications of the studies  
Clinicians, athletes and patients are aware that the upper limits of human cardiac 
physiological adaptation to training is important for informing cardiac screening and 
the differential diagnosis of athlete’s heart from pathological adaptation. This thesis, 
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from meta-analysis to prospective cross-sectional data, supports the contention that 
the upper limits of normal for chamber and wall dimensions (LV and RV) are 
generally expressed by ET. 
It is also pertinent to note that these upper limits will be approached by very few 
elite athletes. Some evidence supports an “eccentric-type” hypertrophy of the LV 
and RV in ET but this occurred less frequently that hypothesised by the MH.  RT’s 
whether Caucasians or West African Blacks did not present with concentric LV 
hypertrophy. It is also important to highlight that absolute wall thicknesses, LV end 
diastolic dimension and ECG changes although increased in athletes when compared 
to sedentary controls, do not fall within the pathological range seen in hypertrophic 
or dilated cardiomyopathy in either resistance or endurance trained athletes.  
Although updated guidelines on the interpretation an athlete’s ECG make some 
broad allowance for African ethnicity (Wilson and Drezner, 2012, Drezner et al., 
2013c), the criteria for further cardiac evaluation still rely on data from Caucasian 
athletes (Corrado et al., 2010). However, this is basically because data from 
homogenous cohorts of Black athletes are rare. To the best of our knowledge, this is 
the first attempt to gain new insight into the pattern of physiological cardiac 
adaptation in a homogenous group of Olympic grade West African resistance 
athletes.  
Our data underscore the need for ethnicity specific criteria for differentiating normal 
cardiac adaptation to exercise from cardiac pathologies. This knowledge will further 
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aid the diagnostic challenges associated with pre-participation screening of athletes 
against fatalities like sudden cardiac death. 
 
7.5 Limitations and future research directions 
A number of possible limitations apply to the present studies and where appropriate, 
specific future directions are directly related to the issues raised: 
1) In study 1, data for RT is relatively scarce, further cross sectional studies are 
required to develop the data base for RT generally and with new imaging technology. 
It would also be pertinent to extend a similar ET / RT study specifically to investigate 
‘old’ and ‘new’ imaging tools with respect to the RV and atria. Functional measures 
in high quality case-control series studies are largely limited to global 
echocardiographic parameters i.e. LV EF, SV and E/A. Future studies should use new 
technologies to investigate global and regional functional parameters.   
2) The studies included in this thesis were cross sectional design as well as meta-
analysis of male athletes. These methodological designs cannot directly support a 
‘cause effect’ relationship between exercise, mode and physiological cardiac 
remodelling.  Further work should expand the participant database to include 
females, older athletes as well as the development of a prospective cohort design. 
Significantly, our studies were limited to the LV and RV in adult male athletes. The 
assessment of the atrial compartments in various athlete groups requires substantial 
development and is particularly relevant to interpretation of clinical data. 
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3) The final study included in this thesis was an exploratory cross-sectional study in a 
very small but highly trained cohort of male RT athletes. It is very likely that 
increasing the sample size may have increased statistical power and ‘uncovered’ 
statistically significant changes in those variables that showed moderate alterations. 
4) Another important limitation in our clinical trials is that ECG and echocardiography 
acquisition and post-processing, though performed by experienced research 
scientists, were not blinded to participant identity, therefore the potential for bias 
exists. Furthermore, although newer echocardiographic imaging tools are more 
useful and provide unique insight to the AH than traditional echocardiographic 
techniques, CMR is the gold standard with greater spatial resolution / sensitivity and 
has been applied to in various studies.  Therefore, on-going studies in the field of AH 
where possible should utilise CMR to determine cardiac morphology. Where CMR is 
not available, newer echocardiographic technologies should be utilised in adequately 
powered cohorts.    
A significant limitation of the current implementation of MSTE is inter vendor 
differences, driven by the fact that the analysis of MSTE derived ԑ and SR is 
performed offline on data stored on proprietary scan line format (Jenkins et al., 
2006, Marwick, 2006, Mor-Avi et al., 2011). The lack of standardization and 
uniformity in respective vendor acquisition and measurement algorithms can result 
in conflicting strain reports, constituting a major constraint to establishing normative 
data (Marwick, 2010). 
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7.6 CONCLUSIONS  
This thesis has provided new insight into the expression of the AH phenotype in male 
athletes. The conclusions with regard to the initial hypothesis, based upon the 
results of the four studies are as follows: 1) Only endurance training had a significant 
impact upon cardiac structure and function, 2) Resistance training did not result in a 
major impact upon cardiac structure and function, 3) Body size significantly 
influences cardiac structural data, 4) Of note most individuals were still presenting 
with “normal” LV geometry questioning the broadly accepted view that endurance 
athletes develop an eccentric hypertrophy. Finally, in a small sample, 
pilot/exploratory study of West African resistance-trained athletes we did not 
observe any significant structural, functional or electrical features of the AH. These 
findings have important implications in the cardiovascular screening of athletes to 
prevent sudden cardiac death. 
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APPENDIX 9.1 Traditional Echocardiographic development of the  left ventricle  
The early developments of echocardiography initially provided an A-mode technique, 
generating reflected signals of differing amplitude (depending on the degree of 
acoustic mismatch) from the region of interest on the hear (Otto and Pearlman, 
2004). Further advancement converted the returning ultrasonic waves to dots of 
varying brightness relative to their amplitude which was aptly termed ‘brightness-
mode’ (B-mode).  
Development of Motion-mode (M-mode) echocardiography technique soon followed. 
M-mode demonstrates temporal movement of the cardiac structures by sweeping 
the B-dots of varying brightness across the screen (Sahn et al., 1978). A key strength 
of the M-mode technique is its temporal resolution of up to 0.2 ms and ability to 
operate at high pulse repetition rates such as 5000 s-1 with each pulse generating a 
scan line of echocardiographic information (Henry et al., 1980). But an M-mode (ice-
pick) technique as a stand-alone is still limited due to lack 2D echocardiographic 
guidance. Therefore, with the M-mode cursor positioned through the base of the LV, 
M-mode technique allowed measurement of wall thickness and chamber dimension 
across the cardiac cycle (Sahn et al., 1974).  
In 1977, Devereux and Reichek reported an anatomic validation of M-mode derived 
LV measurements by carrying out a systematic analysis of the relationship between 
the ante-mortem LV echogram and necropsy anatomic LV to calculate LV mass (g) 
(Devereux and Reichek, 1977). Further work led to the development of mathematical 
models utilizing single dimensions in diastole and systole to derive LV volumes based 
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on geometric assumptions (Teichholz et al., 1976, Troy et al., 1972), but not without 
specific concerns on the assumptions (Lang et al., 2005). With the estimation of LV 
volume, it was possible to calculate ejection fraction (EF %) establishing a measure of 
global LV function. An expert consensus panel on standardisation of  M-mode 
measurements recommended the ‘leading edge to leading edge’  method to ensure 
adequate reproducibility (Sahn et al., 1978).  
Further developments utilised a number of beams to generate B-mode signals across 
an imaging sector. Typically, the B-mode technique has a temporal resolution of 20 
ms. Depth and varying intensity of brightness were allocated which gave rise to the 
first 2D moving echocardiographic images and a build up to a systematic and 
synergistic approach to standard 2D and M-mode techniques  (Henry et al., 1980). 
An added advantage of visualising the LV morphology was a more detailed and 
comprehensive assessment of LV structure and function from the acquisition of a 2D 
image using the bi-plane method of disc and the Simpson’s rule (Wahr et al., 1983, 
Stork et al., 1991).  
The accuracy of volumetric assessment over M-mode was demonstrated in vivo 
(Erbel et al., 1983) and in vitro (Helak and Reichek, 1981). At this point, 
standardization of echocardiography chamber quantification was a major concern 
due to emerging technology and study to study differences. Pragmatic 
recommendations (Sahn et al., 1978, Schiller et al., 1989) on how to measure such 
fundamental cardiac parameters became necessary to ensure consistency, clinical 
validity and reliability. In comparison with cardiac magnetic resonance (CMR), a 
systematic underestimation of absolute LV volume was demonstrated which was 
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attributed to inferior spatial resolution and the bi-plane model (Gutiérrez-Chico et al., 
2005, Mor-Avi et al., 2008b). 
With continuous improvement in image quality as a result of the introduction of 
higher frequency transducers, harmonic imaging, fully digital machines, left sided 
contrast agents and other technologic advancements in the 80’s, echo techniques 
improved dramatically. Echocardiography became the dominant cardiac imaging 
technique because of its portability, affordability and versatility (Gutiérrez-Chico et 
al., 2005, Lang et al., 2005). The American society of echocardiography (ASE), 
working together with the European Association of Echocardiography, a branch of 
the European Society of Cardiology (ESC), critically reviewed the literature and 
updated the recommendations for quantifying cardiac chambers using 
echocardiography (Lang et al., 2005).  
Given the non-invasive, compact nature, comparative low cost, absence of any 
known side effects as well as the ability to allow dynamic imaging of the heart, 
echocardiogram imaging has received wide acceptance in the sports cardiology and 
exercise physiology communities to describe the AH. It is not surprising that the 
increasing prevalence of automated techniques for sophisticated analysis has been 
driven by researchers and manufacturers of ultrasound imaging equipment. A 
number of such technologies have emerged to address image quality, accurate 
quantitative / qualitative assessments and inter observer variability in 
measurements and interpretations of cardiac data. The following sections will focus 
on new echocardiographic technologies some of which have become part of clinical 
routine and have begun to be integrated into the AH research arena. 
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APPENDIX 9.2 Traditional Echocardiographic development of the  right ventricle                                                                                                                         
Accurate assessment of the RV requires integration of multiple echocardiographic 
slices from different views, including parasternal short axis, short axis, RV inflow, 
apical 4-chamber and subcostal views (Lang et al., 2005). Earlier investigators 
proposed an approach of evaluating RV structure from an inflow and outflow 
dimension (Foale et al., 1986). Lai et al (2008) investigated the accuracy of the 
guidelines of the ASE for the two-dimensional (2D) quantitative assessment of right 
ventricular (RV) size and function against MRI-derived RV volumes in patients with 
congenital heart disease and RV volume overload and reported a weak correlation 
between 2D RV measurements by echocardiography and MRI-derived RV volumes 
(Group I: r = 0.15–0.54, Group II: r = 0.33–0.61, Group III: r = 0.32–0.85) in a normal 
RV group (Group I, n = 31), a repaired tetralogy of Fallot group (Group II, n = 33), and 
an unrepaired atrial septal defect and/or partially anomalous pulmonary venous 
connection group (Group III, n = 23) (Lai et al., 2008).  
The ASE’s guidelines and standard committee and the chamber quantification 
writing group, developed in conjunction with the European Association of 
Echocardiography, a branch of the European Society of Cardiology proposed that 
qualitative and quantitative assessment of the RV can be accomplished from the 
apical 4 chamber view (4CH). However, care must be taken to obtain a true non-
foreshortened 4CH view. For RV systolic assessment, the displacement of the 
tricuspid annulus should be observed. In systole, a tricuspid annular plane excursion 
(TAPSE) of 1.5 to 2.0 cm descent towards the apex was grouped as normal RV 
function (Alam et al., 2000, Samad et al., 2002).   
 - 199 - 
  
Given the complex geometry of the RV, direct calculation of RV ejection fraction (EF 
%) and RV volumes remained a challenging feat. Nevertheless, RV fractional area 
change (FAC) measured in the apical 4CH view as an index of RV function and 
correlated with RV EF measured with CMR (r = 0.88). RV FAC is related to disease 
outcome (Maslow et al., 2002, Zornoff et al., 2002). Extending from the anterior 
superior aspect of the RV to the pulmonary artery and including the valvular system 
is the RV outflow tract (RVOT) (see figure x adapted from Lang et al., 2005). It is 
known that the most accurate pulmonary valve (Matsukubo et al., 1977) 
measurement of the RVOT is from the parasternal short axis view (PSAX), proximal to 
the pulmonary valve (Matsukubo et al., 1977, McKenna et al., 1988).  
Furthermore, the examination of the inferior vena cava (IVC) from the subcostal view 
and with a long axis orientation of the transducer contributes to a comprehensive 
assessment of the RV. It allows an accurate assessment of the diameter of the IVC 
and the percent decrease in the diameter during expiration i.e. the collapsibility 
index which correlates with right atria (RA) pressure (Moreno et al., 1984). 
Additional assessment of RV function includes Tissue Doppler imaging (TDI) of 
tricuspid annular velocity (Nagueh et al., 1997, Sutherland et al., 1999). Despite 
these echocardiographic advancements, the assessment of the RV was not uniformly 
carried out and research output remained comparatively low partly due to a lack of 
familiarity with ultrasound techniques that can be used in imaging the RV, and a 
paucity of ultrasound studies providing normative data of right heart size and 
function (Lang et al., 2005, Rudski et al., 2010).  
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 APPENDIX 9.3 Pulsed-Wave Doppler                                                                                                                                          
The development of pulsed-wave Doppler (PWD) combined with 2D imaging allowed 
for evaluation of all 4 cardiac valves as well as cardiac shunts (Matsuo et al., 1977, 
Goldberg et al., 1982) and the ability to evaluate LV filling. Kitabatake and colleagues 
(1982) demonstrated early (E) and late (A) diastolic components and their ratio in 
healthy subjects, hypertension, hypertrophic cardiomyopathy (HCM) and old 
myocardial infarction patients, and reported that healthy individuals have higher 
early diastolic flow velocities when compared to cardiac pathologies (Kitabatake et 
al., 1982).          
 Subsequent guidelines highlighted specific patterns of LV diastolic 
dysfunction (Rakowski et al., 1996). Because PWD offers good inter and intra-
observer variability with a high temporal resolution (Rakowski et al., 1996, Nagueh et 
al., 1997, Ruan et al., 2006), its usefulness as an indicator of global diastolic function 
is widely adopted (Nagueh et al., 2009). However, it is important to note that 
intrinsic properties of the LV – relaxation, compliance, and mitral valve (MV) function 
are encompassed within a global surrogate of LV filling defined by PWD, rather than 
specific elements of LV diastolic function (Nagueh et al., 2009, Mor-Avi et al., 2011). 
Fisman et al (1997), (2002) documented that athletes have significantly greater peak 
flow velocity when compared to controls whereas MacFarlane et al (1991) reported 
no defference between athletes and controls (MacFarlane et al., 1991, Fisman et al., 
1997, Fisman et al., 1990, Ben-Ari et al., 1993).  
Despite this PWD has been used widely in the athletic heart literature since the late 
1980’s to the point where it was included in the meta-analyses of Pluim et al (2000) 
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and Whyte et al (2004). Further technological advancements to extend the 
assessment and segregation of global and regional myocardial properties, led to the 
development of Tissue Doppler Imaging (TDI).  
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Appendix 9.4 Table 9.1: Quality checklist for all studies [Adapted from STROBE 
Statement; (von Elm et al., 2008), PRISMA Statement; (Moher D et al., 2009)].
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Appendix 9.5 Strobe statement— Guideline for reporting of observational studies 
(Von Elm et al., 2008). 
 
Item 
No Recommendation 
 
Title and abstract 1 (a) Indicate the study’s design with a commonly used term 
in the title or the abstract 
YYes 
(b) Provide in the abstract an informative and balanced 
summary of what was done and what was found 
YYes 
Introduction  
Background/rationale 2 Explain the scientific background and rationale for the 
investigation being reported 
YYes 
Objectives 3 State specific objectives, including any prespecified 
hypotheses 
YYes 
Methods  
Study design 4 Present key elements of study design early in the paper YYes 
Setting 5 Describe the setting, locations, and relevant dates, including 
periods of recruitment, exposure, follow-up, and data 
collection 
YYes 
Participants 6 (a) Cohort study—Give the eligibility criteria, and the 
sources and methods of selection of participants. Describe 
methods of follow-up 
Case-control study—Give the eligibility criteria, and the 
sources and methods of case ascertainment and control 
selection. Give the rationale for the choice of cases and 
controls 
Cross-sectional study—Give the eligibility criteria, and the 
sources and methods of selection of participants 
YYes 
(b) Cohort study—For matched studies, give matching 
criteria and number of exposed and unexposed 
Case-control study—For matched studies, give matching 
criteria and the number of controls per case 
YYes 
Variables 7 Clearly define all outcomes, exposures, predictors, potential 
confounders, and effect modifiers. Give diagnostic criteria, if 
applicable 
YYes 
Data sources/ 
measurement 
8*  For each variable of interest, give sources of data and 
details of methods of assessment (measurement). Describe 
comparability of assessment methods if there is more than 
one group               – Controls – Yes; Athlete groups – Yes 
YYes 
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Bias 9 Describe any efforts to address potential sources of bias YYes 
Study size 10 Explain how the study size was arrived at YYes 
Quantitative variables 11 Explain how quantitative variables were handled in the 
analyses. If applicable, describe which groupings were 
chosen and why 
YYes 
Statistical methods 12 (a) Describe all statistical methods, including those used to 
control for confounding 
YYes 
(b) Describe any methods used to examine subgroups and 
interactions 
YYes 
(c) Explain how missing data were addressed                           
Not applicable 
 
(d) Cohort study—If applicable, explain how loss to follow-up 
was addressed 
Case-control study—If applicable, explain how matching of 
cases and controls was addressed 
Cross-sectional study—If applicable, describe analytical 
methods taking account of sampling strategy 
YYes 
(e) Describe any sensitivity analyses YYes 
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Appendix 9.7 Participant information sheet 
 
The “athletic heart”: insights from modern imaging tools in Caucasian and West 
African Athletes. 
Victor Utomi – Research Institute of Sport & Exercise Sciences 
You are being invited to take part in a research study. Before you decide it is important that 
you understand why the research is being done and what it involves. Please take time to 
read the following information. Ask me if there is anything that is not clear or if you would 
like more information. Take time to decide if you want to take part or not. 
1. What is the purpose of the study? 
The purpose of this study is to characterise the structural and functional changes of the 
athlete’s heart in a diverse groups of sportsmen and women using state state-of-the-art 
imaging technology. Initial research suggested that cardiac adaptation to exercise follows 
two types of outcomes as eccentric or concentric hypertrophy subsequent to endurance or 
strength exercise, respectively. Recently, expert commentary and the development of new 
highly-accurate imaging equipment have resulted in the need to re-evaluate the old 
hypothesis of cardiac adaptation to exercise training. New insights from novel imaging tools 
will provide in-depth data about cardiac structure and function in athletes with different 
training backgrounds as well as from different ethnic groups.  Results from this research will 
provide useful information for clinical cardiovascular screening of athletes. 
2. Do I have to take part? 
No. It is up to you to decide whether or not to take part. If you do you will be given this 
information sheet and asked to sign a consent form. You are still free to withdraw at any 
time and without giving a reason. A decision to withdraw will not affect your rights or any 
future service you receive. 
3. What will happen to me if I take part? 
 
LIVERPOOL JOHN MOORES UNIVERSITY 
PARTICIPANT INFORMATION SHEET 
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The study will involve visiting the sports science labs at LJMU or a field-based laboratory to 
carry out some tests on only one occasion. Prior to your arrival, you will need to fill in a 
personal and family history medical questionnaire and sign a consent form.  
The testing session will initially involve measurement of your height and your weight. Next 
you will have an electrocardiogram (ECG), which is a simple, non invasive and painless test 
that examines the electrical activity within your heart. The ECG test involves lying down 
quietly and it takes 5-10 minutes only. Small stickers are placed at strategic points on your 
chest, arms and legs. Flexible leads (known as electrodes) that extend from the ECG machine 
are then attached to these stickers. The electrical rhythm of your heart is recorded and 
printed out. After this, your resting blood pressure (BP) will be measured from a cuff tied to 
your upper arm with a painless automated sphygmomanometer. Finally, you will lie down 
quietly to have an echocardiogram. An echocardiogram is very similar to the ultrasound scan 
that is used for a pregnant woman to check the health of her baby. In this study, an 
echocardiogram will be used to measure the dimensions of the heart and the flow of blood 
in and out of the heart. The echocardiogram will normally take 30 minutes. 
4. Does it hurt?  
Both the ECG and echocardiogram are painless, non-invasive procedures. 
5. Do I need to prepare anything prior to my appointment? 
You should rest for at least 30 minutes prior to your appointment.  Please avoid caffeine 
intake or strenuous exercise for 3 hours prior to testing. 
6. Are there any risks / benefits involved? 
There are no known risks or hazards to electrocardiography and ultrasound at diagnostic 
frequency. You will gain valuable information on your current state of your own hearts 
structure, function and electrical activity. This is not a formal health screening examination 
but if the data collected suggests a medical problem we will provide information to your GP 
with your agreement.  
7. Will my taking part in the study be kept confidential? 
All of the data collected will be anonymised so that your identity will not be revealed. All 
data will be stored on a password protected computer system and any paperwork stored in 
a locked cabinet for a specified time period.  
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Contact Details of Researcher  
If you have any questions relating to any of the techniques used during the research study 
please feel free to contact me to discuss this further. Participation in this research study is 
voluntary and you are free to withdraw at any time without prior explanation.  
Dr Victor S. Utomi (MBBCH, MSc, AFHEA)     
 PHD Candidate         
 School of Sport & Exercise Sciences      
 Liverpool John Moores University      
 Henry Cotton Campus        
 15-21 Webster Street        
 Liverpool L3 2ET        
 V.S.Utomi@2011.ljmu.ac.uk       
 +447427238373       
 +2347068110553 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 - 217 - 
  
Appendix 9.8 Consent form 
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Appendix 9.10 Ethics approval document 
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Appendix 9.11 Normal training related ECG findings – ‘Seattle’ criteria (Drezner et 
al., 2013).     
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 ECG Change Definition 
Sinus Bradycardia HR < 60bpm 
First Degree AV Block PR interval > 200ms 
Incomplete RBBB QRS <120ms 
Early Repolarization Max ST-J elev >=1mm and notching / slurring of terminal QRS 
complex   
LVH on voltage criteria RV5 + SV1 >35 mm - Sokolow Criteria 
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Appendix 9.12: Abnormal ECG - Seattle Criteria (Drezner et al., 2013).  
   
Abnormal (group 2) ECG criteria 
 
Definition 
T-wave Inversion > 1 mm deep in 2 or more leads V2-V6, II 
and aVF, or I and aVL 
ST Segment Depression  ≥ 0.5 mm deep, ≥ 2 adjacent leads 
Pathological Q-waves > 3mm deep and/or > 40 ms duration in ≥ 
leads except III and aVR  
Left Atrial Enlargement Negative portion of P wave ≥1mm in V1/2 
and P duration >120 ms 
Left-axis Deviation  -30˚ to 90˚ 
Right-axis Deviation >110˚ 
Right Ventricular Hypertrophy RV1 + SV5 > 10.5 mm AND RAD >120˚ 
Right Atrial Enlargement: P wave  >2.5 mm tall in II, III or aVF 
Ventricular Pre-excitation PR interval < 120ms with a delta wave in 
QRS 
IVCD Any QRS ≥140 ms including complete LBBB 
Long QT Interval QTc ≥ 470 (M) or ≥ 480 (F) 
Short QT Interval QTc < 320 ms 
Brugada like ECG pattern Brugada coved & ST amplitude J/J+80 >1 in 
V1 - V3 
Profound Sinus Bradycardia  <30 bpm 
Atrial tachyarrhythmias SVT, atrial fibrillation/flutter  
Ventricular Extra-systoles Couplets, triplets, NSVT  
 
 
 
